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ABSTRACT 
 
 
 Urinary tract infections (UTIs) are common bacterial infections, affecting nearly 
half of all women.  The vast majority of UTIs are caused by a heterogeneous collection of 
extraintestinal pathogenic Escherichia coli (ExPEC) strains referred to as uropathogenic 
E. coli (UPEC).  Unlike some pathogens, UPEC do not have a fixed set of virulence and 
fitness factors associated with uropathogenesis.  Thus, biological covariance especially 
predominates in uropathogenesis, and UPEC use a variety of virulence and fitness factors 
to perform essentially the same functions (colonize the urinary tract and establish 
infection).  There are also a number of genetic networks connecting UPEC virulence and 
fitness genes, and gaining any traction understanding UPEC virulence genes and 
virulence gene regulation forces one to gain a better understanding of these networks.  
One of these networks is the reciprocal regulation network connecting E. coli motility-
and adhesin-encoding genes.  It is widely believed that when adhesin genes are expressed, 
motility genes are repressed, and when motility genes are expressed, adhesin genes are 
repressed. 
 The UPEC strain CFT073 genome includes the tos operon, which encodes the 
regulatory, secretion, and adherence machinery of a repeats-in-toxin (RTX) nonfimbrial 
adhesin, TosA (for type one secretion protein A).  This nonfimbrial adhesin promotes 
xx 
 
UPEC adherence to host cells derived from the upper urinary tract and is expressed 
primarily in vivo.  However, little else was known about why the tos operon is 
preferentially repressed in vitro.  I hypothesized that regulators encoded in the tos operon, 
regulators encoded elsewhere in the E. coli genome, and environmental conditions 
encountered in the urinary tract mediate tos operon regulation.  It is also my hypothesis 
that reciprocal regulation of adhesin and motility genes is an integral part of tos operon 
regulation, and regulators encoded in the tos operon are participants in this regulatory 
network.  Using a variety of in vitro approaches, I identified that TosR, a member of the 
PapB family, is a tos operon dual positive and negative regulator.  In addition, I found 
that the tos operon promoter, Ptos, is located upstream of tosR, and there are at least two 
TosR binding sites in the vicinity of Ptos.  Nucleoid-associated proteins H-NS and Lrp, 
both associated with adherence and motility reciprocal regulation, also serve a function in 
negative and positive regulation of the tos operon, respectively.  High levels of leucine 
inhibit positive regulation of the tos operon.  Therefore, the tos operon may also be 
responsive to environmental conditions encountered in the urinary tract (low leucine).  
TosEF, encoded by two genes in the tos operon, were found to suppress motility by 
inhibiting FliC production, and TosR additionally inhibits P fimbria production while 
promoting curli and/or cellulose production.  Thus, tos operon regulation is also coupled 
to adherence- and motility-related gene reciprocal regulation.  Our work has both 
explained tos operon regulation and expanded current knowledge of reciprocal regulation 
to now include RTX nonfimbrial adhesin genes.          	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CHAPTER 1 
INTRODUCTION 
 
 
Urinary tract infections 
 
The burden to public health  
 Nearly half of all women will experience at least one urinary tract infection (UTI) 
in their lifetime (1), and almost a quarter of all women experiencing one UTI will 
experience recurrent UTIs (2).  Coincidental with the prevalence of UTIs, these infections 
result in numerous visits to healthcare providers resulting in annual direct costs of at least 
$3.5 billion (3).  This figure, however, would greatly increase if indirect costs of UTI 
were included (4-6).  In addition, with the rise of antibiotic resistance among organisms 
causing UTIs (6-9), both direct and indirect costs will surely increase as these infections 
become refractory to classical treatments. 
 
Sites of infection and identification  
 The urinary tract itself can be divided into the upper and lower urinary tract.  The 
upper urinary tract consists of the kidneys and ureters, and the lower urinary tract consists 
of the bladder and urethra.  UTIs occur in either division of the urinary tract, but most
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frequently UTIs occur when bacteria colonizing the GI (gastrointestinal) tract access the 
urethra and ascend to the bladder (1, 10, 11).  Bladder colonization by an uropathogen 
usually results in a self-limiting infection, cystitis (12, 13).  However, bacteria can ascend 
to the kidneys leading to a more severe infection, acute pyelonephritis (12-15).  It is also 
possible for bacteria to cross the kidney tubules and capillary endothelium into the 
bloodstream, leading to bacteremia and potentially fatal urosepsis (12-15). 
 Signs and symptoms of UTI vary among individuals, especially when considering 
the mental state, but in the case of lower UTIs these might include urinary urgency, pain 
associated with voiding urine, low-grade fever, and noticing changes in urine 
characteristics (i.e., noticing blood, strong odors, and urine turbidity) (16, 17).  In the 
case of upper UTIs, additional signs and symptoms might include high-grade fever, 
malaise, flank pain, nausea and vomiting, and renal impairment (17-19).  In addition to a 
history of these signs and symptoms, diagnosis of a UTI often occurs by microscopic 
observation of neutrophils and bacteria in the urine, detection of nitrites and leukocyte 
esterases with a urinalysis dipstick, and positive urine cultures (lower limit ≥102 CFU/mL 
[colony forming units per mL]) (16, 17). 
 
Classification and causative organisms of UTIs  
UTIs can be classified as complicated or uncomplicated.  Complicated UTIs occur 
in association with urinary tract obstruction, presence of instrumentation (e.g., a catheter), 
impaired voiding, metabolic abnormalities, and being immunocompromised (20, 21).  In 
addition, a UTI during pregnancy is sometimes classified as a complicated UTI (21), but 
3 
 
debate about this classification remains ongoing.  An uncomplicated UTI occurs in an 
otherwise healthy individual (i.e., in the absence of the complicating features above).  
While numerous bacterial species cause UTIs, species often include Escherichia coli, 
Proteus mirabilis, Klebsiella pneumoniae, and Staphylococcus saprophyticus (22-24).   
 
 
Uropathogenic E. coli (UPEC) and the plurality of virulence factors 
 
UPEC are extraintestinal pathogenic E. coli (ExPEC) 
The overwhelming majority of uncomplicated UTIs (≥80%) are caused by 
uropathogenic E. coli (UPEC) (1, 13, 22, 24, 25).  As the urinary tract is not directly 
continuous with the gastrointestinal tract, by definition UPEC form a subgroup of 
extraintestinal pathogenic E. coli (ExPEC) (26, 27).  However, of all ExPEC strains, 
many colonize sites outside of the urinary tract (26, 27); therefore, the UPEC-ExPEC 
equivalence is not generalizable (i.e., not all ExPEC are UPEC).  In principle, ExPEC can 
be found in any one of the five E. coli phylotypes (referred to as A, B1, B2, D, and E).  
Nevertheless, most known UPEC (and ExPEC) strains are part of the B2 and D lineages 
(25, 28-30).  Indeed, among the most studied UPEC strains (CFT073, UTI89, and 536), 
all are part of the B2 lineage (30).  UPEC strains CFT073 and 536 are pyelonephritis 
isolates, and UTI89 is a cystitis isolate (31). 
 
UPEC diversity 
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While all UPEC are E. coli, there is substantial diversity among E. coli strains 
(32-36).  Indeed, UPEC strain CFT073 has an extra 590,209 bp of chromosomal DNA, 
compared with the commensal E. coli strain MG1655 (36).  One source of such diversity 
is horizontal gene transfer, whereby E. coli acquires foreign DNA through plasmids, 
other episomes (e.g., ICEs [integrative and conjugative elements]), and phage-mediated 
transduction (37, 38).  Many fitness or virulence factors are often encoded in genes 
harbored on pathogenicity islands (PAIs), which are predicted to be horizontally acquired 
genetic elements, 30-100 kbs (kilobases) long, with GC content typically differing from 
that of the E. coli backbone chromosome (39-43).  Of note, but not surprising given the 
genetic diversity discussed above, a well-defined core complement of virulence and 
fitness factors does not exist among UPEC strains (32-36, 40).  Indeed, some UPEC 
virulence or fitness factors are present among avirulent commensal E. coli strains (33-35, 
40).  Nevertheless, some virulence and fitness factors are outlined in Figure 1-1 and 
include iron acquisition systems, secreted toxins, specific metabolism pathways, motility 
systems, fimbrial adhesins, and nonfimbrial adhesins (23, 31-36, 39, 40, 44, 45).  Thus, it 
can be seen that gaining a complete picture of urovirulence and uropathogenesis requires 
one to focus on the combination of many distinct types of virulence factors and possibly 
complex regulatory networks connecting them.  In this work, to remain sharply focused, 
only secreted toxins, metabolism, motility systems, fimbrial adhesins, and nonfimbrial 
adhesins will be discussed. 
 
Secreted toxins 
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Figure 1-1.  UPEC have a variety of virulence and fitness factors to promote UTI.  
Factors classically associated with UPEC virulence and fitness include flagella, adhesins, 
LPS (lipopolysaccharide), capsule, iron acquisition systems, and secreted toxins.  Also 
depicted is a representation of systems not classically associated, or associated in 
nontrivial ways, with UPEC virulence.  These systems include central metabolism, cell 
and DNA replication, and sophisticated gene regulation networks. 
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 The hemolytic activity of some extraintestinal E. coli isolates is a well-known 
phenotype, associated with virulence, and is mediated through HlyA (α-hemolysin) (46, 
47).  Importantly, HlyA is the prototype of the RTX (repeats-in-toxin) family of secreted 
proteins (48).  The RTX family itself harbors a diverse array of proteins with functions 
that include cell lysis, cell-to-cell adherence, lipase activity, and metalloprotease activity 
(49, 50).  All RTX proteins are identified by a glycine- and aspartate-rich repeat 
(GGXGXD) near the C-terminus (carboxy-terminus) of the protein (48-51) and are 
unified by a single method of secretion (type 1 secretion) (49).  Others have already 
speculated that the significance of these repeats is to coordinate the binding of divalent 
metal cations (particularly Ca2+), which facilitates extracellular folding (49, 50).  HlyA, 
in particular, contains 13 tandem repeats of the RTX sequence near its C-terminus, and 
extracellular Ca2+ is associated with HlyA activity (51-54).  
The genes necessary for hemolytic activity and secretion of HlyA are harbored in 
the hly operon (hlyCABD) (55).  HlyC, in conjunction with the ACP (acyl carrier protein), 
mediates acylation of HlyA (56-60).  Acylation of HlyA (at K564 and K690) is necessary 
for host membrane binding and possibly HlyA oligomerization (59-62).  HlyA is the 
RTX cytolysin encoded by the operon.  In addition to erythrocyte lysis (53, 54), this 
protein is cytotoxic toward granulocytes (63, 64), monocytes, and to a lesser extent 
lymphocytes (64).  At the same time, HlyA promotes lysis of renal proximal tubular cells 
(65) and promotes damage and hemorrhaging in the uroepithelium and bladder during 
experimental infection (66).  In addition to cytolysis, HlyA may perturb host cell 
membrane signaling through Akt, a protein kinase.  In particular, HlyA stimulates 
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dephosphorylation of Akt, which perturbs the host inflammatory response and impairs 
host cell survival (67).  Others have shown that HlyA perturbs host cell proteolysis 
pathways, which affects host cell survival, the host cell cytoskeleton, and the 
inflammatory response (68).  
HlyA secretion depends on HlyB, HlyD (both encoded in the hly operon), and 
TolC (encoded at another locus) (69-72); these three genes form the basis of a 
prototypical type 1 secretion system (69).  The order of HlyA secretion events follows.  
HlyB dimers recognize a poorly characterized signal at the C-terminus of HlyA (69, 73, 
74); at least some of the recognition of the HlyA secretion cargo, in addition, may be 
through an HlyB-HlyD complex (69, 75).  Upon ATP binding, an HlyB conformational 
change occurs (69, 74, 75), and HlyA enters the HlyD periplasmic channel with limited 
exposure to the periplasm itself (69, 75-77); trimers of HlyD form a stable complex with 
the outer membrane pore protein, TolC (69, 75).  While in the HlyD secretion channel, it 
is predicted that HlyA begins folding into its native conformation, partially assisted by 
HlyD itself (78).  Subsequently, HlyA exits the channel through TolC, and the secretion 
system is ready for another round of secretion following ATP hydrolysis in the HlyB 
dimers (69).  At some point, the proton motive force may contribute to HlyA secretion, 
but the precise mechanism of this contribution is poorly understood (69, 70). 
Additional toxins found in some UPEC strains include CNF1 (cytotoxic 
necrotizing factor 1) and the SPATE (serine protease autotransporter of 
Enterobacteriaceae) toxins (23, 44).  CNF1 causes cytopathic effects in a variety of cell 
types derived from the upper and lower urinary tract (79).  During an experimental UTI, 
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CNF1 also promotes bladder inflammation and submucosal edema (66).  Many of the 
CNF1-mediated host cell toxic effects proceed through reactive oxygen species-mediated 
damage to the uroepithelium; these reactive species are hypothesized to originate from 
neutrophils succumbing to actin cytoskeleton remodeling by CNF1 (80, 81).   
Sat (secreted autotransporter toxin) is a SPATE family member and toxin that 
mediates vacuole formation in cultured cells derived from the upper and lower urinary 
tract (82, 83).  Of note, kidney cells appear to be markedly susceptible to Sat, suggesting 
that Sat may have some function during upper UTI.  Pic (protein involved in 
colonization) is another SPATE family member expressed during UTI and associated 
with around 15% and 31% of cystitis and pyelonephritis strains, respectively (84).  This 
suggests that Pic serves some important function during UTI.  Vat (vacuolating 
autotransporter toxin), similar to Sat, is another member of the SPATE family that 
mediates vacuolation of host-derived cells (85).  Tsh (temperature-sensitive 
hemagglutinin), although considered a SPATE protein and exhibits some proteolytic 
activity (86), mediates E. coli adherence to erythrocytes, hemoglobin, and extracellular 
matrix proteins (87-89).    
 
Metabolism  
 Although not traditionally classified as a mediator of virulence, UPEC 
metabolism in the urinary tract is a critical contributor to uropathogenesis (90, 91).  
Indeed, gluconeogenesis and the TCA cycle are required during UTI, but are predicted to 
be less important during colonization in more nutrient-rich sites, such as the GI tract (90, 
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91).  Amino acid catabolism is important for UPEC growth in urine and the urinary tract 
(90, 91).  It is of note that metabolic state (i.e., growth in nutrient deplete or replete 
conditions) can be communicated to the UPEC cell in the form of DNA supercoiling and 
differential nucleoid geometry (i.e., promoted by different nucleoid structuring proteins 
discussed below), both of which contribute to gene regulation (92-109).  Thus, a single 
“metabol-nucleoid” phenomenon integrating metabolism, DNA supercoiling, and 
geometry of the nucleoid may be contributing to how genes are regulated in a variety of 
situations E. coli may encounter. 
 
Motility 
 Motility is an important phenomenon during UTI.  Indeed, nonmotile UPEC 
mutants are outcompeted by the parental wild-type strain in a murine model of ascending 
UTI (110, 111).  For instance, nonmotile UPEC cells colonize the kidneys at low levels 
(112).  In this same pursuit, imaging studies have shown that flagellar gene expression is 
coincident with ascension into the upper urinary tract and transient in nature (112).  
Intriguingly, however, flagellar genes are downregulated during an experimental UTI 
(113) and human infection (114).  However, examining gene expression during 
experimental and human UTI, at present, only accounts for a population-level description 
of gene expression (i.e., there is no temporal or spatial information in these data).  
Therefore, it is predictable that population heterogeneity exists for flagellar gene 
expression.  Likewise, a kinetics study following bladder and kidney colonization during 
an experimental UTI found heterogeneity among sequence tagged lineages arriving in the 
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kidney (i.e., not necessarily reflective of the abundance of constructs in the bladder) (115).  
This also supports a model of flagellar gene expression heterogeneity, as this organelle is 
important for kidney colonization.   
 Flagellar assembly occurs in a highly organized fashion.  Indeed, three discrete 
flagellar gene classes (class I, class II, and class III) are responsible for flagellar gene 
expression and assembly (116-119).  Class I genes encode the master flagellar operon 
regulators FlhD and FlhC (116-119).  A multimeric complex of FlhDC (FlhD4C2) is 
responsible for activation of class two flagellar genes (116-119).  Class II flagellar genes 
encode FliA (σ28), FlgM (anti-σ28), the flagellar basal body, and the flagellar hook (116-
119).  Upon basal body and hook assembly, FlgM is secreted from the cell, and FliA 
promotes the expression of class III flagellar genes (116-119).  Class III genes encode 
proteins involved in hook-filament assembly, the flagellar filament (FliC), the flagellar 
cap (FliD), the flagellar motor proteins (MotAB), and several proteins involved in 
bacterial chemotaxis (116-119). 
 Flagellar-mediated motility, often coupled with chemotaxis, occurs when E. coli 
peritrichous flagella are bundled together through coherent counterclockwise flagellar 
and flagellar motor rotation (120, 121); noncoherent and clockwise rotation of flagella 
results in tumbling motion of the bacterium (120, 121).  Methyl-accepting chemotaxis 
proteins, involved in the sensing of attractants and repellants, include Trg, Tar, Tsr, and 
Tap (122-126).  Trg senses saccharides (122, 124); Tar and Tsr sense amino acids (122, 
123, 126); Tap senses dipeptides (122, 125).  It is of note, however, that the trg and tap 
are often not present or severely mutated in UPEC strains (127), which suggests some 
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common ancestry among UPEC strains and that these receptors are not necessary for 
UPEC lifestyles.  Upon attractant binding to a chemotaxis sensor above, a phosphorylated 
CheB will mediate demethylation of one of these sensors and reduce the activity of the 
CheA kinase (120, 121).  Reduced CheA kinase activity will result in less CheY 
phosphorylation (enhanced by CheZ dephosphorylation), and the flagellum and flagellar 
motor will remain in counterclockwise motion (120, 121).  However, upon binding of a 
repellent (or attractant diffusion from the chemotaxis sensor) CheR promotes methylation 
of this sensor and continued kinase activity of CheA (120, 121).  This in turn promotes 
CheY phosphorylation and clockwise rotation of the flagellum and flagellar motor (120, 
121).       
It is intriguing to speculate that flagellar-mediated motility, like flagellar 
assembly, is highly coordinated, especially with other UPEC lifestyles.  Indeed, flagella 
are highly immunogenic and recognized by toll-like receptor 5 (128).  Therefore, it would 
be of some advantage to E. coli if part of the cell population could swim (albeit be 
detectable by the host immune system) and another part of the population be nonmotile 
for a period of time (but refractory to some host immune system sensors) (129).  In 
addition, as reviewed below and in Figure 1-2, adherence and motility are reciprocally 
regulated.  Thus, this is another manner in which flagellar-mediated motility could be 
highly coordinated, especially with other UPEC lifestyles.   
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Figure 1-2.  Motility and adherence are coordinated phenotypes.  (A) A 
representation of the phenomenon of motility and adherence reciprocal regulation is 
depicted.  Pink inhibition bars represent the possibility that some regulation could be 
indirect.  (B) A predicted representation of motility and adherence reciprocal regulation 
as a curve is shown.  Motility and adherence are abstracted to form orthogonal axes, and 
cellular behavior is abstracted to the indicated blue curve.  Green cells with multiple 
flagella represent a regime where the cells are preferentially motile and less adherent; red 
cells showing multiple surface adhesins represent the regime where cells are 
preferentially adherent, and yellow cells with flagella and surface adhesins represent a 
regime where cells may transiently show limited preference between the other two 
regimes.  This third regime could represent a transition period (i.e., into another regime or 
back into a previous one). 
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c-di-GMP (cyclic-di-GMP) and motility  
The universal bacterial second messenger c-di-GMP (cyclic-di-GMP) contributes 
to the coordination of flagellar-mediated motility (130-132).  Enzymes with diguanylate 
cyclase activity, often containing a conserved GGDEF (glycine-glycine-aspartate-
glutamate-phenylalanine) motif, mediate the formation of c-di-GMP from two GTP 
molecules; enzymes with phosphodiesterase activity, often containing a conserved EAL 
(glutamate-alanine-leucine) motif, mediate c-di-GMP degradation (130-132).  At high 
c-di-GMP levels, flagella-mediated motility is reduced (130-132).  This effect is 
mediated through both reducing flagellar levels (130-132) and decreasing flagellar motor 
rotation (133).  However, regulation by c-di-GMP binding and metabolism enzymes is 
complex.  For example, YdiV, containing a degenerate EAL domain, may instead serve a 
function during the repression of flagellar operons (134).  In addition, any one bacterial 
species may harbor many genes encoding proteins with diguanylate cyclase and 
phosphodiesterase activities (131, 135, 136), furthering this regulatory complexity.  
Nevertheless, most diguanylate cyclases and phosphodiesterases are linked either directly 
or indirectly (such as through two-component systems) to a variety of environmental 
signals (130, 131, 137).  The levels of c-di-GMP also rise upon entry into stationary 
phase (138), which suggests that some of these systems may be coupled to cell growth 
phase and reduced motility during stationary phase (139).  The effect of c-di-GMP levels 
on adhesin operons will be discussed below.    
 
Adhesins    
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 UPEC adherence is an important virulence property during UTI, especially to 
overcome the flow of urine.  It is of note that adherence, especially in the context of a 
biofilm, is a key component of microbial multicellularity (131, 140-142).  Of all UPEC 
adhesins, fimbrial adhesins have been the most extensively studied.  Some UPEC strains 
encode genes for the synthesis of as many as 11 distinct fimbrial adhesins (34, 36).  
Indeed, a plethora of diverse fimbrial operons is typical of UPEC strains, compared with 
nonpathogenic E. coli (34).  UPEC strains encode an average of eight fimbrial types, 
compared to an average of three fimbrial types for commensal E. coli (34).  Fimbriae, 
like flagella, are multimeric extracellular organelles and are assembled through a 
chaperone-usher pathway (143).   Of the variety of fimbriae synthesized by UPEC, Type 
1, P, F1C fimbriae, and biofilm mediated adherence will be reviewed below. 
 
Type 1 fimbria 
Type 1 fimbriae are associated with almost all E. coli strains (i.e., no differential 
prevalence among pathogenic and nonpathogenic strains) (144).  As with other fimbriae, 
the fim operon and locus harbors genes necessary for regulation of the fim operon, 
assembly of a chaperone-usher secretion system, and fimbrial assembly (145-147).  
Coupled with nucleoid structuring proteins, FimB and FimE are two recombinases 
involved in phase variation (flipping) of the fimS invertible element, containing PfimA, at 
two inverted repeat sequences bracketing this element (148-152).  FimB mediates the 
ON-to-OFF or OFF-to-ON inversions of fimS, and FimE preferentially mediates the 
ON-to-OFF inversion of fimS (148-150, 152).  The involvement of nucleoid structure in 
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this process will be discussed below.  In addition to FimBE, the chaperone-usher system 
(assembly machinery), major fimbrial subunit (stalk protein), and tip adhesin are all 
encoded by the remaining fim operon genes (fimAICDFGH) (Figure 1-3A) (143, 145-147, 
153-157).  Multimers of FimA comprise the majority of a Type 1 fimbria, and FimFGH 
form the tip adhesin complex (143, 153, 157).  FimH is the major adherence element of 
Type 1 fimbria (153, 157).  The FimH adhesin tip binds to a mannoside moiety found 
associated with a variety of surface glycoproteins and glycolipids (158-162).  Some work 
has explored the selective pressure on the FimH adhesin tip and urovirulence.  Greater 
urovirulence is seen for some FimH variants conferring stronger mannose binding (163).  
However, there does appear to be some fitness cost associated with such FimH variants at 
other sites in a host (163), which suggests that selective pressures and fitness costs are not 
always uniform at all sites in a host and must be balanced by ExPEC. 
 Type 1 fimbria is a well-established virulence factor, especially in the murine 
model of UTI (163-167).  Given the near universal prevalence of Type 1 fimbriae (among 
E. coli strains), however, it seems more likely that the combinations of Type 1 fimbria 
with other virulence determinants are more important than Type 1 fimbria alone.  
Furthermore, during experimental murine UTI, UPEC strains appear to differ in their 
ability to control the fimS invertible promoter element (166, 168, 169).  In particular, F11 
(cystitis strain) favors the ON inversion, and the ON inversion is less favored by CFT073 
(pyelonephritis strain) late in an experimental infection (166, 169).  The importance of 
Type 1 fimbria during human infection is poorly understood; low expression of the fim 
operon is sometimes observed during human UTIs (114).  However, as these expression 
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Figure 1-3. Representation of the structure of several adhesin operons.  (A) The fim 
operon encoding the genes for assembly of Type 1 fimbria is represented to scale.  The 
fim regulatory genes are depicted in blue, structural subunit genes are depicted in purple, 
the chaperone gene is represented in maroon, the usher is shown in orange, and the 
adhesin tip components are shown in yellow.  (B) The pap operon genes necessary for 
assembly of P fimbria are represented to scale.  As above, the color of each pap operon 
gene represents the function of the encoded protein.  (C) Genes of the foc operon 
responsible for the assembly of F1C fimbria are represented to scale.  The color of each 
gene in the foc operon, as above, represents the function of the encoded protein. 
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studies lack temporal-spatial data, it seems probable that subpopulations of E. coli 
expressing the fim operon may be found during infection. 
 
P fimbria 
 The genes necessary to produce P fimbria were among the first cloned virulence 
factor genes (145).  Unlike Type 1 fimbria, P fimbriae are epidemiologically associated 
with pathogenic E. coli strains (34, 170-177).  As is the case for Type 1 fimbria, nearly 
all genes necessary for P fimbrial operon regulation, secretion, and assembly are encoded 
by the pap operon (pap, pyelonephritis associated pilus) (143, 178-181).  PapI and PapB 
are two regulators involved in perturbing nucleoid structure to mediated pap operon 
negative and positive regulation (152, 179-181).  PapB is hypothesized to overcome 
H-NS (heat-stable nucleoid structuring protein) silencing by binding near PpapI and 
mediating papI expression (positive pap regulation) (181).  At sufficiently high levels, 
PapB binds to and represses PpapBA (negative pap regulation) (180).  Thus, PapB control 
over the pap operon exhibits examples of both positive and negative feedback regulation 
(depending on the DNA binding context) (180, 181).  PapB may mediate DNA binding 
through forming an oligomer on an AT-rich region in the vicinity of both PpapI and PpapBA, 
which does not contain inverted repeats often recognized by other regulators (182).  
Instead, it seems likely that PapB recognizes DNA structure over a specific DNA 
sequence (182).  PapI, on the other hand, acts to control Lrp (leucine-responsive 
regulatory protein) binding to two GATC sites (Dam-mediated methylation sites) (152, 
179, 183).  Lrp is both a positive and negative regulator of the pap operon (152, 179, 
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183), and the specific mechanism of this regulation will be explored below.  It is also 
intriguing to speculate that epigenetic regulation of the pap operon, through DNA 
methylation, could couple DNA replication to this process (184). 
 The remaining genes of the pap operon (papAHCDJKEFG) encode the 
chaperone-usher system, major fimbrial subunit, and tip adhesin (Figure 1-3B) (143, 178, 
185).  An additional gene, papX, regulates motility as discussed below (186-188).  The 
major structural unit of P fimbria is composed of PapA multimers (143, 178, 185), and 
the P fimbrial adhesin tip is composed of PapK, PapE, and PapG subunits (143, 178, 185).  
The PapG tip mediates binding to a α-D-Gal-(1-4)-β-D-Gal moiety, which is also known 
as the glycosphingolipid-anchored P blood group antigen (189).   
 Although P fimbria promotes adherence to cells derived from the uroepithelium 
(190), demonstrating that pap operon mutants have virulence defects during experimental 
infection remains challenging.  In independent infections using the murine model of UTI, 
a weeklong study failed to find that pap operon mutants were any less virulent than the 
UPEC parental strain (191).  However, a subsequent signature-tagged mutagenesis screen 
and coinfection studies identified pap operon mutants as being significantly outcompeted 
by parental and other mutant strains, and this mutation could be complemented with a 
cloned pap operon (192).  In addition, a CFT073 pap mutant has a reduced rate of kidney 
infection, compared with the parental CFT073 strain (193).  There is also evidence to 
suggest that the pap operon is expressed during a human infection (194), which includes 
the production of antibodies against P fimbria in infected individuals (195).  Thus, taken 
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together, P fimbria clearly serves a function during a UTI, but this function has been 
difficult to measure.  
 
F1C fimbria 
 F1C fimbriae, like P fimbriae, are associated with UPEC strains, compared to 
nonpathogenic E. coli strains (196-199).  As is the case for both Type 1 and P fimbriae, 
all activities and structures necessary for the regulation, secretion, and assembly of F1C 
fimbria are encoded by the foc operon (200-205).  The foc operon is regulated in a 
manner similar to the pap operon (152, 200-205).  FocB, a PapB homolog, controls 
expression of FocI at PfocI, and FocB negatively regulates PfocBA at high FocB levels (202, 
203).  FocI controls Lrp binding to GATC sites in PfocBA, which in turn mediates positive 
and negative regulation of the foc operon (152, 200-205).  It is of note that FocB and 
PapB cross-regulate the pap and foc operons, respectively (203).  However, A detailed 
description of fimbrial operon cross-regulation will be discussed below.   
 The remaining genes of the foc operon (focAICDFGHY) encode the 
chaperone-usher system, major fimbrial subunit, and tip adhesin (Figure 1-3C) (200-203, 
205).  An additional gene, focX, may contribute to motility repression (187).  The major 
structural unit of F1C fimbria is composed of FocA multimers (200-203, 205), and the 
F1C fimbrial adhesin tip is composed of FocG and FocH subunits (200-203, 205).  FocH 
mediates adherence to specific targets containing GlcCer (glucosylceramide), GalCer2 
(β1-linked galactosylceramide 2), lactosylceramide, globotriaosylceramide, nLc4Cer 
(paragloboside), lactotriaosylceramide, asialo-GM2[GgO3Cer] (gangliotriaosylceramide), 
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and asialo-GM1[GgO4Cer] (gangliotetraosylceramide) moieties (206).  F1C fimbriae 
promote adherence to human kidney epithelial cells found in the distal tubules and 
collecting duct and promote adherence to vascular endothelial cells (207).  In agreement 
with these observations, expression of F1C fimbriae during human infection has been 
demonstrated (197). 
 
TosA, the first E. coli RTX nonfimbrial adhesin 
 A model adhesin for understanding UPEC adherence regulation is the RTX 
nonfimbrial adhesin, TosA (TosA, type one secretion protein A).  tos operon 
(tosRCBDAEF) (Figure 1-4A) regulation will also serve as a model of reciprocal 
regulation between adhesin and flagellar operons.  In addition to harboring tosA, the 
remaining genes of the tos operon (tosRCBDEF) encode a type 1 secretion system 
(TosCBD) and putative regulators (TosREF) (Figure 1-4B) (208).  TosC, TosB, and 
TosD have homology with known type 1 secretion system components TolC, HlyB, and 
HlyD, respectively (208).  TosR is a member of the PapB family, discussed above, and 
TosEF (originally annotated as c0364 and c0365) are both members of the LuxR family 
(208).  The tos operon itself is localized to pathogenicity island-aspV (PAI-aspV), 
harbored by UPEC strain CFT073 (39).  At least one-in-four UPEC isolates harbor the 
tos operon, and the tos operon is a potential predictor of E. coli virulence (35).    
The RTX adhesins, which include TosA, form a growing group of the RTX 
family (50).  TosA is localized to the outer membrane and specifically mediates 
adherence to cells derived from the upper urinary tract (208).  In addition to TosA, 
21 
 
 
 
 
 
Figure 1-4.  The tos operon encodes regulator, secretion system, and adhesin 
homologs.  (A) ORFs (open reading frames) are depicted to scale with colored arrows 
(representing the function of the encoded proteins) in the direction of transcription.  Blue 
arrows represent putative regulator encoding genes, orange arrows represent genes 
encoding the structural proteins for a putative type I secretion system, and a red arrow 
represents the gene encoding the RTX nonfimbrial adhesin, TosA.  (B) The predicted 
molecular weights (kDa), identified homologs, and percent amino acid identity with the 
identified homologs are noted for each protein encoded by a gene in the tos operon.  
Image is modified from (208). 
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membership of this family includes LapA (Pseudomonas putida and Pseudomonas 
fluorescens), LapF (Pseudomonas putida and Pseudomonas fluorescens), BapA 
(Salmonella enterica), SiiE (Salmonella enterica), FrhA (Vibrio cholerae), BpfA 
(Shewanella oneidensis), RtxA (Legionella pneumophila), and MpAFP (Marinomonas 
primoryensis) (50, 209, 210).   
Both LapA and LapF serve functions during biofilm development (211-213).  In 
particular, LapA promotes early surface attachment events (including the switch to 
irreversible surface binding), and LapF promotes biofilm cell-to-cell interactions (i.e., 
biofilm structure) (50, 211-213).  Differential regulation by the nucleoid protein Fis 
(factor for inversion stimulation), of the genes encoding LapA and LapF, may also serve 
a function in modifying LapA- and LapF-mediated biofilm formation (214).  BapA, like 
LapA and LapF, is associated with biofilm formation (215).  bapA expression is 
coordinated with curli fiber synthesis, and BapA has an additional function during 
invasive infection (e.g., liver and spleen infection) (215).   
SiiE is a very large (>5,000 amino acids in length) RTX adhesin composed almost 
entirely of BIg (bacterial Ig-like) folds (50, 216).  The sii operon is on SPI-4 (Salmonella 
pathogenicity island-4), and SiiE is important for cattle intestinal colonization (especially 
binding to and invading polarized epithelial cells) and is a mediator of inflammation in 
mice (217, 218).  SiiE requires extracellular Ca2+ coordination within the BIg folds to 
maintain a rigid structure (216), which may contribute to SiiE-mediated adherence of S. 
enterica to host cells.   
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FrhA is found almost exclusively in Vibrio species and contains repeated 
cadherin-like domains (50, 219), which are known to contribute to eukaryotic cell-to-cell 
interactions (i.e., adherence) (220).  The FrhA RTX nonfimbrial adhesin contributes to 
hemagglutination of erythrocytes, epithelial cell adherence, biofilm formation, chitin 
binding, and intestinal colonization of infant mice (221).  Interestingly, regulators 
associated with Vibrio cholerae flagellar gene expression contribute to positive regulation 
of frhA expression (221).  frhA negative regulation may occur in response to low levels of 
intracellular c-di-GMP and suggests that even nonfimbrial adhesins might participate in 
coordinated adherent and motility phenotypes (221).   
BpfA, like SiiE, contains internal BIg folds in addition to other repeated motifs 
(50).  BpfA, like the other RTX nonfimbrial adhesins above, serves an important function 
during S. baltica biofilm formation (222).  Biofilm formation mediated by BpfA, in turn, 
may be suppressed by an interaction with the inner membrane protein BpfD (222).  High 
intracellular levels of c-di-GMP may promote BpfA dissociation from BpfD and promote 
biofilm formation (222).   
RtxA, an RTX nonfimbrial adhesin from L. pneumophila, contains a von 
Willebrand factor type A domain (50, 223), which may facilitate binding to and invasion 
of amoebae and macrophage cells (50, 224-226).  RtxA may also promote L. 
pneumophila intracellular survival after host cell invasion, and, as such, RtxA is a noted 
virulence factor during experimental murine lung infection (224).   
To date, MpAFP (an antifreeze protein), of M. primoryensis, is the largest known 
RTX nonfimbrial adhesin (>13,000 amino acids long) (209, 210).  The large MpAFP size 
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is again due to the presence of repetitive BIg folds, which coordinate Ca2+ to obtain 
adhesin rigidity (209, 210).  In terms of adherence, MpAFP binds ice (209, 210).  This 
adherence phenomenon is predicted to mitigate damage caused by cell contact with ice 
and suspend M. primoryensis in the extracellular milieu, possibly where nutrient and 
oxygen levels are higher (209, 210).  Like MpAFP and many of the other RTX adhesins 
above, TosA contains a number of internal repetitive motifs (208).  In particular, TosA 
contains at least five tandem direct repeats 335 amino acids long (208).   
Individual challenge and competition assays have revealed that TosA is both an 
important virulence and fitness factor, especially during an invasive infection (i.e., it 
mediates kidney, liver, and spleen infection) (35, 39, 208, 227).  In addition, E. coli 
CFT073 cells producing TosA enhanced lethality in a zebra fish model of bacteremia, 
compared with E. coli CFT073 not producing TosA (208).  Furthermore, mice 
pre-vaccinated with TosA were protected from invasive infection of the spleen when 
challenged with E. coli CFT073 by the transurethral route (208).         
TosA was previously identified through an IVIAT (in vivo-induced antigen 
technology) screen (227), which can be used to identify genes preferentially expressed in 
vivo (228).  In agreement with the IVIAT finding, tosA and the remainder of the tos 
operon were repressed during growth under laboratory conditions (i.e., in lysogeny broth 
[LB] at 37°C) (208, 227), while induced in vivo (as estimated from pooled voided urine 
from experimental murine UTIs) (208, 227).  Little else was previously known about tos 
operon regulation, but considering that TosA is an adhesin, this may suggest that 
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regulation of the tos operon could be related to the same phenomenon governing motility 
and adherence reciprocal regulation.           
 
c-di-GMP and adherence 
 The bacterial secondary messenger c-di-GMP contributes to adhesin regulation 
and biofilm formation (130-132, 142).  E. coli biofilms are networks of cells, 
extracellular matrix proteins (often adhesins), DNA, and extracellular polysaccharides 
(140-142, 229-237).  Biofilms, a form of multicellular behavior, are associated with 
microbial adherence to both biotic and abiotic surfaces (141, 142), and these structures 
have gained some notoriety for imparting an antibiotic-resistant phenotype, being the 
source of some persistent infections, and causing environmental problems (141, 142).  
High levels of c-di-GMP are related to higher levels of E. coli adherence and 
multicellularity (130-132, 142).  Indeed, diguanylate cyclases YdaM, YegE, YedQ, and 
YeaP function to increase CsgD levels, which in turn increases curli fiber and cellulose 
levels (both components of E. coli biofilms) (131, 140, 142, 229-236).  Supplemental to 
CsgD, diguanylate cyclase YaiC may contribute to increasing cellulose levels (131).  Of 
note, many of these enzymes are under the regulatory of control of σS (131), which may 
explain the rise of c-di-GMP levels upon entry into stationary phase (138).  As lower 
levels of c-di-GMP reduce adherence, enzymes with phosphodiesterase activity or 
degenerate EAL domains function by decreasing the levels of curli, cellulose, Type 1 
fimbria, and P fimbria (131, 134, 238).     
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Reciprocal regulation between adhesin and motility gene expression 
 As noted above, adhesin and flagella expression are coordinated (i.e., they are 
reciprocally regulated) (Figure 1-2).  Intuitively, this coordination seems logical; it is 
improbable (and highly counterproductive) for a UPEC cell to both be maximally 
anchored to a specific site (nonmotile) and simultaneously swimming in the extracellular 
milieu (motile).  A great deal of this coordinated behavior in E. coli is mediated through 
proteins encoded by genes at the end of adhesin operons (e.g., papX and focX) (186-188).  
Indeed, a papX mutation was previously identified as a suppressor mutation of a 
nonmotile fimS locked-ON mutation (188).  PapX mediates a decrease in motility by 
binding in the vicinity of PflhDC and repressing expression of flhDC, which encodes the 
master positive regulator of flagellar gene expression as described above (187, 188).  
FocX is virtually identical to PapX (187).  Therefore, it is reasonable to hypothesize that 
FocX also contributes to decreased motility in a similar manner.  In addition, regulators 
encoded by nearly all adhesin operons of another uropathogen, Proteus mirabilis, 
mediate decreased motility when expressed (186, 239).  Perhaps the most studied of these 
motility regulators in P. mirabilis is MrpJ, a homolog of PapX (186, 239, 240). 
 To date, the manner in which flagella and flagellar operons decrease adhesin 
expression is unclear, but attractive mechanisms may include perturbing intracellular 
c-di-GMP levels, nucleoid-mediated regulation, and the activity of bundled flagella 
themselves.  FliA, which controls expression of class III flagellar genes, may control 
expression of the gene encoding phosphodiesterase YhjH (131, 241).  In turn, YhjH 
promotes c-di-GMP degradation and subsequent repression of curli fiber expression (131, 
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241).  Some of the reciprocal regulation between adhesin and flagellar genes may be the 
result of switches between NAPs (nucleoid-associated proteins), which will be reviewed 
below.  The activity of bundled flagella themselves could also mediate downregulation of 
adhesin operons.  For instance, flagellar activity reduces fluid shear viscosity (242).  In 
turn, fluid shear could be sensed by E. coli (243, 244).  Indeed, fluid shear has already 
been implemented in the regulation of Intimin and Tir synthesis and activity (adhesin and 
receptor proteins of enteropathogenic and enterohemorrhagic E. coli) (244) and the 
enhanced adherence phenotype of Type 1 fimbria (245).  In addition, P fimbria is 
resistant to shear forces (possibly from the flow of urine) due to fimbrial stalk coiling 
(246).  High c-di-GMP levels suppress flagellar motor rotation (133), which could further 
drive cells toward an adherent state. 
 Another aspect of reciprocal regulation is the coordination between different 
adhesin operons.  One example of this form of regulation is between PapB (P fimbria) 
and Type 1 fimbria (203, 247).  Indeed, earlier work found that PapB represses the fim 
operon through binding in fimS (247).  In a manner similar to PapB, FocB negatively 
regulates the fim operon (203, 248).  As noted above, FocB and PapB cross-regulate each 
other (203).  Cross-regulation of the foc and pap operons is achieved through specific 
binding of PfocBA and PpapBA by both PapB and FocB (203).  Although the mechanism of 
cross-regulation can only be speculated to be through specific DNA sequence binding, a 
PrfB and SfaB (both PapB family members) may also mediate cross-regulation between 
the prf and sfa operons (249, 250).  However, it is intriguing to note that this cross-
regulation between PapB family members is only well described for family members 
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with high homology (203, 204, 249, 250), which suggests that this form of reciprocal 
regulation is not an unexpected phenomenon.  Whether or not this reciprocal regulation is 
generalizable for additional PapB family members is unknown, but would confirm the 
existence of an adhesin operon expression hierarchy (251, 252).  The precise function of 
nucleoid structure in this form of reciprocal regulation is still unclear.  
 
 
E. coli nucleoid regulation 
 
The E. coli nucleoid and associated proteins 
 To accommodate an entire chromosome within a small cellular volume, E. coli 
must compact its DNA.  Indeed, if completely uncoiled, the circumference of the E. coli 
chromosome would extend around 1500 µm, compared to 1.6-3.9 µm for the E. coli cell 
itself (depending on growth condition) (94, 253).  The problem of chromosomal 
compaction is further underscored by the fact that a rapidly dividing cell could initiate 
chromosome replication before cell division is complete (254-256).  The compacted 
chromosome, including associated proteins and RNAs, is referred to as the E. coli 
nucleoid.   
The E. coli nucleoid itself is a mosaic of both plectoneme (Figure 1-5A) and 
solenoid (Figure 1-5B) compacted regions (94, 257-262), with plectoneme compaction 
predominating (258-262).  The core of the nucleoid is composed of densely packed DNA 
and associated NAPs; plectoneme DNA braids emanate from this core, and the cellular
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Figure 1-5.  Alternative forms of compacted DNA are represented.  (A) An example 
of the braided structure of plectoneme chromosome compaction is indicated.  The 
compacted black line represents a double helix of DNA.  (B) The looped structure of a 
chromosome compacted as a solenoid is shown.  As above, the black line represents a 
double helix of DNA.  (C) A representation of the writhed and coiled architecture of the 
E. coli chromosome is shown.  Thick black lines represent compacted areas of the E. coli 
chromosome within the cell (yellow oval). 
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transcriptional and translational machinery are coincident with these DNA braids at the 
periphery of the cell interior (263, 264).  The entire nucleoid itself is described as having 
a coiled and folded structure (94, 265-267) (Figure 1-5C).  In addition, the E. coli 
nucleoid is further organized into at least six macrodomains (Ori [Origin], NS-right 
[Nonstructured-right], Right, Ter [Terminus], Left, and NS-left [Nonstructure-left]) (94, 
268-271), which have defined boundaries and limited interactions between these domains.   
Cell division, growth phase, and metabolism, especially energy generation, are 
two aspects of E. coli biology coupled to the nucleoid.  For instance, the E. coli 
chromosome is generally in a negative (underwound) supercoiled state (257, 259, 272).  
During cell division, particularly DNA replication, DNA becomes more positively 
supercoiled through the activity of a DNA helicase (259, 273, 274).  DNA gyrase 
subsequently adds negative supercoils (i.e., the DNA becomes underwound) back to the 
chromosome (273-275).  This process requires ATP hydrolysis (273, 275); thus, 
metabolism, particularly energy generation, could be coupled to nucleoid structure, 
especially the supercoiled state of the chromosome (92-94).  Furthermore, these 
phenomena may be linked to the more prominent appearance of different NAPs during 
different growth phases (94, 95, 104-109) Table 1-1.  While H-NS is prominent in 
exponential phase, it can be present in all growth phases (94, 95, 109); Lrp has higher 
prominence near middle to late exponential phase, but Lrp levels could drop at some 
point in stationary phase (94, 95, 104, 105, 109); IHF (integration host factor) α and β 
subunits appear to have prominence during the transition from exponential to stationary
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Table 1-1. Nucleoid structuring proteins vary with growth phase 
Regulator 
 
Most prominent growth phase References 
CbpA Stationary (95, 109) 
CbpB Exponential and stationary (95, 109) 
DnaA Exponential (95, 109) 
Dps Stationary (95, 109) 
Fis Lag and exponential (94, 95, 109) 
Hfq Exponential (95) 
HUα Lag* and exponential (94, 95, 107-109) 
HUβ Exponential and stationary* (94, 95, 107-109) 
H-NS Exponential (94, 95, 109) 
IciA Exponential (95) 
IHFα Stationary (94, 95, 106, 109) 
IHFβ Stationary (94, 95, 106, 109) 
Lrp Exponential and stationary (94, 95, 104, 105, 109) 
StpA Exponential (95, 109) 
*Although this subunit is predominate at this phase, levels of HU are highest in 
exponential phase 
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phase (94, 95, 106, 109).  In addition, Fis appears to be more prominent during lag and 
exponential phase (94, 95, 109).  The expression of the genes encoding the subunits of 
HU (histone-like protein from E. coli strain U93) shows a complex regulatory profile.  
HUα subunits predominate during lag phase, HUαβ subunits are both present during 
exponential phase, and HUβ subunits are also present during stationary phase (94, 95, 
107-109).  All NAPs, however, may be expressed during any growth phase (i.e., in 
addition to the point where levels are the highest).  Nevertheless, the differential 
appearances of NAPs may approximate switches (especially in regulatory occupancy) 
where global gene expression profiles may be perturbed through varying levels (and 
possibly ratios) of regulating NAPs as described below.  Most strains of E. coli encode 
the genes for at least 12 distinct NAPs including CbpA, CbpB, DnaA, Dps, Fis, Hfq, H-
NS, HU, IciA, IHF, Lrp, and StpA (95).  Hha and YdgT are two accessory NAPs 
supplementing gene regulation at AT-rich sequences (276).  However, only the five key 
NAPs previously listed above will be reviewed in detail below including, IHF, HU, Fis, 
H-NS, and Lrp.   
IHF and HU, two homologs (277), are both involved in gene regulation.  IHF is 
often thought of as a DNA architectural catalyst, as it mediates significant bending and 
looping of bound DNA (277-281).  Indeed, IHF-mediated DNA bending is predicted to 
promote FimB and FimE site-specific recombination (279, 282, 283), which will either 
promote or inhibit fim operon expression based on whether fimS invertible element 
containing PfimA is in the ON or OFF orientation after recombination.  DNA looping by 
IHF is also implicated in allowing RNA polymerase to contact distal transcription factors, 
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from specific promoters, to regulate gene expression (281, 284, 285).  The IHF binding 
site itself is a chimera of AT-rich tracts at the 5’ end and the sequence 
(A/T)ATCAANNNNTT(A/G) at the 3’ end (286).  In addition, IHF may be involved in 
the regulation of genes necessary during nutrient-limiting conditions, and rises in 
prominence during stationary phase (94, 95, 109, 287).  Like IHF, HU mediates DNA 
bending and looping (288, 289), and HU also mediates RNA polymerase contact with 
distal transcription factors, from specific promoters (290, 291).  Unlike IHF, however, 
HU does not bind to a specific sequence (292-294).  It is intriguing to note that both IHF 
and HU have two subunits, which may show differential DNA binding activities based on 
dimerization state (106-108). 
 Fis is another NAP, which appears during lag and exponential phase and regulates 
gene expression.  Fis, of all other NAPs discussed here, is the most abundant with nearly 
60,000 copies per cell (95).  Fis has some function in DNA bending and binds AT-rich 
sequences that may be more tractable toward bending (295-297).  As noted above, Fis 
positively and negatively regulates RTX nonfimbrial adhesin genes lapA and lapF, 
respectively (214).  It also regulates genes necessary for entry into exponential growth 
phase, which include metabolic pathways, replication, transcription, and translation 
machinery genes (298-302).  As Fis constrains DNA supercoiling and promotes 
spatiotemporal coordination of supercoiled DNA (302, 303), this may be another 
mechanism where global gene expression is regulated by Fis.  Fis, in addition, induces 
expression of hns (304), which may also contribute to the NAP predominance switching 
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phenomenon during different growth phases discussed above (i.e., hns represses fis).  At 
high Fis concentrations, however, hns may be repressed (304).            
    
H-NS regulation 
 Perhaps one of the most studied NAPs is H-NS.  Indeed, H-NS is one of the NAPs 
at the core of the nucleoid, and H-NS serves a key function in compaction of the nucleoid 
into a coiled structure (94, 305).  As is the case with Fis above, H-NS appears to be 
involved in constraining DNA supercoiling and the spatiotemporal coordination of 
supercoiled DNA available to transcriptional machinery (305-308).  Intriguingly, H-NS 
may regulate Fis (258), which further suggests that complex regulatory networks may 
exist among NAPs.  H-NS itself binds AT-rich sequences (41-43, 94, 309).  However, 
H-NS binding to DNA may be nucleated at a specific sequence (tCGATAAATT) and 
subsequently spread (i.e., oligomerize to form a filament) from this site (258, 310).  In the 
presence of this nucleating site, H-NS binding may even extend into lower affinity 
sequences (258).  In addition, H-NS has affinity for curved DNA (311, 312), which is 
often associated with AT-rich sequences (313). 
 H-NS promotes plectoneme compaction of the nucleoid, and H-NS-mediated gene 
regulation is often through bridging two distinct DNA segments together (307, 314-316).  
Indeed, H-NS oligomers are hypothesized to form a right-handed helical filament 
coordinating this bridging (314).  The favored mechanisms of H-NS-mediated repression 
include obstructing promoters from transcription factors and transcription machinery, 
RNA polymerase trapping, and constraining DNA supercoils (307).  Occlusion occurs 
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when RNA polymerase and other relevant proteins are unable to bind sequences already 
occupied by H-NS, which is largely due to steric inhibition (307, 317).  The occlusion 
phenomenon may be extended to include inhibition of the function of RNA polymerase 
(e.g., open complex formation) (307, 318, 319).  H-NS-mediated DNA looping may also 
contribute to RNA polymerase trapping.  In this case, it is suggested that H-NS mediates 
repression through the prevention of RNA polymerase-mediated elongation of a 
transcript; thus, RNA polymerase is essentially trapped at these promoters, and the 
associated genes will not be transcribed (307, 310, 320-322).   However, the force 
generated by a translocating RNA polymerase is sufficient to displace H-NS (307, 323, 
324), which suggests that H-NS can only trap a stationary RNA polymerase.  Intriguingly, 
it is possible that RNA polymerase itself may cooperate with H-NS binding to participate 
in the formation of RNA polymerase trapping complexes at these promoters (307, 322, 
325).  Both RNA polymerase trapping and RNA polymerase-mediated H-NS repression 
may be sensitive to the presence of alternative sigma factors (317, 326, 327).  This may 
contribute to growth phase regulation switching discussed above (i.e., σS may overcome 
H-NS occupancy at some promoters).  In the case of constraining supercoiling, H-NS 
bridging between DNA strands is sufficient to maintain local supercoiling, even when 
there are double stranded DNA breaks at other sites (305-308).  This suggests that H-NS 
DNA binding could locally overcome the activity of topoisomerases.  Constrained 
supercoiling subsequently modulates activation and repression at promoters sensitive to 
supercoiling (305, 307, 328-330).  In addition, H-NS constrained supercoiling may also 
contribute to RNA polymerase stalling and Rho factor-dependent termination of 
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transcription (322, 331, 332).  This stalling activity may even contribute to post-
transcriptional regulation of gene expression and protein synthesis, but this activity is still 
largely speculative.  
 As is the case with H-NS silencing above, there are multiple mechanisms to 
overcome this activity (307, 315).  Several of these anti-silencing mechanisms include 
H-NS displacement by RNA polymerase, altered nucleoid structure by other NAPs, 
H-NS displacement by classical sequence or motif-specific transcription factors 
(including filament formation inhibition), filament and bridging antagonism by H-NS-
like molecules, anti-silencing by environmental stimuli, such as pH, temperature, and 
osmolarity, and non-coding RNA-mediated anti-silencing (307, 315, 333).  Although 
RNA polymerase may contribute to H-NS-mediated silencing as described above, it may 
be the case that displacement of H-NS by RNA polymerase may be mediated through 
altering promoter geometry (especially in complex with different sigma factors) (307, 
317, 326, 327).  Likewise, a translocating RNA polymerase may displace H-NS (307, 323, 
324), which is another mechanism whereby H-NS-mediated silencing is overcome.  As 
discussed above, the NAP content of the nucleoid varies with growth phase (94, 95, 104-
109).  In the case of anti-silencing by altered nucleoid structure, other NAPs may, thus, 
antagonize H-NS silencing activity (304, 307, 334, 335).  In this sense, anti-silencing of 
H-NS is reminiscent of a switch between nucleoid states and underlying gene regulation 
(i.e., the prominence of NAP regulation at a locus may switch).  Sequence-specific or 
motif-specific regulators can also contribute to overcoming H-NS-mediated silencing 
(181, 307, 315, 336, 337).  These regulators could compete with H-NS for DNA binding 
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sites (307, 315).  In addition, sequence-specific regulators may overcome H-NS-mediated 
silencing through inhibiting the extension of an H-NS filament (307, 315, 338).  In 
addition, these sequence-specific regulators may also alter the geometry of promoters and 
facilitate H-NS filament disengagement from the silenced DNA (307, 315).  Some 
sequence specific-regulators are dispensable for positive gene regulation when H-NS is 
absent, but other regulators may still promote gene expression in other cases (307, 339).  
In H-NS-like molecule antagonism of H-NS silencing, it has been shown that truncated 
H-NS-like molecules may oligomerize with H-NS, but suppress DNA binding and bridge 
formation (307, 315).  Likewise, pH, temperature, and osmolarity are all known to alter 
the structure of DNA (340-342).  As such, H-NS binding may be altered by this different 
geometry (307, 315, 333).  While, these changes in geometry usually result in the 
inhibition of H-NS silencing (307, 315, 333, 343), it has been suggested that H-NS 
silencing could be augmented by these environmental conditions (307).  The DsrA RNA 
is a non-coding RNA that inhibits hns mRNA translation (307, 315, 344).  DsrA activity, 
thus, lowers the cellular pool of H-NS, which in turn has the potential to contribute to 
nucleoid restructuring. 
 H-NS also allows E. coli to have regulatory activities that are not encoded for in 
the genome.  These activities include regulating genes acquired by horizontal transfer 
(306, 307, 315) and silencing expression from intergenic and intragenic promoters (345), 
both cases where E. coli may not encode dedicated regulators for these recently acquired 
genes or sequences.  Harboring foreign DNAs without regulation could potentially be 
detrimental to a host, as the host may expend energy producing unnecessary or toxic 
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proteins.  PAIs, such as PAI-aspV harboring the tos operon, are often noted for 
containing genes that are AT-rich, compared with the rest of the host genome (40-43).  
As noted above, H-NS binds AT-rich sequences (41-43, 94, 309).  Thus, it has been well 
documented that H-NS regulates AT-rich sequences acquired by horizontal transfer (41-
43).  Of particular note for UPEC, nearly all classical virulence factors (i.e., HlyA, 
fimbriae, and iron uptake systems) are upregulated in an hns mutant (346), which further 
underscores the importance of understanding H-NS-mediated regulation.  Specific 
functions for H-NS in the regulation of adhesins and motility genes will be reviewed 
below.  H-NS also suppresses expression from promoters located inside of genes 
(intragenic) or between genes (intergenic), which may otherwise promote expression of 
silencing or nonfunctional RNAs (345).  Therefore, this may be another mechanism 
whereby E. coli mitigates possible detrimental effects of having foreign DNA (i.e., 
expressing unnecessary RNAs or RNAs that silence expression of necessary genes).  
 
Lrp regulation 
Lrp, like H-NS above, is a global regulator of gene expression (105, 152, 179, 183, 
250, 296, 347-355).  Indeed, Lrp regulates nearly 10% of all E. coli genes (105).  The 
vast majority of these genes are most prominently regulated at the transition into 
stationary growth phase (intriguingly, when Lrp levels fall) (105).  Lrp may wrap DNA in 
a manner reminiscent of a solenoid (356); DNA wrapping has also been observed for the 
Lrp homologs, using atomic force microscopy (357).  It does not appear that a single Lrp-
binding site consensus sequence exists.  Nevertheless, using a classical DNase I 
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protection assay, the sequence GN2-3TTT was identified as a putative Lrp-binding 
sequence in the vicinity of PpapI and PpapBA (358).  There is, in addition, some evidence 
that Lrp has affinity for other AT-rich sequences (359).       
 Lrp exists as an octamer, hexadecamer, or leucine-bound octamer (356, 360, 361).  
The Lrp octamers emerge as a consequence of being arranged as a tetramer of dimers 
(356).  However, one of the interfaces between adjacent dimers does not mediate further 
oligomerization, which suggests this structure is essentially open  (i.e., not a closed ring) 
and that asymmetry exists in this octamer (356).  Higher order multimers (i.e., 
hexadecamers) of the Lrp octamers, nevertheless, are observed in the cellular Lrp pool 
(360, 361).  In the presences of leucine, however, these hexadecamers disassociate to 
leucine-bound octamers or fail to form (360, 361).  Furthermore, Lrp-mediated regulatory 
activities may be different for Lrp octamers, hexadecamers, and leucine-bound octamers 
(360-362).  In addition, other amino acids, including alanine, histidine, isoleucine, 
methionine, serine, and threonine, can also modulate Lrp-mediated regulation through 
DNA binding (363), but the extent and consequences of these different binding behaviors 
have yet to be fully realized.  DNA wrapping by Lrp may either obstruct transcriptional 
machinery from binding to relevant sequences or promote RNA polymerase interactions 
with Lrp itself or distal elements necessary for transcription (364-366). 
 Lrp is often studied as a regulator of genes involved in metabolism and is usually 
described as a feast or famine regulatory protein (152, 367).  Indeed, Lrp levels usually 
rise in middle to late exponential phase, but could drop later in stationary phase (94, 95, 
104, 105, 109). Thus, Lrp regulation of the starvation response is complex.  Consistent 
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with its function as a feast or famine regulator, Lrp is regulated by the alarmone ppGpp 
(guanosine tetraphosphate), but this regulation may be complex and indirect (104).  The 
alarmone ppGpp itself rises in response to nutrient stresses (368).  Of the genes regulated 
by Lrp, the general trend is that genes encoding protein involved in anabolic (synthetic) 
pathways are positively regulated by Lrp and genes involved in catabolism (degradation) 
pathways are repressed (105, 152); genes encoding proteins involved in amino acid 
synthesis and degradation are especially noted for differential regulation (105, 152, 369).  
An lrp mutation is also one of the known GASP (growth advantage at stationary phase) 
mutations (370), which further underscores that regulation by Lrp is necessary to promote 
specific behaviors in response to nutrient limitation.  In addition, adhesin and flagellar 
levels are governed by Lrp regulation (148, 152, 179, 202, 204, 279, 348, 352, 354, 355), 
but this regulation will be discussed below.  Taken together, it seems reasonable to 
speculate that Lrp functions to start the switch into stationary phase, and as such controls 
the synthesis of proteins necessary for stationary phase survival, while resources and 
nutrients are still available.      
    
H-NS and Lrp controlled reciprocal regulation (adherence-motility and 
multicellular-unicellular behavior) 
 As noted above, H-NS and Lrp both regulate adhesin operons (Table 1-2).  For 
instance, H-NS is a negative regulator of nearly all adhesin operons described in this 
work (e.g., pap, fim, and foc) (148, 179, 181, 202, 351, 354, 371-374).  Lrp, on the other
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Table 1-2.  Summary of H-NS- and Lrp-mediated reciprocal regulation. 
Regulator Effect 
 
Reference 
H-NS 
 
Dual regulator of motility (375-378) 
 
 
Negative regulator of Type 1 fimbria (148, 150, 374) 
 
 
Negative regulator of P fimbria 
 
 
(181, 183, 354, 371, 
372) 
 
 
Negative regulator of F1C fimbria (202) 
 
 
Negative regulator of biofilm 
(cellulose- and/or curli-mediated) 
 
(235, 326, 376, 379-
381) 
 
 
Negative regulator of S. enterica multicellularity 
(type 6 secretion system-mediated) 
 
(382) 
   
Lrp 
 
Negative regulator of motility (355) 
 
 
Dual regulator of Type 1 fimbria (148, 152, 279, 348, 
351, 352, 383) 
 
 
 
Dual regulator of P fimbria (152, 179, 183) 
 Dual regulator of F1C fimbria 
 
(152, 200-202, 204, 
205) 
 
 Positive regulator of biofilm 
(cellulose- and/or curli-mediated) 
 
This work 
 Positive regulator of the P. mirabilis Dienes phenomenon 
(type 6 secretion system-mediated multicellularity) 
 
This work 
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hand, is a dual regulator (both positive and negative regulator) of these and other adhesin 
operons, depending on the DNA binding context (148, 152, 179, 202, 204, 279, 348, 352, 
354).  Thus, a switch between these two regulators, particularly gaining prominence in 
regulatory occupancy in the E. coli chromosome, could account for this differential 
regulation (Figure 1-6).  In one specific example, H-NS is the presumptive negative 
regulator of the pap operon (Figure 1-7A) (183, 354, 371, 372).  When the distal GATC 
(Dam methylation) site is methylated and the proximal GATC site is unmethylated, Lrp 
binds the proximal sites (Lrp-binding sites 1, 2, and 3), and the pap operon is OFF  
(Figure 1-7B) (152, 179, 183).  When PapB displaces H-NS, the papI regulatory gene is 
expressed, and the distal GATC site is unmethylated, PapI acts to promote Lrp binding to 
the distal sites (Lrp-binding sites 4, 5, and 6) (152, 181, 183, 384) (Figure 1-7C).  A 
similar regulation model is also predicted to exist for the foc operon (152, 200-205).  
Unfortunately, H-NS-mediated negative regulation of the pap operon can be complex.  
For instance, alleviation of H-NS negative regulation could be masked by the fact that 
Lrp is also a negative regulator of the pap operon.  Nevertheless, it is accepted that H-NS 
can be a negative regulator of the pap operon, independent of Lrp (354).  Thus, the 
prominence in regulation of the pap operon can switch from an H-NS state (negative 
regulation) to an Lrp state (dual regulation), which suggests that an H-NS and Lrp switch 
is involved in pap operon regulation.  It is important to note, however, that H-NS and Lrp 
are both global regulators (42, 105, 152, 179, 183, 250, 296, 326, 346-355, 370, 372, 375, 
377, 378, 385-389).  Therefore, this switch may only be an abstraction of the two NAPs 
and associated regulators perturbed by the changing ratio of 
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Figure 1-6.  A switch between H-NS and Lrp may be involved in adherence and 
motility reciprocal regulation.  A schematic representing a switch between occupancy 
of Lrp (white oval) and H-NS (black oval) in the E. coli chromosome (black circle) is 
noted.  Correspondingly, if the switch is in the Lrp occupancy predominating state 
(possibly as seen in the switch from exponential and stationary phase), adherence is 
predicted to predominate over motility (adhesins, colored bars).  When the switch is in 
the H-NS occupancy predominating state (possibly as seen in exponential phase), motility 
is predicted to predominate over adherence (flagella, green curves).  Pink bars between 
the adherent and motile states represents the necessity that some of the reciprocal 
regulation of adherence- and motility-related genes is indirect.    
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Figure 1-7.  Regulation of the pap operon is dependent on NAP (nucleoid-associated 
protein) binding context and epigenetics.  (A) H-NS, a negative regulator of the pap 
operon, binds to the locus represented in the figure and manipulates DNA methylation 
state.  The pap operon-related promoters are, thus, OFF (gray arrows).  (B) Lrp-binding 
site 5 is methylated, and Lrp will not bind the activating Lrp-binding sites (4, 5, and 6), 
denoted “ON” and indicated by faded ovals.  Lrp-binding site 2 is unmethylated, and Lrp 
binds to repressive Lrp-binding sites (1, 2, and 3), denoted “OFF” (solid white ovals).  
The pap operon-related promoters are OFF (gray arrows), and H-NS may still bind to this 
locus (faded black ovals).  (C) Lrp binding site 2 is methylated, and Lrp will not bind the 
Lrp-repressive binding sites, indicated by faded ovals.  PapB (green ovals) displaces H-
NS and promotes papI expression.  In turn, PapI (purple circles) promotes Lrp binding to 
the unmethylated activation sites.  The pap operon-related promoters are, thus, turned ON 
(black arrows).  When PapB levels increase, PapB will bind to an area in the vicinity of 
PpapBA, which will turn the pap operon-related promoters OFF.  This is represented by 
faded green ovals [i.e., the pap operon is ON in (C)]. 
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H-NS and Lrp at a variety of regulated sequences (Figure 1-2).  This leads to the notion 
that such switches can be virtual (i.e., they are indirect, instead of being a literal 
competition for binding sites at a specific locus).  
 Regulation of the fim operon includes a similar switch between H-NS, Lrp, and 
IHF (Table 1-2) (148, 150, 152, 279, 348, 351, 352, 374).  In particular, H-NS negatively 
regulates fimB, which encodes the FimB recombinase modulating both OFF-to-ON and 
ON-to-OFF inversions of the fimS invertible element (148-150, 152).  The fimE gene, 
which encodes the FimE recombinase modulating ON-to-OFF recombination, is also 
negatively regulated by H-NS (148-150, 152).  Intriguingly, H-NS biases the fimS switch 
in the OFF state (Figure 1-8A), which suggests that H-NS regulation of the fim operon is 
complex (i.e., a FimB or FimE recombination event to the OFF state coupled with 
transcription from the inverted PfimA may be necessary for this H-NS-mediated biasing 
into the OFF state) (374).  Lrp, in conjunction with IHF, positively and negatively 
regulate fim expression (148, 152, 279) (Figure 1-8B).  Lrp binding to the fim locus may 
weakly alter transcription of fimB (upregulate) and fimE (downregulate) (390).  Lrp 
regulates the inversion of fimS (both ON-to-OFF and OFF-to-ON), through specific 
binding to sites within this element (148, 152, 279, 348, 351, 352, 383).  Indeed, there are 
three Lrp binding sites in the fimS element, and when Lrp binds sites 1 and 2, site-specific 
recombination of the promoter is favored (383).  As Lrp wraps or bends DNA, Lrp 
binding may facilitate site-specific recombination at the inverted repeats bracketing fimS, 
by bringing the inverted repeats into proximity with each other (279).  In contrast, Lrp 
binding to sites 1, 2, and 3 inhibits site-specific recombination.  In addition, branched 
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Figure 1-8.  Like regulation of the pap operon, fim operon regulation is dependent 
on NAP binding context and inversion of the fimS promoter element.  (A) H-NS 
binds and represses expression of the inverted repeat (depicted by inverted black 
arrowheads) recombinase genes fimB and fimE (gray arrows).  H-NS binding in the 
vicinity of the fimS element also inhibits recombination of this element.  As PfimA faces 
toward the recombinases, the fim operon is OFF (gray arrow).  (B) When Lrp binds to 
Lrp-binding sites 1 and 2, with IHF binding to IHF-binding sites I and II, recombination 
at the fimS element could be promoted, and PfimA could be directed into the ON or OFF 
orientation, denoted “ON/OFF”.  In the case of the ON orientation, PfimA faces away from 
the recombinase genes (black arrow).  Also depicted is differential regulation of fimB and 
fimE; fimB is induced (black arrow) and fimE is repressed (gray arrow) in the depicted 
scenario.  In addition, Lrp-binding site 3, sensitive to Lrp binding to leucine, inhibits 
recombination of fimS.  As such, it may be thought of as locking the fim element into a 
particular orientation, denoted “Lock”.  Lrp binding to site 3 is depicted with a faded oval 
(i.e., recombination will be able to proceed in this scenario). 
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chain amino acids seem to favor Lrp dissociation from site 3, which integrates 
environmental cues to Lrp-mediated regulation of the fim operon (383).  IHF, the other 
fim operon dual regulator, binds one site in the vicinity of fimS and another site in fimS to 
promote DNA bending and FimB- and FimE-mediated recombination, perhaps in a 
manner similar to Lrp above (148, 279).  Again, this shows how Lrp and H-NS, along 
with IHF, could be thought of as a switch vying for prominence in fim regulation. 
 Expression of flagellar genes appears to be linked to an H-NS and Lrp switch 
(Figure 1-6 and Table 1-2).  Indeed, an hns mutation substantially decreases motility, 
and an lrp mutation increases motility (355, 375, 376).  It is interesting to note, however, 
that H-NS is a dual regulator of flagellar gene regulation (378).  In particular, H-NS 
binding to a site after the transcriptional start site of PflhDC mediates positive regulation of 
flagellar genes, whereas H-NS binding to additional sites in the vicinity of PflhDC may 
contribute to downregulation of motility genes (378).  In addition, H-NS negatively 
regulates hdfR, which encodes a known negative regulator of flhDC (376).  H-NS also 
negatively regulates rcsD, which encodes a kinase regulating the activity of RcsB, 
another negative regulator of flhDC (376, 377).  Likewise, H-NS represses csgD, a gene 
encoding the curli operon regulator (235, 376, 380).  CsgD, in turn, decreases motility 
(376, 391).  At present, it remains unclear why an lrp mutation promotes motility, but it 
has been suggested that lack of positive regulation of adhesin operons and associated 
motility regulators may explain this phenotype (355).  Nevertheless, as both NAPs are 
involved in regulating motility, particularly H-NS both positively and negatively and Lrp 
negatively, elements of the switch discussed above are part of this regulation.  Additional 
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regulators (associated with the underlying H-NS and Lrp-mediated regulation), however, 
could be part of this switch, underscoring the possible virtual nature of this switch.   
 The switch between multicellular (sometimes adherent) and unicellular 
(sometimes motile) lifestyles exhibits elements of H-NS and Lrp control (Table 1-2).  H-
NS, for instance, negatively regulates genes associated with curli biosynthesis (326, 376, 
379, 381).  H-NS, in addition, negatively regulates a number of enzymes with 
diguanylate cyclase activity (i.e., mediating c-di-GMP formation) (376).  Thus, H-NS 
may inhibit cellulose synthesis in a CsgD- and c-di-GMP-dependent manner (392-394).  
Cellulose and curli are both components of some adherent biofilms (140, 229-236).  This 
negative regulation is relieved by an hns mutation in CFT073 (Figure 1-9A), a UPEC 
strain that ordinarily does not produce curli and cellulose (238).  Furthermore, ectopic 
expression of lrp promotes synthesis of curli and/or cellulose (Figure 1-9B).  
Additionally, Type 1 fimbrial operon regulation includes a possible switch between H-NS 
and Lrp (148, 150, 279, 348, 351, 352, 374), and these fimbriae contribute to biofilm 
formation (395, 396).  These examples further underscore that elements of the H-NS and 
Lrp switch may be associated with changes between multicellular and unicellular 
behaviors.   
H-NS and Lrp also coordinate the production and activity of type 6 secretion 
systems (Table 1-2). In terms of further regulating a switch to multicellularity, H-NS 
silences the expression of the SPI-6 type 6 secretion system genes in S. enterica (382).  
This type 6 secretion system is hypothesized to inhibit competing bacteria and 
homogenize and synchronize the S. enterica population to promote infection (382), which  
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Figure 1-9.  H-NS negatively regulates and Lrp positively regulates curli and/or 
cellulose production in Escherichia coli strain CFT073.  (A) After 48 hours of 
incubation at 37 °C on a YESTA (yeast extract and tryptone agar) plate containing 40 
µg/mL Congo red and 1 µg/mL Coomassie Brilliant Blue R-250, a UPEC strain CFT073 
hns mutant binds the Congo red dye indicating the production of curli and/or cellulose; 
the UPEC CFT073 wild-type strain does not bind the Congo red dye.   (B) After 48 hours 
of incubation at 37 °C on a YESTA plate containing Congo red, Coomassie Brilliant Blue 
R-250, ampicillin (100 µg/mL), and 10 mM L-arabinose, UPEC CFT073 harboring 
pBAD-lrp exhibits the rdar (red, dry, and rough) phenotype indicating the production of 
curli and/or cellulose; UPEC CFT073 harboring the empty pBAD plasmid does not 
exhibit the rdar phenotype.     
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can be thought of as a multicellular behavior.  In the same pursuit, Lrp has some 
regulatory function governing the Dienes phenomenon in P. mirabilis, another 
uropathogen (Figure 1-10).  The Dienes phenomenon occurs during swarming motility (a 
type of multicellular behavior) and is dependent on a type 6 secretion system (397).  Lrp, 
in addition to mediating the Dienes phenomenon, is implicated in promoting swarming 
motility (398).  Genes encoding energy and metabolic pathways also appear to be 
important for swarming motility (399-401), which possibly extends differential nucleoid 
regulation to this behavior.   
 Swarming motility itself, however, blurs the distinction between adherence and 
motility.  For example, flagella themselves become numerous on the cell surface (i.e., 
resembling a cell with numerous fimbriae on its surface, instead of a cell with a few 
peritrichous flagella) and mediate swarm cell interaction (e.g., adherence) to each other 
during movement across a surface (402).  Thus, swarming motility may be a unique 
blending of adherence and motility.  Although not explored, it is also reasonable to 
speculate that the P. mirabilis type 6 secretion system, as was suggested for the S. 
enterica type 6 secretion system above, may have a function synchronizing and 
coordinating the cell population and communicating nucleoid state to neighboring cells.   
E. coli encodes numerous NAPs, which change in prominence during the switches 
between E. coli growth phases.  Thus, generalizing a switch governing adherence and 
motility reciprocal regulation, through H-NS and Lrp, may require the activity of 
additional regulators including other NAPS.  This is especially true as both H-NS and Lrp 
negatively regulate lrp (403).  Thus, an underlying mechanism may be necessary to 
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Figure 1-10.  Lrp modulates the Dienes phenomenon during multicellular swarming 
motility in P. mirabilis.  (A) A Dienes line (black arrow) is formed between wild-type P. 
mirabilis HI4320 and an HI4320 pefE mutant.  No Dienes line is formed between the P. 
mirabilis HI4320 lrp mutant and the pefE mutant and wild-type HI4320.  (B) A Dienes 
line (black arrow) is formed between P. mirabilis strain BB2000 and the P. mirabilis 
HI4320 lrp mutant.  No Dienes line is formed between the P. mirabilis BB2000 type 6 
secretion system mutant (Δt6ss) and the lrp mutant.  (C) A Dienes line forms between a P. 
mirabilis HI4320 recF mutant (similar swarming pattern to the lrp mutant) and the 
HI4320 pefE mutant above.  No Dienes line forms between P. mirabilis HI4320 and the 
HI4320 recF mutant.   (D) A Dienes line forms between the P. mirabilis HI4320 recF 
mutant and P. mirabilis BB2000 wild-type and the type 6 secretion system mutant.       
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reconcile this result with the apparent switching phenomenon described above (i.e., allow 
a cell to express lrp even with abundant H-NS).  Nevertheless, differential prominence of 
H-NS and Lrp, is an element of adherence and motility reciprocal regulation and the 
switch between multicellular and unicellular lifestyles. 
 
 
tosA regulation, a hypothesis of unification between the E. coli nucleoid and adhesin 
and motility reciprocal regulation 
 
Statement of the problem 
 As described above, the tos operon is poorly expressed when UPEC strain 
CFT073 is cultured under typical laboratory conditions, but well expressed during an 
experimental murine UTI (208, 227).  Thus, this finding represents a gap in our 
understanding of the environment UPEC encounters during a UTI and how nucleoid 
states couples with environmental cues to regulate the tos operon.  As TosA is an adhesin, 
studying regulation of the tos operon could identify and fill gaps in our knowledge of 
reciprocal regulation of adhesin and motility system genes and potentially how nucleoid 
state couples to these lifestyles.   
 
Hypothesis one: regulators encoded by genes in the tos operon, in addition to 
nucleoid structure, contribute to tos operon positive and negative regulation.  
Environmental stimuli are also coupled to specific regulators of the tos operon. 
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 The tos operon itself encodes three putative DNA binding proteins.  These DNA 
binding proteins include TosR (PapB family homolog), TosE, and TosF (both LuxR 
family members).  PapB family members are known to be both positive and negative 
regulators of cognate adhesin operons (179, 180, 202, 203, 404).  Therefore, TosR is one 
logical candidate for being a dual regulator of the tos operon, and dual regulation of this 
operon may be achieved through differential TosR DNA binding in the vicinity of Ptos.  
However, it is not clear whether TosE and TosF have functions associated with tos 
operon regulation or additional regulatory functions (e.g., reciprocal regulation).  In 
addition, the nucleoid structuring proteins H-NS and Lrp both contribute to adhesin 
operon regulation (148, 150, 179, 181, 202, 204, 279, 326, 348, 351, 352, 354, 371-374, 
376, 379, 381).  Thus, regulation of the tos operon may be mediated through a 
perturbation of nucleoid structure.  The H-NS and Lrp regulatory switch discussed above 
is also a logical candidate for underpinning regulation of the tos operon.  H-NS may 
repress the tos operon, as is the case for other adhesins operons (148, 179, 181, 202, 351, 
354, 371-374), and Lrp may mediate positive or negative regulation of the tos operon, as 
is the case for other adhesin operons (148, 179, 202, 204, 279, 348, 352, 354).  Sensing 
environmental stimuli may be relayed to the cell in the form of differential regulation by 
NAPs, which may also contribute to tos operon regulation.  Upon completion of this 
work, a clearer picture of tos operon regulation will emerge.  This work will also expand 
our understanding of nucleoid structuring proteins and regulators associated with the tos 
operon.      
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Hypothesis two: regulators associated with the tos operon and tos operon regulation 
(including NAPs) are involved in the switch governing E. coli adhesin and flagellar 
operon reciprocal regulation. 
 The regulation of many adhesin operons is coupled to a switch underlying 
reciprocal regulation between adhesin and flagellar operons (186-188, 239, 240, 355).  A 
great deal of this reciprocal regulation is mediated by both nucleoid structuring proteins 
and genes encoded at the 3’ end of adhesin operons (148, 150, 179, 181, 186-188, 202, 
204, 239, 240, 279, 326, 348, 351, 352, 354, 355, 371-379, 381).  Thus, H-NS- and Lrp-
mediated regulation of additional genes, coupled with regulation of the tos operon, could 
contribute to the phenomenon of reciprocal regulation of adherence and motility in E. coli.  
Likewise, as TosE and TosF are encoded by the terminal regulator genes of the tos 
operon, these regulators may also contribute to decreased motility.  PapB family 
members, in addition, could cross-regulate each other (203, 204, 248-250).  Therefore, 
exploring how TosR-mediated regulation of the tos operon is coupled to adhesin 
reciprocal regulation is a logical area of study.  Upon completion of this work, both a 
clearer and broader picture of E. coli reciprocal regulation will emerge.  This work will 
also present a clearer picture of how nucleoid structure couples tos operon regulation 
with the phenomenon of reciprocal regulation, in a unified manner. 
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CHAPTER 2 
A CONSERVED PAPB FAMILY MEMBER, TOSR,  
REGULATES EXPRESSION OF THE UROPATHOGENIC ESCHERICHIA COLI  
RTX NONFIMBRIAL ADHESIN TOSA WHILE CONSERVED  
LUXR FAMILY MEMBERS, TOSE AND TOSF, SUPPRESS MOTILITY 
 
Modified from: M. D. Engstrom, C. J. Alteri, and H. L. T. Mobley. 2014. Infection 
and Immunity 82: 3644-56.  
 
Abstract 
 
A heterogeneous subset of extraintestinal pathogenic Escherichia coli (ExPEC) 
strains, referred to as uropathogenic E. coli (UPEC), cause most uncomplicated urinary 
tract infections.  However, no core set of virulence factors exists among UPEC strains. 
Instead, the focus of urovirulence has shifted to studying broad classes of virulence 
factors and the interactions between them.  For example, the RTX nonfimbrial adhesin 
TosA mediates adherence to host cells derived from the upper urinary tract.  The 
associated tos operon is well expressed in vivo, but poorly expressed in vitro, and encodes 
TosCBD, a predicted type 1 secretion system.  TosR and TosEF are PapB and LuxR 
family transcription factors, respectively; however, no function has been assigned to 
these potential regulators.  Thus, the focus of this study was to determine how TosR and 
TosEF regulate tosA and affect the reciprocal expression of adhesins and flagella.  
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32% (101/317) of sequenced UPEC strains were found to encode TosA.  Nearly all 
strains carrying tosA [91% (92/101)] simultaneously carry the putative regulatory genes.  
Deletion of tosR alleviates tosA repression.  The tos promoter was localized upstream of 
tosR using transcriptional fusions of putative promoter regions with lacZ.  TosR binds to 
this region affecting a gel shift.  A 100 bp fragment 220-319 bp upstream of tosR inhibits 
binding suggesting localization of the TosR binding site.  TosEF, on the other hand, 
down-modulate motility when overexpressed by preventing expression of fliC encoding 
flagellin.  Deletion of tosEF increased motility.  Thus, we present an additional example 
of the reciprocal control of adherence and motility.   
 
 
Introduction 
 
Urinary tract infections (UTIs) are the second most common bacterial infection in 
humans (405).  UTIs can be classified as complicated or uncomplicated infections.  
Uncomplicated UTIs, occurring in otherwise healthy individuals, are self-limited 
infections of the bladder, referred to as cystitis (12, 13, 406).  However, upon bacterial 
ascension into the kidney, a more serious infection referred to as pyelonephritis can 
develop (12, 13).  Pyelonephritis, in turn, can lead to the development of bacteremia and 
sometimes fatal urosepsis (14, 15).   
UTIs normally occur when uropathogens that colonize the intestine alongside 
commensal organisms gain access to the periurethral area and then ascend to the urinary 
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bladder (407, 408).  A heterogeneous subset of extraintestinal pathogenic Escherichia 
coli (ExPEC) strains, referred to as uropathogenic E. coli (UPEC), cause the 
overwhelming majority of uncomplicated UTIs (13).  UPEC strains carry a battery of 
virulence factors including adhesins, toxins, and iron acquisition systems, which promote 
uropathogenesis (23, 44).  However, no core set of virulence factors has been identified.  
Instead, any given UPEC strain appears to use various virulence factors from these three 
classes of virulence determinants to colonize the urinary tract (33, 35).  This thesis 
requires that we consider established, newly discovered, and putative virulence factors, as 
well as the interactions among them, to better understand urovirulence. 
Adhesins represent one broad class of virulence determinants.  Fimbrial adhesins 
assembled via the chaperone-usher pathway are the most extensively studied adherence 
factors (143, 409).  Indeed, the genes necessary to synthesize two chaperone-usher 
fimbriae, Type 1 and P fimbriae (pyelonephritis associated pili), were among the first 
cloned virulence factor genes (145, 410) and are important during experimental and 
human UTI, respectively (34, 164-167, 170, 172).  In addition, seven other putative 
chaperone-usher fimbriae are encoded by prototype UPEC strain CFT073 alone (36).  On 
the other hand, nonfimbrial adhesins have garnered less attention than chaperone-usher 
adhesins.  These adhesins, nevertheless, can also contribute to uropathogenesis (39, 208, 
411-413), underscoring the importance of continued study of this adhesin class.   
In addition to adhesins, flagella-mediated motility also contributes to the 
development of ascending infection to the upper urinary tract (110-112).  It is now 
recognized, however, that adherence genes and flagellar genes can be reciprocally 
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coordinated (187, 188, 240, 355, 414, 415).  In this network, it is logical that an adherent 
bacterium should not be motile and a motile bacterium should not be adherent.  That is, 
when fimbrial genes are expressed, flagellar genes should be repressed and vice versa.   
With respect to nonfimbrial adhesins, we have previously described that UPEC 
strain CFT073 encodes within its aspV pathogenicity island (PAI-aspV), an RTX 
(repeats-in-toxin) nonfimbrial adhesin, referred to as TosA (or type one secretion protein 
A; originally annotated UpxA) (36, 39).  RTX proteins are typically thought of as toxins 
that are secreted through a type 1 secretion system and diffuse away from the bacterium 
to mediate effects on the host.  This is exemplified by the family prototype α-hemolysin 
(46, 48, 63, 64, 66, 68, 416).  However, adhesins secreted in the same manner, but 
remaining associated with the bacterial cell surface are a growing group of RTX proteins 
composed of at least six other well characterized members (50).  We presume that TosA 
contributes to uropathogenesis by binding to receptors on the surface of host epithelial 
cells derived from the upper urinary tract.  Indeed, deletion of tosA creates a fitness and 
virulence defect for E. coli CFT073 during an experimental transurethral co-challenge of 
mice with the parental wild-type strain (39) or independent challenge (227).  This same 
mutant also shows a fitness defect in the spleens and livers during bacteremia, suggesting 
a function for TosA during urosepsis (208).  The tosA gene was previously found in an 
estimated one-fourth of UPEC strains (35, 39). 
An intriguing feature of the tos operon is its strong in vivo expression, but poor in 
vitro expression (208).  Indeed, TosA was discovered in an IVIAT (in vivo induced 
antigen technology) screen that identified gene products preferentially expressed in vivo 
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(227).  The mechanism that explains tight regulation is not understood.  Therefore, the 
focus of this study was to identify regulatory elements associated with tosA expression 
and the consequences of this regulation as it relates to the reciprocal regulation of 
motility and adherence.  We found that TosR, a PapB family member, represses 
expression of tosA, while TosE and TosF, two members of the LuxR family, mediate the 
repression of motility.  This work furthers our understanding of how adhesins are 
regulated and helps to describe the underlying network governing the interplay between 
adherence and motility. 
 
 
Materials and Methods 
 
Strain construction   
E. coli CFT073 deletion mutants ΔtosR, ΔtosEΔtosF, and ΔtosRΔtosEΔtosF, were 
generated and screened via PCR in an unmarked ΔlacZ background using primers 
described in Table 2-1 and the lambda red recombineering method previously described 
(417).  The original ΔlacZ construct was selected for on lysogeny broth (LB) agar (10 g/L 
tryptone, 5 g/L yeast extract, 0.5 g/L NaCl, 15 g/L agar) containing chloramphenicol (20 
µg/mL), and unmarked as previously described (417).  All other mutants were selected 
for on LB plates containing kanamycin (25 µg/mL).  In the case of ΔtosR aph+, this 
deletion mutation was unmarked as above to produce ΔtosR.  The tosR mutation was also 
moved into a clean background of wild-type E. coli CFT073 by transduction using phage 
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Table 2-1.  Primers used in this study. 
Primera 
 
Sequence (5’-3’) 
ΔlacZ F 
 
GAAATTGTGAGCGGATAACAATTTCACACAGG
ATACAGCTGTGTAGGCTGGAGCTGCTTC 
 
ΔlacZ R 
 
CTTACGCGAAATACGGGCAGACATAGCCTGCCC
GGTTATTAATGGGAATTAGCCATGGTCC 
 
ΔlacZ Screen F GAAAGCAGACCAAACAGCGG 
 
ΔlacZ Screen R TAACAGAACGGGAAGGCGAC 
 
ΔtosR F ATAATAAATTAAACATTGAATAATGTGTAATGG
TATGGCAGTGTAGGCTGGAGCTGCTTC 
 
ΔtosR R ACTAAAAACTATTATTATAATATTCACTTAGCA
ATGCGCAATGGGAATTAGCCATGGTCC 
 
ΔtosR Screen F 
 
CGACGTGCGCCATCGTGTCTG 
ΔtosR Screen R 
 
GATTGTGCCGAAGTTAACTCCGCCC 
ΔtosEΔtosF F 
 
TATATACTTCTTGTAGAAGGCATAATGTATGAA
TATAATGGTGTAGGCTGGAGCTGCTTC 
 
ΔtosEΔtosF R 
 
CTTATCTACATAATAATAGACCTTTGTAAAATA
ACTGTATATGGGAATTAGCCATGGTCC 
 
ΔtosEΔtosF Screen F 
 
GGCTGACGGAGCGGGAAGTCTG 
ΔtosEΔtosF Screen R 
 
GCCCACTCATCAGTGAGTACCC 
 
pBAD-tosR-HisA F 
 
NNNNCCATGGCTTGTAATGGTATGGCAGATCAT
ATACAG 
 
pBAD-tosR-HisA R NNNNNAAGCTTCGCCCGAAAACTATTATTATAA
TATTCACTTAGCAATGCGCA 
 
pBAD-tosEF F 
 
NNNNCTCGAGTAATATAATGATTGTTACGCACA
ATAAATATC 
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pBAD-tosEF R 
 
NNNNCTGCAGTTATCTACATAATAATAGACC 
pBAD Screen F 
 
TGCCATAGCATTTTTATCC 
pBAD Screen R 
 
CTGATTTAATCTGTATCAGG 
PR F 
 
NNNNNGAATTCGTCAGTCGAAACTCAGGAGTG
TGGAGG 
 
PR R 
 
NNNNNGGATCCCTGTATATGATCTGCCATACCA
TTACACAT 
 
PC F 
 
NNNNGAATTCATTTTTATATCCACCCCCCCTTTA
A 
 
PC R 
 
NNNNGGATCCTTTTATGATTTTTATTTAAAATAT
T 
 
PA F 
 
NNNNGAATTCTTTATTATATTATTAATATCATG
GC 
 
PA R 
 
NNNNGGATCCATAAAATCCTTAGGCTAATTAAA
AC 
 
Promoter Screen 1 
F (PR) 
 
NNNNGGTACCATAAACTGCCAGGAATTGGGGA
TCG 
Promoter Screen 2 F (PC 
and PA) 
 
CCGCCGGGAGCGGATTTGAA 
Promoter Screen R (PR, 
PC, and PA) 
 
GATCGGTGCGGGCCTCTTCG 
PtosR Shift F 
(PtosR1 F) 
 
AAGTTTTGGGGTGCAGTCCAC 
PtosR Shift R 
(PtosR7 R) 
 
CTGTATATGATCTGCCATACCATTACACAT 
lacZ Shift F 
 
GCGAATACCTGTTCCGTCATAGCG 
lacZ Shift R 
 
CATCGCCAATCCACATCTGTGAAAG 
PtosR1 R TAGATATTATTGTTATCCATCATGT 
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PtosR2 F 
 
TTTAATCACTACCGCCTTGGTCGCT 
PtosR2 R 
 
GCATTTTTTTGGTAAAAATCAATTTTTATA 
PtosR3 F 
 
TAATATAGATATTATCTGCATATAA 
PtosR3 R 
 
AAAAAGTGAAATCTCAAAACAAAAAAT 
PtosR4 F 
 
CCATTTGTTTTATTTTATAAATAATTTTTTG 
PtosR4 R 
 
TACTAGAGATTACATCTAAAAAATT 
PtosR5 F 
 
TTAGATAAAAACCCTACAGAGAAGT 
PtosR5 R 
 
CCTCAATCAAAAAACCATTAAATGAAATTTA 
PtosR6 F 
 
TTATTGGTTTTATTGGTTTTAAATTTCATTT 
PtosR6 R 
 
TATTGATTCACATTATAAATACATATT 
PtosR7 F 
 
GCAAAAAAAATTTGATGCAAACAAATATG 
tosA-tosE F 
 
CTCAGTTAGTCAAGTTAACGGCATCGG 
tosA-tosE R 
 
GATGACAGGCTACTTATTGATTCTACTGG 
tosE-tosF F 
 
CCATGGGTGGAATGTAGCAAGTATTGC 
tosE-tosF R 
 
GCGTGGATAATATCCCTGAGAAAATC 
a F, forward; R, reverse 
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ΦEB49 (418),  with the following modification: phage lysate and overnight culture were 
incubated together at room temperature for 20 min at a ratio of 1:5.  These constructs 
were verified with PCR using the primers listed in Table 2-1.  The ΔtosR mutation was 
also verified with DNA sequencing. 
 TosR-His6 was constructed by cloning tosR into the NcoI and HindIII sites of 
pBAD-myc-HisA (Invitrogen).  A tosEF overexpression construct was generated by 
cloning tosEF into the PstI and XhoI sites of pBAD-myc-HisA.  All constructs were 
verified with PCR, and the pBAD-tosR-His6 construct was verified by DNA sequencing.  
Plasmids were maintained in LB containing ampicillin (100 µg/mL).  Primers used for 
generating and screening plasmid constructs are described in Table 2-1. 
 lacZ transcriptional fusions of intergenic and intragenic regions within the tos 
operon were generated by cloning the 600 , 233 , and 198 bp regions upstream of tosR, 
tosC, and tosA, respectively, into the EcoRI and BamHI sites of pRS551 (187), 
generating pRS551-(PR, PC, PA)-lacZ.  Constructs were verified by PCR and DNA 
sequencing in the case of pRS551-PC-lacZ and pRS551-PA-lacZ.  Plasmids were 
maintained in LB containing kanamycin (25 µg/mL).  The primers used to generate and 
screen these transcriptional fusions are listed in Table 2-1. 
 
Bioinformatics   
A structural prediction of the TosA 335 amino acid tandem repeats (208) was 
constructed by entering this sequence into the Phyre2 server (419) under the normal 
modeling mode option.  Likewise, the 101, 105, and 110 amino acid sequences of TosR, 
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PapB, and FocB, respectively were entered in the Phyre2 server as above.  The highest 
scoring predicted structure was selected as the putative structure of the TosA repeat 
amino acid sequence.  In addition, the highest scoring models for TosR, PapB and FocB 
were similarly selected as the putative structure of these proteins.  To construct a GC 
sliding window plot of the tos operon, 12,200 bp including the entire tos operon and 
adjacent nucleotide sequences were entered into the seqinr R environment (420).  We 
modified a sliding window plot of GC content program 
(http://a-little-book-of-r-for-bioinformatics.readthedocs.org/en/latest/src/chapter2.html) to 
construct a 200 bp sliding window GC content plot of the tos operon in R (version 3.0.1), 
which was fit to a representation of the tos locus.  Average GC content for each gene and 
the total E. coli CFT073 chromosome was estimated using the sequence statistics feature 
of SeqBuilder (DNASTAR). 
 The prevalence of the genes encoding predicted regulators TosR, TosE, and TosF, 
was estimated by entering the first 100 amino acids of TosA from E. coli CFT073 into 
the BLAST query tool available on the Broad Institutes’ UTI Bacteremia initiative 
website (https://olive.broadinstitute.org/comparisons/ecoli_uti_bacteremia.3) [E. coli UTI 
Bacteremia initiative, Broad Institute (broadinstitute.org), unpublished data].  A search 
was performed against the genomes present in this database, with an arbitrary E-value 
cutoff of 1x10-20.  The results from this search represent strains carrying the tosA gene.  
The E. coli CFT073 amino acid sequences for TosR, TosE, and TosF were then subjected 
to the same BLAST search.  The resulting hits from these searches were correlated with 
tosA prevalence.  Predicted amino acid sequences of TosR, TosE, and TosF variants were 
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aligned with MegAlign (DNASTAR) using Clustal V.  In addition, within the seqinr 
(420), Biostrings (421), and gdata (422) R environments, we analyzed the GC content of 
tos genes from the UPEC strains described above using several algorithms that we 
developed. 
    
Deletion mutant and overexpression construct experimental culture conditions 
 The tos operon deletion constructs were cultured at 37 °C in LB containing 
kanamycin (25 µg/mL) to mid-log phase (A600 ≈ 0.5).  Bacteria were harvested at 6000 x 
g for 10 min.  The cell pellet was again resuspended in 10mM HEPES, pH 8.3-8.9, and 
centrifuged again.  The bacterial cell pellet was resuspended in 10 mM HEPES, pH 8.3-
8.9.  The cell suspension was stored at -30 °C prior to quantification with a Pierce BCA 
Protein Assay Kit (Thermo Scientific) and Western blot. 
 The pBAD-tosR-His6 construct was induced in the unmarked ΔtosR background, 
with 0.05, 0.2, 0.6, 3, and 10 mM L-arabinose in LB containing ampicillin (100 µg/mL) 
until the culture reached mid-log phase (A600 ≈ 0.5). Whole cell proteins were collected, 
stored, and quantified.   
To assay fliC expression, the pBAD-tosEF construct was induced in E. coli 
CFT073 with no or 30 mM L-arabinose in tryptone broth (10 g/L tryptone and 5 g/L 
NaCl) containing ampicillin (100 µg/mL) for 2.5 h.  Material was harvested as described 
above, with the exception that the culture was centrifuged only once at 1100 x g for 10 
min prior to resuspension in 10 mM HEPES, pH 8.3-8.9, and stored at -30 °C.  
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Western blots of deletion mutants and overexpression constructs   
To detect TosA, total protein from tos deletion mutants, E. coli CFT073, or E. coli 
CFT073 (pBAD overexpression constructs) was collected and Western blots were 
performed.  Briefly, equal amounts of total proteins, as determined using a Pierce BCA 
Protein Assay Kit (Thermo Scientific), from specific constructs were resolved, 
transferred, and blotted with polyclonal Anti-TosA antibodies (208), polyclonal 
Anti-FliC antibodies (414), or an anti-His6 antibody (Invitrogen).     
 
β-galactosidase assay 
Miller assays were performed as previously described (423) with the exception 
that bacteria harboring the lacZ transcriptional fusions described above were cultured to 
mid-log phase (A600 ≈ 0.6-0.8) in LB containing kanamycin (25 µg/mL) and, after resting 
on ice and centrifugation, were resuspended in Z Buffer (pH 7.0; 60 mM Na2HPO4⋅7H2O, 
40 mM NaH2PO4, 1 M KCl, 1 mM MgSO4, 50mM β-mercaptoethanol).  
 
TosR-His6 purification 
TosR-His6 protein was isolated by incubating 50 mL cultures of CFT073 
harboring pBAD-tosR-His6 to mid-log phase (A600 ≈ 0.5) in LB containing ampicillin 
(100 µg/mL) and subsequently inducing expression with 10 mM arabinose for 2.5 hours.  
Bacteria from this culture were pelleted at 2700 x g and stored at -30 °C.  TosR-His6 was 
extracted using a modified QIAexpressionist protocol (Qiagen).  Briefly, the cell pellet 
was resuspended in lysis buffer (pH 8.0; 50 mM NaH2PO4, 300 mM NaCl, and 40 mM 
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imidazole) and passed three times through a French Pressure Cell at 1200 lbs/in2.  
Cellular debris was cleared by centrifugation at 10,000 x g.  The Ni-NTA agarose 
(Invitrogen) was equilibrated as described in the QIAexpressionist protocol (Qiagen), 
with the exception that half of the volume of Ni-NTA and lysis buffer were used in this 
step.  Cleared lysate was incubated with Ni-NTA agarose at room temperature for 30 min 
and subsequently ran through a column.  The column bed was washed three times with 
washing buffer (pH 8.0; 50 mM NaH2PO4, 300 mM NaCl, and 60 mM imidazole) and 
bound proteins were eluted with elution buffer (pH 8.0; 50 mM NaH2PO4, 300 mM NaCl, 
and 250 mM imidazole).  Eluted proteins were concentrated with 10 kDa Amicon Ultra 
Centrifugal Filters (Millipore), and quantified using a 2-D Quant Kit (GE Healthcare); 
this concentrate was dissolved in 10 mM HEPES, pH 8.3-8.9.  Purity of the TosR-His6 
concentrate was assessed on a 12% SDS-polyacrylamide and staining with SimplyBlue 
SafeStain (Life Technologies).  The presence of TosR-His6 was confirmed by Western 
blot as described above.    
 
Electrophoretic mobility shift assay of the tos operon promoter 
PCR was performed to amplify PtosR and lacZ DNA probes using the gel shift 
primers described in Table 2-1 and Easy-A high fidelity enzyme (Agilent).  These probes 
were terminally labeled with Digoxigenin-11-ddUTP (DIG-ddUTP) using a 2nd 
generation DIG Gel Shift Kit (Roche Applied Science).  Assessing probe labeling 
efficiency, TosR-His6 DNA binding reactions, and resolving and detecting shifted DNA 
probes were all performed as described in the same kit protocol, with the exception that 
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the 25-min binding reactions contained only binding buffer (pH 7.6; 100 mM HEPES, 5 
mM EDTA, 50 mM (NH4)2SO4, 5 mM DTT, 1% (vol/vol) Tween, 150 mM KCl) in 
addition to proteins and labeled or unlabeled DNA probes.  The concentrations of gel 
running and transfer buffers were increased to 1X TBE (89.0 mM Tris, 89.0 mM boric 
acid, 2.0 mM EDTA, pH 8.0), and the Anti-DIG-AP detection antibody dilution used was 
decreased to 1:1000, from 1:10,000.  
 Unlabeled ~100bp PtosR fragments were generated using primers described in 
Table 2-1 as above.  An electrophoretic mobility shift assay was again performed as 
above on DIG-ddUTP PtosR using the aforementioned PCR products as unlabeled 
competitors.  However, 5% the amount of labeled probe was used in these competition 
electrophoretic mobility shift competition assays, compared with the above reactions.   
 
RNA extraction and RT-PCR 
cDNAs were synthesized from equal amounts of RNAs extracted from wild type 
E. coli CFT073 and ΔtosR constructs in exponential phase (A600≈0.4-0.5) cultured in LB 
as previously described (227).  An exception to this extraction protocol was to stop half 
the amount of cellular material previously described with half the amount of stopping 
solution (5% phenol in ethanol).  RT-PCR was performed on equal amounts of the above 
cDNAs using the primers directed against the tosAE intergenic region or the tosEF 
intergenic region are described in Table 2-1.  Equal volumes of each PCR were loaded 
into sample lanes, and DNA amplicons were resolved on a 1% (wt/vol) agarose gel.        
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Motility assays 
Overnight cultures of E. coli CFT073 harboring pBAD-myc-HisA, pBAD-tosR-
His6, and pBAD-tosEF were normalized to A600=1.0 in 10 mM HEPES, pH 8.3-8.9 and 
stabbed into soft agar (10 g/L tryptone, 5 g/L NaCl, 2.5 g/L agar) containing ampicillin 
(100 µg/mL) with 33.3 mM L-arabinose.   After 17 hours of incubation at 30 °C, the 
diameter of the zone of swimming was measured.  ΔtosR, ΔtosEΔtosF, ΔtosRΔtosEΔtosF, 
and wild-type constructs were also assayed as above, with the exception that the soft agar 
did not contain antibiotics or L-arabinose.   
 
Growth curve generation 
Overnight cultures of E. coli CFT073 harboring pBAD-myc-HisA, pBAD-tosR-
His6, and pBAD-tosEF were diluted 1:100 into tryptone broth (10 g/L tryptone and 5 g/L 
NaCl) containing ampicillin (100 µg/mL) and 30 mM L-arabinose.  Constructs were 
cultured at 30 °C for 24 hours in a Bioscreen C Automated Growth Curve System, with 
A600 readings recorded every 15 min.  This procedure was the same for ΔtosR, 
ΔtosEΔtosF, ΔtosRΔtosEΔtosF, and wild-type constructs, with the exception that the 
tryptone broth did not contain antibiotics or L-arabinose.   
 
Statistical analysis 
Statistical significance of all single comparisons were determined using an 
unpaired Student’s t-test.  Multiple comparisons were made using an unpaired ANOVA 
followed by a Tukey’s multiple comparisons test.  With the exception of the tos operon 
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GC content plot graphed in R (version 3.0.1), all other graphs and statistical testing were 
performed in GraphPad Prism (version 6.0).   
 
 
Results 
 
The tos operon of E. coli CFT073 encodes the TosA adhesin, type 1 secretion system, 
and three putative regulators 
In E. coli CFT073, the tos operon encodes the high molecular weight RTX 
nonfimbrial adhesin, TosA (Figure 2-1A and 2-1B).   In addition, the tos operon encodes 
genes for a putative type 1 secretion system, tosCBD.  TosC is predicted to form the outer 
membrane pore through which TosA is released from the secretion system, TosB is the 
predicted ATPase/TosA recognition factor, and TosD forms the predicted periplasmic 
channel through which TosA passes (69, 208).  Three ORFs of previously unknown 
function, now annotated tosR, tosE, and tosF, are also located within the tos locus.  TosR 
is a homolog of the PapB family of adhesin regulators, and TosE and TosF align with 
LuxR family members (208).  
To assess whether TosA may possess structural features found in other 
nonfimbrial adhesins (50), a bioinformatics approach was taken to predict TosA features. 
We previously identified that TosA contained five tandem 335 amino acid sequence 
repeats (208).  A Phyre2 model (Figure 2-1A) (419) predicts that the structure of these 
repeats is similar to that of the bacterial immunoglobulin-like domain group three (BIg 3) 
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Figure 2-1. The tos operon encodes the genes for the RTX non-fimbrial adhesin 
TosA, a secretion system, and putative regulators, but does not have uniform GC 
content.  (A) The entire predicted 2516 amino acid (aa) sequence of TosA is represented 
by a red horizontal line.  Near the amino-terminus, a predicted transmembrane domain is 
designated ‘TM’ (vertical green line).  Tandem blue, green, and red boxes represent the 
predicted bacterial immunoglobulin-like (BIg) family 3 folds.  The corresponding 
predicted Ig fold structures (modeled using Phyre2 against SiiE from S. enterica, with 
98.5% confidence) are represented in the black box insert.  Near the carboxyl-terminus, 
the positions of ten tandem RTX repeats are denoted with orange vertical lines.  The 
sequence logo of the RTX repeats is noted (208).  (B) Within the tos locus, blue arrows 
represent genes (tosR and tosEF) encoding predicted DNA binding proteins, orange 
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arrows represent genes (tosCBD) encoding a predicted type 1 secretion system, and a red 
arrow represents the gene (tosA) encoding the RTX non-fimbrial above.  The entire tos 
locus is fit to a 200 bp sliding window plot of the GC content.  A black line denotes the 
average GC content of 80 UPEC genomes, while orange-red and blue lines represent the 
average GC content of tosCBDA, and tosR and tosEF in the same 80 genomes, 
respectively.   
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repeats found in the Salmonella enterica nonfimbrial adhesin SiiE (216).  Like other RTX 
nonfimbrial adhesins (50), TosA also contains 10 RTX repeats near its carboxyl-terminus 
(208) and a putative transmembrane domain near its amino terminus.   
 
tos operon genes are broadly conserved among UPEC strains   
As the GC content of genes within an operon tends to be similar (424), to 
determine whether this was also the case for the tos operon, we tracked the tos operon 
GC content using a 200 bp sliding window (Figure 2-1B).  The GC content of the 
structural genes (tosCBDA), 48.5%, is similar to that of the E. coli CFT073 backbone 
(averaging 50.5%).  However, the GC content of the putative regulatory genes, tosR, tosE, 
and tosF, is 29.1%, significantly lower than that of the chromosome, in general, and that 
of tosCBDA, in particular.  Thus, these data reveal that the putative tos operon regulatory 
genes have distinct GC content. 
 Given the differences in GC content among tosR and tosEF in E. coli CFT073, to 
determine whether these same regulatory genes are conserved in tos operons of other 
UPEC strains, we analyzed 317 sequenced genomes found in the Broad Institute’s UTI 
Bacteremia initiative database [E. coli UTI Bacteremia initiative, Broad Institute 
(https://olive.broadinstitute.org/comparisons/ecoli_uti_bacteremia.3)].  Among UPEC 
strains associated with this study, tosA was found in 32% (101 of 317) of isolates, a 
slightly higher prevalence than previously estimated by us in a PCR-based survey of our 
UPEC strain collection (35).  Of the strains encoding tosA, the overwhelming majority 
[92 of 101 (91%)] also encoded tosR and tosEF.  Among strains with single copies of 
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tosA and at least one gene among tosR and tosEF (96/101), our GC content analysis 
program was able to determine GC content for 83.3% (80/96) of these strains.  The GC 
content disparities among tos structural and regulatory genes described above held among 
these strains encoding the tos genes (Figure 2-1B).  Thus, while the GC content of tosR 
and tosEF (29.5%) is considerably lower than that of tosCBDA (46.8%), these genes are 
conserved and linked to each other within UPEC strains.  In agreement with this, we did 
not find these putative regulators in a UPEC background not encoding tosA.  However, 
4.0% (4/101) and 7.9% (8/101) of strains that encode tosA do not encode tosR and tosEF, 
respectively.  Therefore, the tosR and tosEF regulators are conserved and linked among 
the overwhelming majority of sequenced UPEC strains encoding tosA.  This conservation 
among UPEC strains, despite GC content differences, strongly suggests that tosR and 
tosEF encode factors promoting fitness in some situations.   
 
TosR, TosE, and TosF amino acid sequences show a clonal nature to the tos operon 
To determine whether the TosR amino acid sequence is conserved among UPEC 
strains, the predicted TosR amino acid sequence was aligned against the UPEC strains 
encoding genes for TosR in the Broad Institute’s UTI Bacteremia initiative database 
(Figure 2-2A).  Based on the unique TosR amino acid sequences, we assigned each TosR 
sequence into one of five sequence variant groups.  All variants have an overall predicted 
sequence identity of 59.0% among each other.  Variant 1 accounts for 84.5% of TosR 
sequences and is the variant found in E. coli CFT073.  Variants 2, 3, 4, and 5 are less 
prevalent, accounting for 3.1%, 7.2%, 3.1%, and 2.1% of TosR sequences, respectively. 
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Figure 2-2.  Multiple sequence alignment of TosR, TosE, and TosF amino acid 
sequence variants.  (A) Shaded residues denote conservation with the predicted TosR 
consensus sequence where at least three residues at a given position are conserved.  (B) 
The shaded residues are those residues conserved with the predicted TosE consensus 
sequence where at least four residues at a given position are conserved.  The sequences 
denoted ‘S’ are predicted to result from a TosE frameshift mutation.  (C) Residues that 
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match the TosF consensus, where at least two residues at a given position are conserved, 
are shaded. 
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It is interesting to note that L35, L36, L55, V56, Y74, F75, and S76 are completely 
conserved among all TosR sequence variants.  These residues have been previously 
shown to be involved in PapB oligomerization (425).  In addition, E53 and H54, of TosR 
sequence variants 1-3, and D53 and Y54, of TosR sequence variants 4 and 5, have 
identical or similar properties to D53 and Y54 of PapB, which are again involved in PapB 
oligomerization (425).  Further conservation is observed at residue C65, which is 
important for PapB DNA binding (425).  Likewise, K61 is completely conserved among 
all TosR sequence variants and has similar properties to R61 of PapB, which is important 
for DNA binding (425).  Thus, from these observations, it can be suggested that strong 
selective pressure drives sequence conservation among TosR sequence variants.  It is also 
intriguing to note that TosR sequence variants 4 and 5 appear to be encoded on a putative 
plasmid (see Appendix A, Table A-1)  
 TosE and TosF are also conserved among UPEC isolates.  As with TosR, TosE 
and TosF were grouped based on their unique amino acid sequences.  For TosE, there are 
four variants, including two frameshift mutants that are predicted to disrupt TosE 
function (Figure 2-2B).  Variant 1 accounts for 79.6% of TosE sequences and is the 
variant found in E. coli CFT073.  Frameshift mutants 1, 2, and variant 2 account for 7.5%, 
5.4%, and 7.5% of TosE sequences, respectively.  TosF has three sequence variants, 
albeit two are virtually identical (Figure 2-2C).  Variant 1 accounts for 86.0% of 
sequences and is also the variant found in E. coli CFT073.  TosF variants 2 and 3 account 
for 7.5% and 6.5% of amino acid sequences, respectively.  A strain that encodes TosR 
variant 1 encodes TosE variant 1, frameshift mutant 1, or frameshift mutant 2 and TosF 
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variant 1 or 2.   If a strain encodes TosR variant 2, it always encodes TosE frameshift 
mutant 2 and TosF variant 1.  All strains that encode TosR variant 3 encode TosE variant 
2 and TosF variant 3.  However, little consistent homology with non-hypothetical LuxR 
family members makes functional characterization of conserved residues in TosEF 
variants difficult, compared to TosR above.  
  
TosR is a negative regulator of tosA and a PapB family homolog 
To test the hypothesis that one or more of the identified putative regulators 
associated with the tos operon exert a regulatory function on tosA expression, deletion 
mutations of these putative regulatory genes were constructed in E. coli CFT073.  
Deletion of tosR resulted in a substantial increase in TosA production as assessed by 
Western blots of whole cell proteins using anti-TosA serum (Figure 2-3A).  However, no 
change in TosA production was observed after deletion of tosE and tosF.  Additionally, 
overexpression of tosE and tosF did not result in altered TosA levels (see Appendix B, 
Figure B-1).  Overexpression of TosR-His6 from an arabinose-inducible construct 
partially complemented the tosR deletion in the unmarked mutant background, repressing 
tosA expression (Figure 2-3B), consistent with TosR being a negative regulator of tosA 
and that TosR-His6 is biologically activity.    
To rule out whether increased tosA expression was due to a secondary mutation, 
we transduced the tosR deletion mutation into a clean E. coli CFT073 background.  This 
ΔtosR mutation transductant still overproduced TosA, compared to the wild-type E. coli 
CFT073 parental strain (Figure 2-3C).  However, removing the aph cassette from the 
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Figure 2-3.  tosA is negatively regulated by the PapB family member, TosR.  (A) A 
Western blot with polyclonal anti-TosA serum reveals that TosA (~250-kDa) is 
overproduced in a ΔtosR construct, but is poorly produced in both the ΔtosEΔtosF 
construct and WT [wild-type (ΔlacZ)] E. coli CFT073.  (B) A trans-complementation 
assay in a ΔtosR background using TosR-His6 induced from plasmid (pBAD-tosR-HisA) 
with arabinose concentrations ranging from 0 to 10 mM shows that TosA levels (detected 
as above), are inversely related to TosR-His6 (~15 kDa) levels (detected on a Western 
blot using a His6 antibody).  (C) TosA levels [detected as in (A) and (B)] remain high in a 
ΔtosR aph+ phage transduced construct, as compared to the wild-type control.  All lanes 
in a respective Western blot were loaded with equal amounts of whole cell protein as 
determined using a Pierce BCA Protein Assay Kit (Thermo Scientific).   (D) Alignment 
of TosR (variant 1), FocB, and PapB reveals that all three share amino acid sequence 
identity at domains previously shown to be important for oligomerization (black boxes) 
and DNA binding (grey arrows).  The consensus sequence represents residues conserved 
between the shown PapB family members. 
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same transductant reveals that this tosR mutation did not result in overproduction of 
TosA (see Appendix C, Figure C-1), which may suggest an additional mutation could 
promote TosA synthesis and be a caveat for the TosA overproduction and 
complementation studies above.   
The predicted TosR amino acid sequence of E. coli strain CFT073, when 
subjected to BLAST, identified PapB family regulators as potential homologs.  Using 
sequence alignment against other PapB family regulators found in E. coli strain CFT073 
(Figure 2-3D), TosR shares 27.7% amino acid sequence identity with PapB and 26.7% 
identity with FocB.  As noted above, TosR, PapB, and FocB also carry conserved 
residues previously shown to contribute to oligomerization and DNA binding (Figure 2-
3D) (425).  All three proteins share significant sequence similarity with each other, and 
the predicted TosR protein structure is nearly identical to the structure of FocB (202) 
(Figure 2-4A, Figure 2-4B, and Figure 2-4C). 
 
TosR-His6 binds to PtosR, which contains the tos operon promoter 
To determine whether the promoter driving tosA expression could be identified, 
we generated lacZ transcriptional fusions of tos intergenic and intragenic regions (Figure 
2-5A), which, from their location upstream of tosA or its cognate secretion system, were 
predicted to be the most probable location of Ptos (Figure 2-5B).  These included the 600 
bp upstream of tosR (with the addition of the first 30 bp of tosR), the 233 bp upstream of 
tosC (including the final 181 bp of tosR), and the 199 bp between tosD and tosA.  Using 
Western blot, we attempted to find an optimal condition for TosA synthesis.  Conditions 
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Figure 2-4. Predicted structures of PapB family homologs.  Phyre2 models based off 
of the amino acid sequences of TosR (A) and PapB (B) are indicated (both modeled 
against FocB with 100% confidence). The previously solved structure of FocB (C), 
which was used to model TosR and PapB, above, is also depicted.  
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Figure 2-5.  The region upstream of tosR exhibits transcriptional activity.  (A) 
Within a representation of the tos operon, sequences harboring possible sites for tos 
promoters are denoted PR, PC, and PA.  (B) A black arrow indicates the position where the 
PR, PC, and PA sequences are inserted into the BamHI and EcoRI sites upstream of lacZ in 
pRS551 to produce the indicated transcriptional fusions.  The empty construct was native 
pRS551 plasmid.  (C) The activity of each transcriptional fusion was assayed by the 
Miller assay.  Transcriptional activity, measured indirectly through β-galactosidase 
activity (in Miller units), associated with the PR construct is significantly higher than that 
of PC and PA constructs (p<0.0001).  Black or grey bars indicate average values of Miller 
units for each construct (n=6). Significance was determined by using Tukey’s multiple 
comparisons test following ANOVA (p<0.0001).  Error bars indicate SD about the mean. 
 
 
 
83 
 
included culturing wild-type E. coli CFT073 to stationary phase, during exponential 
phase, cultured statically, exposed to different osmotic stresses, exposure to human urine, 
low iron, and different carbon sources.  However, none of the aforementioned conditions 
resulted in reproducibly high TosA synthesis, compared with the ΔtosR mutation cultured 
to exponential phase (data not shown).  Thus, the transcriptional fusions were all assayed 
using the Miller assay in the ΔtosR background cultured to exponential phase, which is an 
optimal condition for tos operon expression.  All three putative constructs have elevated 
transcriptional activity, compared to the empty vector control (Figure 2-5C).  However, 
the construct designated PR, which contains PtosR, was significantly upregulated among all 
constructs (p<0.0001). In full agreement with our previous findings regarding tos operon 
structure (208), we concluded that PtosR contains Ptos, the tos operon promoter.  
PapB family members usually mediate a regulatory function through binding 
DNA upstream of a PapB family member gene.  To determine whether this is the case for 
TosR, we performed an electrophoretic mobility shift assay on the DNA sequence 
upstream of tosR, PtosR (Figure 2-6A).  TosR-His6 shifted labeled PtosR DNA, and 
competition with unlabeled PtosR in the same binding reaction inhibited labeled probe 
shifting (Figure 2-6B).  TosR-His6 did not bind to an unrelated labeled lacZ sequence, 
demonstrating that TosR-His6 binds specifically to PtosR DNA.   
The sequence immediately upstream of a gene encoding a PapB family member is 
often AT-rich (182, 426), where tandem repeated AT-rich nonomers often demarcate 
PapB family member binding sites (182, 247).  Indeed, the region immediately upstream 
of tosR is AT-rich (Figure 2-1B).  Therefore, to identify the putative TosR binding site,
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Figure 2-6.  TosR-His6 binds DNA derived from the region upstream of tosR.  (A) 
Within a representation of the tos operon, the location of the 399 bp PtosR sequence used 
for the DNA binding assay below is indicated.  (B) Digoxigenin (DIG) terminally labeled 
PtosR or a lacZ fragment was treated with the indicated amounts of TosR-His6 and with or 
without excess unlabeled PtosR, as indicated.  Shifted and unshifted probes were detected 
with an anti-DIG antibody.  
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we PCR-amplified seven ~100 bp fragments of PtosR, each overlapping by 50 bp. An 
electrophoretic mobility shift assay was performed using these PtosR fragments as 
unlabeled competitors (Figure 2-7A).  Unlabeled PtosR2 (220-319 bp upstream of tosR) 
unshifted labeled PtosR, while all adjacent fragments did not.  Plotting the positions of the 
seven PtosR fragments reveals that an AT-rich repetitive sequence is complete only in 
PtosR2, with only partial presence in the two adjacent fragments PtosR1 and PtosR3  (Figure 
2-7B).  Thus, we predict that the TosR binding site is centered within this sequence.  
 
TosE and TosF contribute to the reciprocal regulation of adherence and motility 
It has been previously observed that adhesin operons regulated by PapB family 
members harbor genes that encode proteins that suppress motility.  These genes are 
located at the 3’ end of adhesin operons (187, 188, 355, 427).  To first confirm that tosEF 
are indeed part of the tos transcript, we performed RT-PCR using primers directed 
against the junctions between tosA and tosE and tosE and tosF.  We found that tosEF 
were part of the tos transcript, as a strain that overexpresses tosA (ΔtosR) has a 
corresponding higher amount of transcript with the tosAE (Figure 2-8A) and tosEF 
junctions (Figure 2-8B).   
To determine whether TosEF affect motility, we performed motility assays in the 
presence and absence of tosE and tosF expression. TosEF overproduction resulted in a 
substantial decrease in swimming motility when this construct was stabbed into soft agar 
and incubated for 17 hours, as compared to an empty vector control (p<0.0001) (Figures 
2-9A and 2-9B).  Likewise, compared to the ΔtosR and WT backgrounds, a 
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Figure 2-7.  The TosR binding site is centered on PtosR2.  (A) The Digoxigenin (DIG) 
terminally labeled PtosR probe is unshifted only by addition of excess unlabeled PtosR2 or 
full length unlabeled PtosR.  (B) PtosR fragments 1-7 are indicated on a PtosR region 
schematic.  The complete sequence of PtosR2 is indicated with a boxed region indicating 
the predicted TosR binding site.  The tosR open reading frame (ORF) is indicated.  
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Figure 2-8.  tosEF are part of the tos operon.  RT-PCR assays with primers directed 
against the intergenic region between tosAE (A) and tosEF (B) were performed in the 
indicated backgrounds.  The expected fragment sizes of 619 bp (A) and 402 bp (B) are 
only observed in reactions containing cDNAs (RT+), but not in reactions containing only 
input RNA (RT-).  Equal amounts of input RNAs were used to synthesize all cDNAs, and 
equal amounts of all cDNAs were used as inputs in the PCRs shown.  Likewise, equal 
volumes of all PCRs were loaded in each lane.  
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Figure 2-9.  TosEF down-modulate motility.  (A) UPEC CFT073 harboring either 
pBAD-tosEF or pBAD-myc-HisA was stabbed into soft agar and incubated for 17 hours 
with 33.3 mM L-arabinose.  White lines represent the swimming zone diameter for each 
induced construct.  (B) Average swimming zone diameters are represented by black or 
grey bars (n=9).  Error bars represent SD about the mean, and significance between 
diameter differences was determined using Student’s t-test (p-values indicated).  (C) 
Average (n=9) swimming zone diameters of the indicated deletion backgrounds or wild-
type UPEC CFT073, measured after 17 hours, are represented by black, grey, or white 
bars (n=9).  Error bars are the same as above. Significance, indicated by associated p-
values, was determined by using Tukey’s multiple comparisons test following ANOVA 
(p=0.002).  Error bars indicate SD about the mean (D) Growth curves of the indicated 
constructs are traced over a period of eight hours.  Each point represents an average A600 
reading at a given time point (n=12).  (E) E. coli K12 MG1655 harboring either pBAD-
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myc-HisA or pBAD-tosEF was stabbed into soft agar and incubated 17 hrs with 33.3 mM 
L-arabinose.  Average (n=9) swimming zone diameters of each overexpression construct 
are represented by black or grey bars.  Error bars are the same as above, and significance 
between diameter differences was determined using Student’s t-test (p-values indicated).  
(F) Western blot with polyclonal anti-FliC serum reveals that FliC (~65 kDa) (black 
arrow) levels are reduced in wild-type CFT073 harboring pBAD-tosEF induced with the 
indicated concentrations of L-arabinose, as compared to the same background harboring 
pBAD-myc-HisA. All lanes of this Western blot were loaded with equal amounts of 
whole cell protein as determined by using a Pierce BCA Protein Assay Kit (Thermo 
Scientific). 
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ΔtosRΔtosEΔtosF mutant was statistically significantly, but modestly, more motile in soft 
agar (p≤0.01) (Figure 2-9C).  The differences in swimming motility, in soft agar, 
between ΔtosR, ΔtosEΔtosF, and WT CFT073 were not significant.  It remains unclear 
why such a disparity exists between the TosEF overproduction construct and tos deletion 
constructs. However, no differences in growth rates between constructs could account for 
the differential motility observed above (Figure 2-9D).  Intriguingly, we found that 
overexpression of tosEF in E. coli K12 MG1655 (a non-UPEC strain) also inhibits 
motility (Figure 2-9E), suggesting that TosEF suppress motility through a broadly 
conserved mechanism.  Indeed, we found that overexpression of tosEF in E. coli CFT073 
cultured in tryptone broth results in reduced production of FliC (Figure 2-9F).  Thus, this 
shows that TosEF, coincident with tosA expression, mediate motility repression by 
reducing flagellin expression.  Furthermore, to test whether both TosEF together suppress 
motility, we performed the same motility assays above with tosE and tosF individually 
cloned (Figure 2-10).  Intriguingly, both TosEF are required for full motility suppression. 
 
 
Discussion 
 
UTIs are common human infections.  While most uncomplicated UTIs are caused 
by UPEC, no core set of virulence factors has been identified.  Thus, a comprehensive 
understanding of uropathogenesis demands an understanding of broad virulence factor 
classes and the underlying networks connecting them.  We previously identified a novel 
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Figure 2-10.  TosEF together suppress motility.  E. coli CFT073 harboring the 
indicated pBAD was stabbed into soft agar and incubated 17 hours with 33.3 mM L-
arabinose.  Average (n=6) swimming zone diameters of the indicated constructs are 
shown, and error bars represent SD about the mean.  Significances of the differences 
between swim zone diameters of the empty vector and vectors harboring tosE and tosF 
were determined using Tukey’s multiple comparisons test following ANOVA 
(p<0.0001), and * and **** represent p<0.05 and p<0.0001, respectively.  
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E. coli adhesin, referred to as TosA, which is expressed only in vivo during experimental 
infection (208, 227).  At that time, it was unclear how the tos operon is regulated.  Here, 
we have shed light on tosA regulation and its function in the reciprocal regulation 
between adherence and motility.  TosR negatively regulates expression of the tos operon, 
while TosEF downregulate motility when the TosA adhesin is expressed. 
We previously found that TosA contains an internal repetitive region of around 
1675 amino acids comprised of five repeats of 335 amino acids.  Protein structure 
prediction revealed that these internal repeats may have a structure similar to the bacterial 
immunoglobulin-like domain group three (BIg 3) repeats found in another nonfimbrial 
adhesin of S. enterica, SiiE (216).  These immunoglobulin folds mediate protein ligand 
interactions, which endow adhesive properties to SiiE (428).  In addition, these 
immunoglobulin folds, coupled with Ca2+-binding, could also promote SiiE length 
extension (216), bringing it into proximity with its cognate receptor on the host cell.  
However, whether the BIg 3 repeats found in TosA mediate adherence, extend TosA such 
that an element in the carboxyl-terminus can mediate adherence, or some combination of 
these two is still unknown.  
tosR, tosE, and tosF, in addition to tosCBDA, are part of the tos locus and are well 
conserved among UPEC strains also encoding tosA.  As differences in GC content often 
demarcate operon boundaries (424), the GC content differences between the tos 
regulatory and structural genes suggest that tosCBDA might be modular, where the 
respective regulator genes might be deleted from or inserted into the tos operon.  
However, we do not preclude the possibility that these GC content differences also reflect 
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an additional tos operon regulatory mechanism, such as differential nucleoid structuring 
or mRNA stability perturbations.  Nonetheless, all three regulator genes are broadly 
conserved among UPEC strains also carrying tosA, and the typical operon structure is 
represented by tosRCBDAEF.  This broad conservation of these regulatory genes may 
suggest that each serves some fitness function in different situations where UPEC may be 
found. 
The tos operon is conserved among UPEC strains.  The vast majority of these tos 
operons, harbored by UPEC strains, fit tightly into one of five closely related variants, 
based on the predicted TosR amino acid sequence encoded by the respective operon.  
Further support for this clonal nature of the tos operon comes from the fact that TosR 
variants are associated with specific TosE and TosF variants.  We conclude that the tos 
operon present in E. coli CFT073 represents the archetype of the tos operon, as its TosR 
and TosEF sequence variants are the most prevalent among UPEC strains.  However, the 
origin of the tos operon in its present form is still a matter of conjecture.  Nevertheless, its 
presence on the E. coli CFT073 PAI-aspV makes acquisition by horizontal gene transfer 
likely.  PAIs, such as PAI-aspV, are often acquired in such a manner.  
The gene encoding TosR is located immediately upstream of tosCBDA.  Deletion 
of tosR results in robust tosA expression, which leads us to conclude that TosR is a 
negative regulator of tosA expression.  Phage transduction of the original ΔtosR mutation 
into a clean background resulted in high expression of tosA, suggesting that this 
phenotype is not the result of an unknown secondary mutation.  In addition, a His-tagged 
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version of TosR complements the tosR deletion mutation demonstrating that TosR itself 
mediates this negative regulation. 
Members of the PapB family regulate adhesin operons by binding in the DNA 
minor groove (182, 202).  Minor groove binding proteins often take advantage of the 
inherent DNA structure of AT-rich regions to mediate target recognition and binding 
(277, 311, 429, 430), which is the likely case for PapB family members (182, 247, 426).  
Indeed, the region upstream of the tos operon, which contains the tos promoter, is an 
AT-rich sequence.  A biologically active His-tagged TosR specifically binds an AT-rich 
sequence within PtosR.  Therefore, we propose that TosR mediates its negative regulatory 
effect by binding in the minor groove of an AT-rich sequence within the tos operon 
promoter.  
Based on the present study, we can begin to speculate how tos regulation fits into 
other genetic networks within uropathogenic E. coli.  While focusing on these underlying 
networks, such as motility and adherence reciprocal regulation, provides a more complete 
picture of tosA regulation, this broad mechanism is beyond the scope of the present study.  
Nevertheless, TosA is an adhesin, and the reciprocal regulation that exists between 
adhesins and flagellar motility (187, 188, 240, 355, 415) represents a starting point for 
understanding the relationship between tosA and the complete E. coli virulence network.  
Immediately downstream of tosRCBDA are the two genes encoding TosE and TosF, 
whose predicted amino acid sequences qualify them as members of the LuxR helix-turn-
helix family of transcriptional regulators (208).  Simultaneous deletion or overexpression 
of tosEF does not affect tosA expression.  However, genes encoding factors that down-
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modulate motility are often found downstream of adhesin operons (187, 188, 355).  When 
a respective adhesin operon is induced, these motility down-modulating genes are also 
expressed.  Indeed, consistent with this prediction, TosE and TosF overproduction results 
in a down-modulation of motility.  Motility repression has also been observed among 
other LuxR family members, such as CsgD, FimZ, and RcsB (431-433). 
It was previously unknown, however, whether tosE and tosF are transcriptionally 
coupled to tosRCBDA under any conditions; it was only known that their expression, like 
that of tosRCBDA, is poor in vitro (208).  We predict that expression of tosRCBDA and 
tosEF are coordinated to support reciprocal regulation of adherence and motility.  For 
example, it is possible that the loss of tosR results in increased expression of tosCBDA 
and tosEF, consistent with the tos transcript structure described above.  Subsequent loss 
of tosEF, in the ΔtosR background, results in enhanced swimming motility by virtue of 
the loss of tosEF.  This increased expression and possible co-transcription is also 
supported by the fact that a ΔtosEΔtosF mutant alone does not replicate the phenotypes of 
a ΔtosRΔtosEΔtosF mutant.   
The reason for the modest motility differences observed in the tos operon deletion 
mutants, compared with the tosEF overexpression construct remains unclear.  
Nevertheless, one intriguing possibility might be that tosEF expression in tos operon 
mutants is not as uniformly high as an overexpression vector construct may be.  In this 
hypothesis, only certain cell sub-populations might express sufficiently high levels of 
tosEF to suppress motility, and others expressing lower levels of tosEF might not fully 
suppress motility.  Thus, the composite of these two phenotypes is a swim zone of 
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reduced diameter, but not a severely reduced diameter.  It is also possible that more 
modest expression of tosEF from the chromosome is insufficient to override the 
dependency for an additional, yet undefined, signal to mediate motility suppression.  
Therefore, the effect that TosEF has on motility in this scenario would be more modest.      
We postulate that motility repression, in the case of TosEF, is an event that occurs 
upstream of fliC expression, as evidenced by the fact that TosEF overproduction results 
in reduced FliC synthesis.  However, fliC is expressed as a class III gene late in the 
flagellar assembly gene network (119).  Thus, while the tos operon and its expression 
appear to be part of the network underlying reciprocal regulation between adherence and 
motility, more work is required to elucidate the precise mechanism of TosEF regulation 
of the flagellar assembly gene network.      
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CHAPTER 3 
REGULATION OF THE EXPRESSION OF 
UROPATHOGENIC ESCHERICHIA COLI NONFIMBRIAL ADHESIN TOSA BY 
PAPB HOMOLOG TOSR, IN CONJUNCTION WITH H-NS AND LRP 
 
Modified from: M. D. Engstrom and H. L. T. Mobley. 2016. Infection and Immunity 
84: 811-21.  
 
Abstract 
 
Urinary tract infections are a major burden to human health.  The overwhelming 
majority of UTIs are caused by uropathogenic Escherichia coli (UPEC).  Unlike some 
pathogens, UPEC do not have a fixed core set of virulence and fitness factors, but do 
have a variety of adhesins and regulatory pathways.  One such UPEC adhesin is the 
nonfimbrial adhesin TosA, which mediates adherence to the epithelium of the upper 
urinary tract. The tos operon is AT-rich, resides on pathogenicity island-aspV, and is not 
expressed under laboratory conditions. Because of this, we hypothesized that tosA 
expression is silenced by H-NS.  Lrp, based on its prominent function in the regulation of 
other adhesins, is also hypothesized to contribute to tos operon regulation.  Using a 
variety of in vitro techniques, we mapped both the tos operon promoter and TosR 
bindings sites.  We have now identified TosR as a dual regulator of the tos operon, which 
regulates the tos operon in association with H-NS and Lrp.  H-NS is a negative regulator 
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of the tos operon, and Lrp is a positive regulator of the tos operon.  Leucine inhibits Lrp-
mediated tos operon positive regulation.  In addition, TosR binds to the pap operon, 
which encodes another important UPEC adhesin, P fimbria.  Induction of TosR synthesis 
reduces production of P fimbria.  At the same time, ectopic expression of tosR promotes 
synthesis of curli and/or cellulose.  H-NS- and Lrp-mediated regulation also makes key 
contributions to reciprocal regulation of flagellar and adhesin genes.   These studies 
advance our knowledge of regulation of adhesin expression associated with uropathogen 
colonization of a host. 
 
 
Introduction 
 
Urinary tract infections (UTIs), among the most common bacterial infections of 
humans (12), can occur in otherwise healthy individuals when bacteria colonizing the 
gastrointestinal tract gain access to the periurethral area.  Most individuals with UTI 
develop an infection of the bladder, referred to as cystitis (12).  However, the infecting 
bacterium may ascend the ureters to infect the kidneys (pyelonephritis) and, in some 
cases, enter the bloodstream leading to bacteremia and sometimes fatal urosepsis (12-15). 
A diverse group of extraintestinal pathogenic Escherichia coli strains, referred to 
as uropathogenic E. coli (UPEC), cause the overwhelming majority of uncomplicated 
UTIs (13, 434).  While numerous UPEC virulence factors have been identified, including 
adhesins, motility systems, toxins, and iron acquisition systems, a core set of virulence 
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factors has not been strictly defined (33, 35, 44).  However, it is critical to understand 
specific virulence factors and how they are regulated. 
Previous work identified and characterized the E. coli RTX (repeats-in-toxin) 
nonfimbrial adhesin TosA (for type one secretion protein A as the predicted secretion 
mechanism) (35, 36, 39, 208, 227, 435).  In particular, tosA and the other tos operon 
genes have poor in vitro expression (208, 227, 435).  TosA, a >250 kDa surface-exposed 
protein, mediates UPEC adherence to epithelial cells derived from the upper urinary tract 
(208).  This is in contrast to a number of other RTX proteins, which are fully secreted 
into the extracellular milieu and act as toxins (49, 72, 436-438).  We estimated that ~32% 
of UPEC strains carry genes encoding TosA and its cognate type 1 secretion system, 
TosCBD (435).  In strain CFT073, the tos operon resides on PAI-aspV (pathogenicity 
island-aspV) (39).  The tos operon, in addition to tosA and predicted cognate secretion 
system genes tosCBD, also encodes the regulatory genes tosR, tosE, and tosF (208, 435).  
TosE and TosF together suppress motility (435), a feature also found in other adhesin 
operon regulators (187, 188).  TosR, a member of the PapB family, was previously 
identified as a negative regulator of the tos operon (435).    
PapB, the prototypical member of its family, is a well-characterized positive and 
negative transcriptional regulator of the pap operon (179, 180, 384) that encodes the 
structural and secretion machinery necessary for P fimbria assembly (145, 439).  P 
fimbriae are epidemiologically associated with UPEC strains (170) and have been shown 
to be important during experimental UTI (170, 192, 440, 441).  PapB mediates 
transcriptional regulation by binding within the DNA minor groove (182), which suggests 
100 
 
that PapB might recognize structured DNA in a manner proposed for nucleoid-associated 
proteins (429, 442-445).  In addition, the well-known nucleoid structuring protein, Lrp, 
also contributes to both positive and negative regulation of the pap operon (179, 347, 350, 
354). 
H-NS regulates the expression of many genes through binding structured AT-rich 
DNA sequences, compacting the bacterial chromosome into defined nucleoid 
macrodomains (41-43, 94, 309).  PAIs are often identified by their AT-richness (40-43), 
and AT-rich genes and PAIs are often silenced by H-NS (41-43).  In addition, H-NS also 
contributes to negative regulation of adhesin operons and dual regulation of motility 
operons (181, 326, 346, 354, 372, 375, 377, 378, 385-389). Indeed, PapB mediates 
positive regulation of the pap operon by anti-silencing H-NS repression (181).  
Lrp and H-NS are key regulators associated with a variety of other genes, 
including adhesins in addition to P fimbria (42, 105, 152, 179, 183, 250, 296, 326, 346-
355, 372, 375, 377, 378, 385-389).  In agreement with this, it has been predicted that Lrp 
and H-NS may antagonize the activity of each other, or they could act together to also 
potentiate gene regulation (351, 354, 444, 446).  This type of regulation resembles a 
regulatory switch, in which one nucleoid structuring protein switches in predominance or 
occupancy at key regulatory elements to perturb gene regulation.  This switch may be 
mediated by varying protein composition during different growth phases (i.e., Lrp levels 
increase during mid-exponential phase and decrease thereafter) (94, 95, 109).  However, 
in the case of the pap operon, switch regulation between H-NS and Lrp may not be 
mediated by direct competition for DNA binding sites (354), but instead this switch 
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regulation could be the result of indirect effects between H-NS and Lrp.  It is unknown 
whether H-NS and Lrp switch regulation is responsible for tos operon regulation and 
whether H-NS and Lrp regulation of the tos operon is direct or indirect.  
 Whether TosR, like PapB, might function in the capacity of an activator in 
addition to repressing the tos operon was previously unknown.  Thus, in this study, we 
examined the capacity of TosR to function as both a tos operon activator under certain 
conditions and as a repressor under others.  Additionally, we propose that an H-NS and 
Lrp regulatory switch, similar to the one described above, is responsible for tos operon 
regulation.  We also examined the capacity of TosR to negatively regulate P fimbria 
production.  To our knowledge, TosA is the first nonfimbrial adhesin and RTX protein to 
be integrated into the reciprocal regulation network between different adhesins and 
between adhesins and motility systems.  This cross-regulation also suggests that 
hierarchical regulation of adhesins and motility is much broader than previously thought.     
 
 
Materials and Methods 
 
Bacterial strains 
A phage transductant of the original tosR deletion mutation (435) was unmarked 
using the FLP recombinase as previously described (435).  The ΔhnsΔlrp CFT073 strain 
was engineered through phage-mediated transduction of a previous CFT073 Δlrp 
mutation (355) into a previous lambda Red-engineered CFT073 Δhns mutant unmarked 
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as described above.  Transductants were selected for on lysogeny broth (LB) agar (10 
g/liter tryptone, 5 g/liter yeast extract, 0.5 g/liter NaCl, 15 g/liter agar) containing 
kanamycin (25 µg/mL).  Deletion mutations were verified by PCR. 
 
Engineered plasmids 
Untagged tosR and lrp genes were cloned into pBAD-myc-HisA (Invitrogen) as 
previously described (435).  The pBAD-tosR-His6 and pRS551-Ptos-lacZ were previously 
engineered (435). The pBAD empty vector, pBAD-tosR, pBAD-tosR-His6, and pBAD-
lrp constructs were maintained in LB (10 g/liter tryptone, 5 g/liter yeast extract, and 0.5 
g/liter NaCl) containing 100 µg/mL ampicillin, while the pBAD-lrp construct was also 
maintained in M9 medium (12.8 g/liter Na2HPO4•7H2O, 3 g/liter KH2PO4, 0.5 g/liter 
NaCl, 1.0 g/liter NH4Cl, 2 mM MgSO4, 0.4% glycerol, and 0.1mM CaCl2) containing 
ampicillin (100 µg/mL) (CFT073 ΔtosR strain).  In addition, the pRS551-Ptos-lacZ and 
pRS551 empty vector constructs were maintained in LB containing ampicillin (50 
µg/mL), except as noted below. 
 
5’ RACE  
Plasmid pRS551-Ptos-lacZ was transformed into CFT073 ΔlacZ and CFT073 
ΔtosRΔlacZ and maintained in LB containing ampicillin (100 µg/mL).  The 5’ RACE 
(rapid amplification of cDNA ends) procedure was performed as similar to previous 
methods (447).  cDNA was produced using the lacZ cDNA primer listed in Table 3-1 
and SuperScript II reverse transcriptase as previously described (435).  Input RNAs were
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 Table 3-1.  Primers used in this study. 
Primera Sequence (5’-3’) 
LacZ cDNA (R) GCGGATTGACCGTAATGGGATAGGT 
3’ Linker TTTAGTGAGGGTTAATAAGCGGCCGCGTCGTGA
CTGGGAGCGC 
 
Linker Forward (F) GCCGCTTATTAACCCTCACTAAA 
LacZ Nested One (R) GACGACGACAGTATCGGCCTCAGGAAG 
LacZ Nested Two (R) CATTCAGGCTGCGCAACTGTTGGGAAGG 
Ptos13 (F) AAGTTTTGGGGTGCAGTCCAC 
Ptos13 (R) AAAAAGTGAAATCTCAAAACAAAAAAT 
Ptos34 (F) TAATATAGATATTATCTGCATATAA 
Ptos34 (R) TACTAGAGATTACATCTAAAAAATT 
Ptos57 (F) TTAGATAAAAACCCTACAGAGAAGT 
Ptos57 (R) CTGTATATGATCTGCCATACCATTACACAT 
PpapBA (F) CTCACTGTAACAAAGTTTCTTCGAATA 
PpapBA (R) GTTTCCCCCTTCTGTCGGGCCCCTG 
lacZ (F) GCGAATACCTGTTCCGTCATAGCG 
lacZ (R) CATCGCCAATCCACATCTGTGAAAG 
a F, forward; R, reverse 
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hydrolyzed by adding NaOH (final concentration 0.16 mM) and boiled for 10 minutes.  
This reaction was neutralized by the addition of HCl (0.16 mM).  A 3’ Linker, listed in 
Table 3-1, was ligated to the above cDNA using T4 RNA ligase (New England Biolabs).  
After ligation, the enzyme was inactivated by incubation at 65 °C for 20 minutes.  First 
round nested PCR was performed with the forward linker primer and lacZ nested primer 
one listed in Table 3-1.  The second round nested PCR was performed with the forward 
linker primer and lacZ nested primer two.  The resulting PCR fragment from the second 
round of nested PCR was sequenced.   
 
Electrophoretic mobility shift assays (EMSAs) 
tosR-His6 was induced in wild-type CFT073 and extracted using a 
QIAexpressionist protocol (Qiagen) and Ni-nitrilotriacetic acid (NTA) agarose 
(Invitrogen) as previously described (435).  Input DNAs for EMSAs were generated 
using Ptos13, Ptos34, Ptos57, PpapBA, and lacZ primers listed in Table 3-1.  Input DNAs were 
terminally labeled with a Digoxigenin-11-ddUTP (DIG-ddUTP) using a 2nd generation 
DIG Gel Shift Kit (Roche Applied Science) as described previously (435).  DNA binding 
reactions and detection of shifted DNA fragments were performed using a modified 
Roche DIG Shift Kit protocol and anti-DIG-alkaline phosphatase detection antibody 
(Roche Applied Science) as previously described (435), with the exception that between 
400 nM and 4 µM TosR-His6 was used in each DNA binding reaction; between 2 pg/µL 
(PpapBA and lacZ) and 10 pg/µL (Ptos13, Ptos34, and Ptos57) DIG-ddUTP labeled fragments 
were used in the DNA binding reactions.   
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Western blots 
To detect TosA from induced overexpression constructs, pBAD-tosR, pBAD-
tosR-His6, and pBAD-lrp were transformed into a variety of CFT073 backgrounds and 
induced in LB containing 0, 0.06, 0.6, or 10 mM L-arabinose (pBAD-tosR, pBAD-tosR-
His6, and the pBAD empty vector) or 0, 0.6, 1.2, 2.4, or 10 mM L-arabinose (pBAD-lrp) 
for four hours.  Four hours was chosen to allow E. coli to transit through exponential 
phase, ensure high titer to maximize the likelihood of observing TosA, TosR, and PapA 
among bacterial cells in the culture, and avoid prolonged incubation of the cultures within 
stationary phase.  Prior to induction, overnight bacterial cultures were diluted 1:100 
(CFT073 wild-type) and 1:40 (CFT Δlrp and Δhns strains).  The pBAD-lrp construct 
transformed into CFT073 ΔtosR was induced for 4.5 hours with 0, 0.6, 1.2, or 10 mM 
L-arabinose in M9 minimal medium either containing 10 mM L-leucine or no exogenous 
L-leucine.  Prior to induction, CFT073 ΔtosR harboring pBAD-lrp was cultured 
overnight in LB, pelleted at 6,000 × g, washed in M9 medium, and diluted 1:20.  Total 
proteins from the inductions were collected in 10 mM HEPES (pH 8.3-8.9), quantified 
with a Pierce BCA Protein Assay Kit (Thermo Scientific), and assayed by Western blot 
with polyclonal anti-TosA antibodies or an anti-His6 antibody (Invitrogen) as previously 
described (435).  To detect PapA, total proteins were assayed as above in a CFT073 wild-
type background harboring pBAD-tosR-His6, induced in LB containing 0, 0.6, or 10 mM 
L-arabinose; the only exception was that polyclonal anti-PapA antibodies (Rockland) 
were used in place of anti-TosA antibodies.    
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 To detect TosA from CFT073 wild-type and CFT073 Δhns, Δlrp, and ΔhnsΔlrp, 
each background construct was cultured in LB for approximately 2.5 hours to exponential 
phase (A600 ≈ 0.3-0.5).  Prior to being cultured to exponential phase, CFT073 wild-type 
and Δlrp overnight cultures were diluted 1:100 in LB, and Δhns and ΔhnsΔlrp overnight 
cultures were diluted 1:40 prior to culturing in LB.  Total proteins were collected in 10 
mM HEPES (pH 8.3-8.9), quantified with a Pierce BCA Protein Assay Kit (Thermo 
Scientific), and assayed by Western blot with polyclonal anti-TosA antibodies as 
described above. 
 
Promoter activity assay 
Promoter activities from the pRS551-Ptos-lacZ or pRS551 empty construct, 
transformed into wild-type CFT073, Δhns, Δlrp, and ΔhnsΔlrp strains were determined 
using a modified Miller assay as previously described (435).  The modification to the 
Miller assay was the use of β-methylumbelliferyl β-D-galacopyranoside (0.5 mg/mL) as 
substrate instead of o-nitrophenyl-β-galactoside.  
 
Growth curves 
Overnight cultures of E. coli CFT073 harboring pRS551-Ptos-lacZ, were diluted 
1:100 (wild-type and Δlrp) and 1:40 (Δhns and ΔhnsΔlrp) into LB (10 g/liter tryptone, 5 
g/liter NaCl) containing ampicillin (50 µg/ml).  Constructs were cultured at 37 °C for 24 
h in a Bioscreen C automated growth curve system, with A600 readings being recorded 
every 15 min.    
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Results 
 
The tos operon promoter is located upstream of the tos operon regulator gene, tosR 
Our previous work localized the tos operon promoter (Ptos) to a 630 bp sequence 
upstream of tosR (435).  To determine the precise location of Ptos and map associated 
promoter elements, we conducted analysis of both RNA-Seq (not strand-specific) data 
(unpublished) and 5’ RACE (rapid amplification of cDNA ends).  From analyzing 
mapped normalized tos operon cDNA reads obtained from E. coli CFT073 cultured in 
human urine (unpublished), we hypothesized that the tos operon transcriptional start site 
is 23 bp upstream of tosR, based on the presence of a gap between tosR and the upstream 
ORFs c0358 and c0359 (Figure 3-1A).  However, transcripts from genes encoded on the 
opposite DNA strand (c0366 and c0367) at the 3’ end of the tos operon make it difficult 
to predict transcriptional termination sites, as the RNA-Seq technique employed here is 
not strand-specific.  For verification of the predicted transcriptional start site, 5’ RACE 
was performed on transcripts expressed from the pRS551-Ptos-lacZ transcriptional fusion, 
used to ensure a high concentration of transcripts containing the tos operon start site 
expressed from plasmid-based Ptos.  Following two rounds of nested PCR on cDNAs with 
a 3’ linker of a known sequence ligated to this segment, we amplified a PCR product of 
approximately 344 bp (Figure 3-1B), which was consistent with the transcriptional start 
site obtained from the RNA-Seq analysis.   
 Sequencing the 5’ RACE PCR product, we identified the identical distal 5’ 
sequence (transcriptional start site) as the RNA-Seq analysis, which in turn allowed us to 
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Figure 3-1.  Ptos is predicted to be located upstream of tosR.  (A) The tos operon is 
presented along with a log-transformed cDNA read plot corresponding to cDNAs 
obtained from the tos operon of UPEC strain CFT073 cultured in filter-sterilized human 
urine.  The scale indicates mapped reads.  Two parallel lines below the read plot 
represent the two strands of DNA, and the directions of the arrows represent the strand on 
which the indicated genes are encoded.  Only a partial sequence of c0358 is depicted in 
the read plot.  (B) Resolving 5’ RACE products obtained from transcripts expressed from 
the vector pRS551-Ptos-lacZ yields a product between the indicated 300 bp and 400 bp 
weight markers.  (C) Mapped cDNAs (in blue) are depicted below the top shaded DNA 
sequence; a blue arrow indicates the location of tosR.  A black arrow at the left depicts 
the upstream most read obtained from the RNA-Seq experiment, which was also 
precisely the same sequence identified from sequencing the PCR product obtained in (B).  
An angled black arrow indicates the transcriptional start site of the tos operon.  The 
predicted -35 and -10 sequences of the tos operon promoter, Ptos, are depicted.  
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map a modified σ70 promoter upstream of the transcriptional start site (Figure 3-1C).  
This promoter shows 67% identity (TTGAtg) with the canonical σ70 -35 sequence and 
100% identity with the canonical σ70 -10 sequence (TATAAT).  Consistent with other σ70 
promoters (448, 449), these -35 and -10 sequences are separated by 16 nucleotides.  The 
transcriptional start site is 7 bp downstream from the end of last nucleotide -10 sequence, 
a spacing also consistent with σ70 promoters (449).  In addition, the first base in the 
predicted transcript, adenosine, is typical of many transcriptional start sites (450, 451).  
However, a putative ribosome-binding site upstream of the predicted TosR translational 
start site could not be clearly identified, which could suggest that TosR translation is 
inefficient.   
 
TosR is both a positive and negative regulator of the tos operon 
We have previously identified a repressor function for TosR (435).  As the 
location of the previously identified TosR-binding site (435) is not near Ptos (160 bp 
upstream of the newly identified promoter), we hypothesized that there could be 
additional, weaker binding sites near the tos operon promoter. To test this prediction, we 
performed an electrophoretic mobility shift assay (EMSA) on digoxigenin (DIG)-labeled 
DNA fragments of Ptos containing the strong TosR-binding site, an intergenic region 
between the strong TosR binding site and Ptos, and a region containing Ptos (Figure 3-2A 
and 2B).  As expected, we found that the region of Ptos containing the strong TosR-
binding site had a reduced electrophoretic mobility (i.e., was shifted) when incubated 
with TosR.  Additionally, we found that TosR shifted the Ptos fragment containing the tos 
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Figure 3-2.  An EMSA indicates that TosR binds Ptos at promoter distal and 
proximal positions and with varying strengths.  (A) The indicated amounts of TosR-
His6 were incubated with terminally DIG-labeled Ptos fragments.  Shifted and unshifted 
DNA fragments were detected with an Anti-DIG antibody.  The EMSA is representative 
of two independent experiments.  (B) A schematic of Ptos region indicates the positions of 
the Ptos fragments used for the above EMSA, the location of the operon promoter (angled 
black arrow), the stronger TosR-His6 binding site distal to the promoter (white box with 
solid margin), and the weaker TosR-His6 binding site proximal to the promoter (white 
box with dashed margin). 
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operon promoter.  As this latter fragment was almost fully shifted only at the highest 
levels of TosR (4 µM), we also reasoned that TosR weakly binds this region, compared 
with the strong binding site previously identified.  At least 50 bp separates the strong and 
weak TosR binding sites in Ptos (Figure 3-2B).  In addition, it is possible that TosR has 
some affinity for AT-rich sequences, as is also the case for other PapB family members 
(182).  This is supported by the observation that TosR slightly shifts the intergenic region 
between the strong and weak binding site (i.e., the intensity of the Ptos34 unshifted 
fragment is weaker at the highest TosR concentration).  Although, affinity for AT-rich 
sequences alone cannot explain all of the TosR binding activity, as AT-rich regions of 
Ptos failed to be effective competitors for TosR binding to the strong binding site in the 
vicinity of Ptos (435).  However, this does not rule out the possibility that TosR 
recognizes a structural element, especially as another promoter, PpapBA (see Appendix D, 
Figures D-1A and 1B), is regulated by the prototype member of the PapB family (179, 
180, 384).  In agreement with this, BLASTN revealed no significant sequence similarity 
between the weak and strong TosR binding sites.  The region of DNA in the vicinity of 
PlacZ, unrelated to both Ptos and PpapBA, does not exhibit a curved architecture (Figure D-
1C).       
Other PapB family members have been described as dual regulators of their cognate 
operons (179, 180, 384).  Thus, based on the various degrees of TosR binding strengths 
for sites in the vicinity of Ptos, we speculated that TosR could also have an additional 
positive regulatory function on the tos operon.  To test whether TosR could induce 
expression of the tos operon, we used a pBAD-tosR-His6 construct and a pBAD-tosR 
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untagged construct to assay TosA synthesis at various tosR induction levels.  Using a 
Western blot of proteins from whole cell preparations obtained from these pBAD 
overexpression constructs, we found that TosA levels are inversely related to induced 
tosR levels (Figure 3-3A).  For induced levels of TosR below the detectable limit of our 
anti-His6 antibody, we observed high levels of TosA synthesis; with high levels of TosR-
His6, detectable with anti-His6 antibody, TosA levels were low.  Likewise, these 
functions appear independent of the presence of the His6 tag, as both tagged and untagged 
TosR proteins yielded similar results.  Expression was also independent of the presence 
of arabinose alone, as an empty pBAD vector failed to regulate TosA synthesis.  It is 
important to note, however, that each of these findings is based on ectopic expression of 
tosR.  Therefore, it may be the case that additional regulators could supplement TosR-
mediated activation and repression under native conditions.  E. coli CFT073 also has no 
arabinose utilization gene mutations, and arabinose will be metabolized during these 
assays, which may contribute to the absence of TosR at some induction levels.  Induction 
from the pBAD vector may also be subject to the all-or-nothing phenomenon, where cells 
may be binned into either uniformly high or low expression of a gene under 
transcriptional control of the arabinose inducible promoter (452-454).  Titration from this 
vector, therefore, may be limited (455), especially when considering both the all-or-
nothing phenomenon and arabinose utilization.  Nevertheless, in terms of the newly 
identified TosR binding sites and concentration dependence on its regulatory functions, 
we predict that TosR-mediated positive regulation occurs at the strong binding site, and 
TosR-mediated negative regulation occurs at the weak binding site (Figure 3-3B). 
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Figure 3-3.  TosR is a dual positive and negative regulator of TosA. (A) Western blots 
using polyclonal anti-TosA antibodies or an anti-His6 antibody were performed to detect 
TosA (>250 kDa) or TosR (~15 kDa).  Total proteins for the Western blot were obtained 
from wild-type UPEC strain CFT073 harboring the indicated pBAD constructs induced 
with the noted concentrations of L-arabinose.  Equal amounts of proteins were loaded as 
determined using a Pierce BCA Protein Assay Kit.  The Western blot is representative of 
two independent experiments.  (B) TosR (blue ovals) is predicted to mediate positive 
regulation at Ptos through binding the strong TosR-binding site (green arrow and white 
box with a solid margin) and negative regulation through binding the weak TosR-binding 
site (red bars and white box with a dashed margin). 
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Nucleoid structuring proteins contribute to TosR regulation of the tos operon 
The tos operon is localized to the PAI-aspV pathogenicity island in UPEC strain 
CFT073 (39).  It is well accepted that genes on PAIs, and other AT-rich sequences, are 
often bound and regulated by nucleoid structuring proteins including H-NS and Lrp (41-
43, 296, 359).  A 400 bp region containing Ptos is AT-rich (74% AT).  In addition, both of 
these nucleoid-structuring proteins regulate the expression of many genes, including 
adhesin and flagellar genes (42, 105, 152, 179, 183, 250, 296, 326, 346-355, 370, 372, 
375, 377, 378, 385-389).  To determine whether or not a 240 bp AT-rich region near Ptos 
is similarly curved to an analogous region in PpapBA, suggesting Lrp and H-NS-mediated 
nucleoid structuring, we utilized a web-based tool 
(http://www.lfd.uci.edu/~gohlke/dnacurve/) to predict DNA curvature.  We found that 
both regions have a similar predicted curved geometry (Figure D-1A and 1B), which 
suggests Lrp and H-NS could regulate the tos operon.  To further predict whether H-NS 
and Lrp bind to Ptos, we examined this sequence for putative H-NS and Lrp binding sites 
(see Appendix E, Figure E-1).  There are four clusters of putative Lrp binding sites 
(GN2-3TTT), based on PpapBA (358), downstream and partially overlapping the predicted 
strong TosR binding site and upstream and partially overlapping the predicted weak TosR 
binding site.  One of the predicted Lrp binding sites also overlaps Ptos.  In addition, there 
are also two putative high affinity H-NS binding sites with 80% (aCaATAAATT) and 
70% (ataATAAATT) identity to a sequence with known high affinity for H-NS (258, 
456) located upstream of the weak TosR binding site and downstream of Ptos, near the 
predicted transcriptional start site.  Intriguingly, running BLASTN on this same Ptos 
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sequence reveals a putative CitB binding site 22 bp upstream of Ptos (Figure E-1) (457).  
However, the function of this sequence in relation to tos operon regulation remains 
unclear.  
To determine whether H-NS and Lrp do indeed regulate the tos operon, we 
performed Western blots on proteins from whole cell preparations obtained from CFT073 
Δhns and Δlrp backgrounds (Figure 3-4A).  TosA levels were dramatically increased in 
the Δhns background compared to wild-type CFT073, suggesting that H-NS could 
function as a negative regulator of the tos operon.  However, it is important to note that 
H-NS perturbs the expression of a number of different genes (42, 179, 326, 346, 372, 375, 
377, 378, 385-389); therefore, it remains unclear if additional regulators supplement H-
NS-mediated negative regulation of the tos operon. The loss of Lrp failed to increase tos 
operon expression, as was observed for loss of H-NS. 
 With respect to the multitude of PapB family members, however, it is not always 
obvious how nucleoid structure and the cognate PapB family members integrate to 
govern expression of the adhesin.  To determine whether H-NS and Lrp contribute to 
TosR regulation of the tos operon, we performed the same pBAD-tosR-His6 
overexpression experiment (with reduced ampicillin concentration) described above in 
the CFT073 Δhns (Figure 3-4B) and Δlrp (Figure 3-4C) backgrounds.  As above, loss of 
hns resulted in increased TosA synthesis, but high levels of TosR did not decrease TosA 
levels in the CFT073 Δhns background.  Conversely, we found that the TosR-mediated 
positive regulation was dependent on Lrp; no change in TosA levels could be detected 
regardless of TosR level in the CFT073 Δlrp background.  Likewise, a shift to a lower 
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Figure 3-4.  TosR-mediated negative and positive regulation is perturbed in UPEC 
CFT073 Δhns and Δlrp backgrounds.  (A) A Western blot using polyclonal anti-TosA 
antibodies was performed on total proteins obtained from the indicated UPEC CFT073 
backgrounds.  Bands corresponding to TosA are indicated in the figure, and a cross-
reacting band is indicated with an X.  The Western blot is representative of two 
independent experiments.  Equal amounts of proteins were loaded as determined using a 
Pierce BCA Protein Assay Kit.  Western blots were also performed as above using 
polyclonal anti-TosA antibodies or an anti-His6 antibody in the UPEC CFT073 Δhns (B) 
or Δlrp (C) backgrounds harboring pBAD-tosR-His6 induced with the indicated 
concentrations of L-arabinose.  The Western blot is representative of two independent 
experiments.     
 
 
 
 
 
 
 
 
118 
 
antibiotic concentration for the Δhns and Δlrp backgrounds harboring pBAD-tosR-His6 
does not perturb TosR regulation itself; the lower antibiotic concentration did not perturb 
TosR-mediated regulation in the wild-type E. coli CFT073 background (data not shown).  
As for H-NS, Lrp is also a global regulator (105, 152, 179, 183, 250, 296, 347-355).  
Therefore, it remains unclear if additional gene products also supplement Lrp and TosR-
mediated positive regulation of the tos operon. 
 
Induction of lrp expression is sufficient to drive TosA synthesis 
Observing that Lrp is required for tos operon expression, we tested whether exogenous 
expression of Lrp alone would be sufficient to induce tos operon expression.  To 
determine whether Lrp acts as a positive regulator of tos operon, as is the case with the 
pap operon (179, 347, 354), we performed a pBAD-lrp overexpression experiment in 
wild-type CFT073.  Western blot of whole cell proteins from this overexpression 
construct revealed that low levels of lrp induction increased TosA levels (Figure 3-5A).  
In turn, high levels of lrp induction diminished TosA levels.  However, this effect was 
dependent on the presence of TosR (Figure 3-5B).  Likewise, in M9 minimal medium 
Lrp overexpression mediates less production of TosA in the wild-type CFT073 (Figure 
3-6), compared with the same assay performed with the tosR mutant (Figure 3-7).  Taken 
together, Lrp appears to be a positive regulator of the tos operon, but can also contribute 
to tos operon negative regulation in the presence of TosR.  It is important to note, 
however, that the same caveats of lrp overexpression should also be considered as with 
tosR overexpression above. 
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Figure 3-5.  Lrp is a positive regulator of TosA.  (A) A Western blot using polyclonal 
anti-TosA antibodies was performed on total proteins obtained from UPEC CFT073 
harboring pBAD-lrp and induced with the indicated concentrations of L-arabinose.  
Bands corresponding to TosA are indicated in the figure.  Equal amounts of proteins were 
loaded as determined using a Pierce BCA Protein Assay Kit.  The Western blot is 
representative of two independent experiments.  (B) A Western blot was performed as 
above using total proteins obtained from a ΔtosR UPEC CFT073 strain harboring 
pBAD-lrp induced with the indicated concentrations of L-arabinose.  TosA was detected 
as above.  
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Figure 3-6.  lrp overexpression does not support high TosA production in wild-type 
UPEC CFT073 cultured in M9 minimal medium.  A Western blot using polyclonal 
anti-TosA antibodies was performed on total proteins obtained from UPEC CFT073 
harboring pBAD-lrp and induced with the indicated concentrations of L-arabinose in M9 
minimal medium.  Equal amounts of proteins were loaded as determined using a Pierce 
BCA Protein Assay Kit. 
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Figure 3-7.  Exogenous L-leucine negatively regulates Lrp-mediated tos operon 
positive regulation in M9 minimal medium.  A Western blot was performed using total 
proteins obtained from a UPEC CFT073 ∆tosR strain harboring pBAD-lrp induced with 
the indicated concentrations of L-arabinose in M9 minimal medium with and without 10 
mM L-leucine.  Bands corresponding to TosA, detected with polyclonal anti-TosA 
antibodies, are indicated in the figure.   
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Exogenous leucine inhibits tos operon regulation  
Some genes regulated by Lrp are positively or negatively regulated by exogenous 
leucine (152, 296, 348, 352).  To test whether exogenous leucine positively or negatively 
regulates the tos operon, we performed our pBAD-lrp overexpression assay using the 
CFT073 ΔtosR background in M9 minimal medium with and without exogenous leucine 
(10 mM).  In the CFT073 ΔtosR background, induction of lrp expression resulted in 
higher TosA levels only in the absence of exogenous leucine (Figure 3-7).  This 
demonstrates that Lrp-mediated positive regulation of the tos operon is subject to 
regulation by leucine, especially in M9 minimal medium.  Furthermore, overexpression 
of pBAD-tosR-His6 in LB with and without additional leucine reveals that TosR-
mediated positive regulation is sensitive to exogenous leucine levels (see Appendix F, 
Figure F-1). To verify that low leucine, compared with LB, is an environmental 
condition encountered by various UPEC strains in vivo (32), we analyzed the differential 
expression of genes responsive to exogenous leucine (Table F-1 and Table F-2).  We 
found that UPEC may indeed respond to lower leucine levels in vivo, as many genes 
downregulated or inhibited by Lrp-leucine were upregulated in the human urinary tract.  
However, this upregulation is not uniform among all strains in the host urinary tract.  It 
may be that this differential expression occurs at different times throughout infection or 
that stochastic regulation by nucleoid proteins (371, 458-462) reduces the ability of 
RNA-Seq to make consistent descriptions of gene regulation between UPEC strains.  
Nevertheless, the fact that at least some of these genes are upregulated by UPEC strains 
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during a urinary tract infection suggests that there is at least some resolution to describe 
regulation by nucleoid regulators in response to leucine. 
   
An H-NS and Lrp regulatory switch drives tos operon transcriptional regulation 
It has been previously proposed and noted that Lrp might act to anti-silence H-NS 
repression (351, 354, 444, 446).  We hypothesize, therefore, that an H-NS and Lrp 
regulation switch (i.e., predominance of either H-NS or Lrp) explains the observed 
regulation of the tos operon.  In particular, if H-NS-mediated negative regulation is 
abolished, Lrp is no longer required for tos operon expression.  To test this hypothesis, 
we performed a Western blot on a CFT073 ΔhnsΔlrp mutant (Figure 3-8A).  TosA levels 
remain high in the ΔhnsΔlrp, which strengthens the premise that Lrp functions to 
overcome H-NS negative regulation of the tos operon.  Coupled with the finding that 
TosR regulation is abolished in the Δlrp background, these results suggest that an H-NS 
and Lrp regulation switch likely contributes to tos operon regulation, and TosR has a 
function within this regulatory switch.  It is important to note, however, that both H-NS 
and Lrp are global regulators (152, 179, 183, 250, 296, 347-355).  Therefore, it cannot be 
ruled out that regulation between H-NS and Lrp, at Ptos, is indirect. 
We next tested whether the proposed H-NS and Lrp regulatory switch would 
function at the transcriptional level at Ptos.  To determine whether Ptos is transcriptionally 
responsive to H-NS and Lrp, we measured the activity of our pRS551-Ptos-lacZ 
transcriptional fusion in both wild-type CFT073 and CFT073 nucleoid-structuring 
mutants using a Miller assay (Figure 3-8B).  As previously observed (435), the Ptos 
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Figure 3-8.  Lrp is not required for Ptos transcriptional activation in the Δhns 
background.  (A) A Western blot using polyclonal anti-TosA antibodies was performed 
on total proteins obtained from the indicated CFT073 backgrounds.  Equal amounts of 
proteins were loaded as determined using a Pierce BCA Protein Assay Kit.  (B) A Miller 
assay was performed using β-galactosidase translated from the lacZ gene of the pRS551-
Ptos-lacZ vector harbored in the indicated backgrounds.  Bars represent mean values of 
Miller units obtained from two biological replicates, with two technical replicates each.  
Error bars represent one standard deviation around the mean, and **** represents p-
values <0.0001 obtained by comparing lacZ expression from the pRS551-Ptos-lacZ 
construct harbored in the respective mutant or wild-type UPEC CFT073 background with 
the Δlrp background (determined using ANOVA followed by Tukey’s multiple 
comparisons test). 
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promoter showed high activity in wild-type CFT073.  Additionally, Ptos showed high 
activity in the CFT073 Δhns mutant.  Ptos promoter activity was greatly reduced in the 
CFT073 Δlrp background.  In the CFT073 ΔhnsΔlrp background, however, Ptos activity 
was restored to slightly higher than wild-type levels.  No growth differences were 
observed among bacterial strains harboring pRS551 (Figure 3-9).  These findings suggest 
that native Lrp levels induce Ptos on the pRS551 construct by overcoming H-NS-mediated 
negative regulation.  Thus, regulation of the tos operon by the H-NS and Lrp regulatory 
switch is at the transcriptional level.  From its Ptos DNA binding activities and association 
with H-NS and Lrp regulation of the tos operon, we further suggest that TosR also 
transcriptionally regulates the tos operon.  Intriguingly, a number of genes downregulated 
by H-NS were generally upregulated in the human urinary tract (Table F-3).  However, 
like the leucine responsive genes above, the same caveats are true for genes negatively 
regulated by H-NS.  Nevertheless, our findings suggest that the H-NS portion of the 
regulatory switch above is less prominent in vivo, consistent with the observed increase in 
tos operon expression (208, 227, 435).    
 
TosR contributes to pap operon regulation and curli and/or cellulose production 
Both H-NS and Lrp are global regulators that affect the expression of a variety of 
genes, including adhesin and flagellar genes (42, 105, 152, 179, 183, 250, 296, 326, 346-
355, 370, 372, 375, 377, 378, 385-389).  It is, therefore, not surprising that fimbrial 
regulators associated with H-NS and Lrp could also participate in cross-regulation 
between adherence and motility genes (203, 204, 248-250).  Both PapB (P fimbrial 
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Figure 3-9.  All UPEC CFT073 strains harboring pRS551-Ptos-lacZ have an 
equivalent growth phenotype.  A plot of a growth curve experiment conducted over ten 
hours, with the indicated mutant and wild-type UPEC CFT073 strains harboring pRS551-
Ptos-lacZ, is depicted.    
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operon) and FocB (F1C fimbrial operon) share approximately 80% amino acid sequence 
identity and regulate their respective pap and foc operons.  Cross-regulation between 
PapB and FocB is a well-characterized phenomenon (203).  In contrast, TosR has only 
28% amino acid sequence identity with PapB.  To determine whether TosR can also 
regulate the pap operon, we performed our pBAD-tosR-His6 overexpression assay and 
Western blot with an anti-PapA antibody (Figure 3-10A).  With increased TosR levels, 
PapA2 levels were decreased. 
 Previous work characterizing PapB and FocB cross-regulation explored the ability 
of both proteins to mediate this regulation through binding to PpapBA and PfocBA (203).  To 
determine whether TosR might also mediate pap operon cross-regulation through binding 
PpapBA, we performed an EMSA on a DIG-labeled PpapBA fragment and, as a control, a 
fragment of lacZ (Figure 3-10B).  TosR shifted the PpapBA fragment but failed to shift the 
control lacZ fragment.  Thus, we conclude that despite markedly low amino acid identity 
between PapB and TosR, TosR mediates negative regulation of the pap operon through 
specific binding of PpapBA.  Intriguingly, like the weak Ptos binding site, BLASTN reveals 
no substantial sequence homology with the strong Ptos binding site and PpapBA. 
 PapB family members have not previously been ascribed a regulatory function in 
the production of curli fibers and/or cellulose.  Nevertheless, to determine whether 
ectopic tosR expression could contribute to the regulation of other adhesins and the 
switch to multicellularity, we performed a pBAD-tosR-His6 expression assay on YESTA 
(yeast extract and tryptone agar) plates containing ampicillin (100 µg/mL) and 10 mM L-
arabinose.  Spots of E. coli strain CFT073 harboring pBAD-tosR-His6, pBAD-papB, 
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Figure 3-10. TosR negatively regulates P fimbriae synthesis.  (A) A Western blot 
using polyclonal anti-PapA antibodies, to detect PapA2 (~23 kDa), was performed on 
total proteins obtained from UPEC CFT073 harboring pBAD-tosR-His6 and induced with 
the indicated concentrations of L-arabinose.  This blot is representative of two biological 
replicates.  Equal amounts of proteins were loaded as determined using a Pierce BCA 
Protein Assay Kit.  (B) The indicated amounts of TosR-His6 were treated along with 
terminally DIG-labeled PpapBA or lacZ fragments.  Shifted and unshifted DNA fragments 
were detected using an Anti-DIG antibody.  The EMSA is representative of two 
independent experiments.  
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pBAD-focB, or the empty pBAD plasmid were incubated on the above YESTA plates for 
48 hours, and after this incubation period only E. coli CFT073 harboring the pBAD-tosR-
His6 construct exhibited the rdar (red, dry, and rough) phenotype indicative of the 
production of curli and/or cellulose (230-233) (see Appendix G, Figure G-1A).  Thus, 
tos operon expression may be coordinated with the expression of biofilm components, 
and TosR may exert regulatory control over these biofilm components in addition to the 
tos and pap operons.  Intriguingly, ectopic expression of FocB may weakly promote E. 
coli CFT073 binding the Congo red dye (Figure G-1B), which suggests that other PapB 
family members and adhesins could be weakly coordinated with curli and/or cellulose 
production.       
 
Lrp and H-NS serve key functions in motility and adherence reciprocal regulation 
 Lrp is a putative negative regulator of motility in a Type 1 fimbria locked ON E. 
coli CFT073 strain (355).  To determine whether an lrp mutation could suppress the low 
production of FliC in an hns mutant (375, 376), we performed a Western blot using 
polyclonal anti-FliC antibodies on total proteins obtain from the ∆hns∆lrp CFT073 strain 
(see Appendix H, Figure H-1A).  We found that an lrp mutation is insufficient to restore 
FliC levels to near wild-type levels, which suggests that nucleoid structure, particularly 
mediated by H-NS, is vital for reciprocal regulation to occur.  To determine whether 
reciprocal regulation between adhesins occurs in the same ∆hns∆lrp CFT073 strain, we 
again performed a pBAD-tosR-His6 overexpression assay and Western blot using 
polyclonal anti-PapA antibodies on total proteins obtained from this strain (Figure H-1B).  
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PpapBA is expressed in another ∆hns∆lrp E. coli strain not harboring the tos operon (354).  
However, we observed no PapA synthesis in the UPEC CFT073 ∆hns∆lrp strain, a stain 
where high TosA synthesis was observed (Figure 3-8A).  Consistent with the results 
above, nucleoid structure is a key component of adhesin reciprocal regulation (i.e., to 
prevent a few adhesin regulators, such as TosR, from simply dominating over the other 
adhesin operons, such as the pap operon).  
    
             
Discussion 
 
 Here, we present a model of tos operon regulation involving PapB family member, 
TosR, and two global gene regulators, H-NS and Lrp (Figure 3-11).  TosR is a positive 
and negative transcriptional regulator of the tos operon.  We predict that TosR mediates 
this dual regulation through differential binding to the region of DNA containing Ptos, the 
tos operon promoter, by TosR.  The global regulator, H-NS, transcriptionally silences 
expression of the tos operon, while another global regulator, Lrp, overcomes H-NS 
silencing to mediate positive regulation of the tos operon.  When TosR levels are low, 
TosR promotes Lrp-mediated positive regulation of the tos operon.  However, when 
TosR levels are high, TosR promotes H-NS-mediated negative regulation of the tos 
operon.  We also predict that H-NS and Lrp interact either directly or indirectly to modify 
tos operon positive regulation.  Additionally, TosR negatively regulates expression of the 
P fimbrial (pap) operon.  Using RNA-Seq and 5’ RACE, we identified the transcriptional 
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Figure 3-11.  Model of tos operon regulation and its involvement in reciprocal 
regulation of adhesins and flagella.  The tos operon is indicated with blue text, and tosA 
is represented with red text.  A blue arrow indicates that TosR, TosE, and TosF are 
translated from genes transcriptionally linked to the tos operon.  Under typical laboratory 
conditions H-NS silences expression of the tos operon (red bar).  Under low and high 
concentrations, respectively, TosR positively and negatively (+/-) regulates (yellow 
arrow) Lrp-mediated positive regulation of the tos operon (green arrow).  The inverse is 
true for H-NS-mediated regulation (yellow arrow).  Low levels of TosR inhibit H-NS-
mediated negative regulation and high levels promote H-NS-mediated negative of the tos 
operon (-/+).  Lrp may also indirectly relieve H-NS-negative regulation of the tos operon, 
and H-NS may also indirectly inhibit Lrp-mediated positive regulation of the tos operon 
(pink bars).  In turn, TosR also negatively regulates P-fimbriae synthesis (red bar), and 
together cognate regulators, TosE and TosF, negatively regulate flagella synthesis (red 
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bar).  High levels of leucine, in addition, negatively regulate Lrp-mediated positive 
regulation of the tos operon (red bar). 
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start site of the tos operon 23 bp upstream of tosR and Ptos 30 bp upstream of tosR.  The 
promoter sequence has only a few modifications from the canonical σ70, which include 
two base substitutions from the canonical -35 sequence and spacing between the -35 
and -10 sequences one base pair shorter than for the average σ70 promoter (448, 449).  
Additionally, the first base of the transcript, adenosine, is also typical of other σ70 
promoters (450, 451), and the spacing between the promoter and the start of the transcript 
(7 bp) is also observed with other σ70 promoters (449). Thus, together these results 
suggest that Ptos could be a strong promoter, which is consistent with our previous 
observation of strong activity from the pRS551-Ptos-lacZ transcriptional fusion (435).  
This finding, however, is confounded by the weak expression of the tos operon 
previously observed (208, 227, 435), which points to negative transcriptional regulation 
at Ptos by other proteins as a possible mechanism of tos operon regulation.  
Our group previously reported that the tos operon is repressed when cultured 
under laboratory conditions (LB broth, both aerated and static, at 37°C) (208, 227, 435).  
Some of this negative regulation is attributed to TosR (435).  However, other PapB 
family members act as dual regulators (both activator and repressor) of their cognate 
operons (179, 180, 384).  We found this was also the case for TosR, which shows a 
reciprocal relationship with TosA levels: if TosR levels are low, TosA levels are high; 
when TosR levels are high, TosA levels are significantly reduced.  Thus, TosR is a dual 
regulator of the tos operon.  We predict that at least some of this differential behavior is 
mediated through TosR binding to two sites within Ptos, one site when TosR levels are 
low (strong binding site) and the other when TosR levels are higher (weak binding site).  
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Regulation of the tos operon, involves not only TosR, but includes both H-NS and 
Lrp.  We predict that TosR-positive regulation of the tos operon, when TosR levels are 
low, may be mediated through an alleviation of negative regulation by H-NS, thereby 
promoting Lrp-mediated positive regulation.  In terms of the predicted H-NS binding site 
upstream of Ptos (Figure E-1), we speculate that TosR binding either displaces an H-NS 
filament or prevents further H-NS polymerization at this site, both known mechanisms of 
overcoming H-NS silencing (315).  Subsequently, this activity may allow Lrp to bind to 
predicted binding sites in the vicinity of Ptos to promote positive regulation.  This model 
is further supported by TosR-mediated positive regulation of the tos operon no longer 
being required in the Δhns background.  Furthermore, Lrp-mediated positive regulation is 
no longer necessary in the same Δhns background, and TosR positive regulation is 
abolished in the Δlrp background.  Lrp alone is also sufficient to promote expression of 
the tos operon, especially in the absence of leucine, which further supports our prediction 
of Lrp-mediated positive regulation of the tos operon.  Thus, in terms of the predicted Lrp 
binding sites (Figure E-1) in the vicinity of Ptos and previous work on Lrp by others 
(364-366), we speculate that Lrp binding may facilitate RNA polymerase contact with 
either Lrp itself or additional unknown elements near Ptos.  Similarly, we propose that 
TosR-negative regulation of the tos operon, when TosR levels are high, may be mediated 
through interference of Lrp-promoted positive regulation. We also predict that TosR-
mediated negative regulation is dependent on H-NS.  We speculate, in terms of the 
second predicted TosR and H-NS binding sites (Figure E-1) in vicinity of Ptos, that TosR 
binding to this site occludes Lrp binding and subsequent occlusion of RNA polymerase 
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from Ptos.  Further support for this conclusion comes from the finding that TosR is no 
longer a negative regulator of the tos operon in a Δhns background.  Also integrating the 
two predicted H-NS binding sites into this regulation model, it is possible that bridging at 
these sites could promote negative regulation (306, 314, 315, 463, 464). 
From the strong activity of Ptos in a ΔhnsΔlrp background, we also predict that an 
H-NS and Lrp regulation switch is responsible for much of the tos operon regulation.  
The switch may act through alteration of the predominance of H-NS and Lrp regulation at 
Ptos, which is consistent with modulation of nucleoid levels of each during different 
growth phases (94, 95, 109).  However, as H-NS and Lrp are pleiotropic regulators (42, 
105, 152, 179, 183, 250, 296, 326, 346-355, 370, 372, 375, 377, 378, 385-389), this 
switch may also be through indirect interactions.  To emphasize the possibility that H-NS 
and Lrp indirectly interact, pink bars are depicted in our model (Figure 3-11).  In 
agreement with this idea of a switch between the two nucleoid proteins, the strong 
decrease in Ptos activity observed with the loss of Lrp, is increased when H-NS is also 
absent.  This leads us to predict that Lrp functions to overcome H-NS negative regulation 
of the tos operon, consistent with our belief that an H-NS and Lrp switch governs tos 
operon expression.  It is also an intriguing possibility that this same switch is similar to a 
previous description of nucleoid contributions to reciprocal regulation of adherence and 
motility (388).  However, whether this H-NS and Lrp regulation switch is mediated by 
direct antagonism of each component or indirect effects will need to be examined further.   
We note that the estimated leucine content of pooled human urine (~0.01 mM) 
(401) is much lower than that of LB (~8 mM) (465).  This suggests that UPEC would 
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adjust gene expression to accommodate the low leucine levels found in human urine.  
Thus, growth in an environment with relatively low levels of leucine is an environmental 
stress encountered by UPEC during an infection.  As exogenous Lrp, specifically in M9 
minimal medium, does not positively regulate the tos operon in the presence of high 
leucine levels, we also conclude that low leucine is an environmental cue that upregulates 
the tos operon.  We also propose that the presence of higher levels of leucine in LB at 
least partially accounts for poor tos operon expression when cultured in this medium.   
As evident from the variety of genes, including those localized to adhesin operons 
in addition to flagellum-mediated motility genes regulated by H-NS and Lrp (42, 105, 
152, 179, 183, 250, 296, 326, 346-355, 370, 372, 375, 377, 378, 385-389), cross-
regulation is a possible feature of this regulatory switch (203, 204, 248-250).  We found 
that TosR is a negative regulator of P fimbria production.  We predict that this negative 
regulation is potentiated through TosR binding to PpapBA, the pap operon promoter. This 
is a surprising finding in that the previously well described cross-regulation between 
PapB family members occurred between PapB and FocB, which shared 80% amino acid 
sequence identity (203).  TosR and PapB share only 28% amino acid sequence identity.  
We hypothesize that these results have important implications for studying adhesin 
expression.  Further work should explore whether TosR, like PapB and FocB, also 
regulates FimA and FocA levels (203) and whether PapB and FocB contribute to tos 
operon regulation.  Nevertheless, it is now our conclusion that such cross-regulation 
between PapB family members and different types of adhesins (i.e., fimbrial and 
nonfimbrial adhesins) is a broader phenomenon than previously thought.  Thus, a more 
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detailed exploration of adhesin cross-regulation, especially between unrelated or poorly 
related adhesins and adhesin regulators, should be undertaken to gain a more accurate 
picture of microbial adhesin regulation.  These future explorations should include 
determining whether reciprocal regulation between adhesins is an important fitness trait 
during infection.  For example, P fimbria and TosA both make contributions during 
experimental UTI (170, 192, 440, 441), but it is unknown whether TosR inactivation 
could suppress a tosA mutation through allowing UPEC to continue to synthesize P 
fimbria instead of simultaneously inhibiting P fimbria production and attempting to 
produce a nonexistent TosA adhesin.   
Finally, previous work (435) has already established that TosEF, expressed when 
the tos operon is expressed, negatively regulate FliC levels.  Together with the TosR 
findings above, we have also found that tos operon regulation participates in reciprocal 
regulation of adherence and motility.  It is intriguing to note that a protein encoded by the 
terminal gene of the pap operon, papX, suppresses motility in UPEC strain CFT073 (187, 
188).  Future work may, thus, also explore whether overexpressing lrp in tosEF and papX 
mutant constructs decreases motility.  Taken together, these results could delineate the 
function of the H-NS and Lrp regulatory switch in reciprocal regulation and during 
infection.  
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CHAPTER 4 
CONCLUSIONS AND PERSPECTIVES 
 
 
Summary of results 
 
In these studies, I have presented the finding that TosR, TosE, and TosF are 
conserved among UPEC (uropathogenic Escherichia coli) strains. Furthermore, I have 
elucidated the transcriptional organization of the tos operon.  I have also described the 
function of TosR as a tos operon dual regulator, determined that H-NS (heat-stable 
nucleoid structuring protein) and Lrp (leucine-responsive regulatory protein) serve 
important functions during regulation of the tos operon, and determined that exogenous 
leucine contributes to negative regulation of the tos operon.  I also determined that TosE 
and TosF repress motility, TosR contributes to reciprocal regulation of adhesins, and 
H-NS and Lrp make important contributions to adherence and motility reciprocal 
regulation.  Here, the main findings of this work are summarized: 
• TosR, TosE, and TosF are broadly conserved among UPEC strains encoding 
structural genes tosCBDA.  There are five variants TosR and four variants of TosE 
and TosF.  These classifications are based on the predicted amino acid sequences 
of TosR and the TosEF regulators.   
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• The GC contents of tosR, tosE, and tosF are distinct from the remainder of the tos 
operon (tosCBDA).  This suggests that regulatory genes tosR, tosE, and tosF were 
acquired by the tos operon after the structural genes.   
• tosRCBDAEF form a single transcript. 
• The tos operon promoter, Ptos, is 30 bp upstream of tosR, consistent with the 
predicted transcriptional architecture of the tos operon. 
• TosR is both a positive and negative regulator of the tos operon, depending on the 
cellular concentration of TosR.  As there are at least two TosR binding sites in the 
vicinity of Ptos, with different predicted binding affinities, differential DNA 
binding may account for TosR dual regulation.  
• H-NS is a negative regulator of the tos operon, and Lrp is a positive regulator of 
the tos operon.  TosR positive and negative regulation of the tos operon depends 
on Lrp and H-NS, respectively.  However, Lrp-mediated positive regulation of the 
tos operon appears to be independent of TosR.  Exogenous leucine inhibits both 
Lrp- and TosR-promoted positive regulation of the tos operon. 
• TosE and TosF together suppress motility by reducing FliC levels.   
• TosR also suppresses production of P fimbria, which may proceed through 
binding in the vicinity of PpapBA.   
• H-NS and Lrp contribute to reciprocal regulation of adherence and motility  
 
 
Final Conclusions, perspectives, and future directions 
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My final perspective on tos operon regulation, based on the work reviewed below 
and proposed hypotheses (with tests), follows.  In vitro [LB medium], the tos operon is 
both expressed and repressed, with repression overwhelmingly predominating among the 
UPEC cell population.  The high cellular copy number of H-NS (95) normally represses 
the tos operon.  Lrp, at lower concentrations than H-NS (95), is unable to induce the 
chromosomal copy of the tos operon.  Reduced positive regulation by Lrp is further 
compounded by the fact that leucine levels are relatively high in LB medium (465), 
which partially inhibits Lrp-positive regulation of the tos operon.  However, some cells in 
the UPEC population still express the tos operon even under conditions not normally 
permissive to tos operon induction.  That TosR overexpression could still induce the tos 
operon (i.e., Lrp can overcome leucine levels in LB), and that Lrp still positively 
regulates the Ptos-lacZ construct, supports the conclusion that some cells in the population, 
even under conditions that are not permissive for tos operon expression, could still 
express the operon.  I predict that TosR relieves H-NS repression and promotes Lrp 
binding in the vicinity of Ptos.  I predict that TosR overexpression also has a normalizing 
effect on tos operon expression (i.e., increases the fraction of cells expressing the tos 
operon from a vanishingly small number to nearly uniform expression).  Without tosR 
overexpression, I hypothesize that Lrp may promote tos operon expression, with TosR 
functioning in a feedforward loop to further favor tos operon expression.  A high level of 
Lrp, itself promoting tos operon expression, favors this particular explanation.  This, and 
Ptos-lacZ expression being mediated by Lrp, as discussed above, is also evidence for the 
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H-NS and Lrp switch processes discussed in this work (i.e., regulation of the tos operon 
in the UPEC cell is either predominated by H-NS or Lrp and switches between the two).  
At the same time, TosR binds in the vicinity of PpapBA to reduce P fimbria levels, and 
TosEF levels accumulate to suppress flagellar levels in the UPEC cell.  Thus, as TosA 
levels increase, motility and other adhesin levels decrease.   
As TosR levels accumulate in the UPEC cell with overexpression of tosR in LB, I 
propose that TosR binds to a weaker affinity site in the vicinity of Ptos and inhibits 
expression of the tos operon, likely through occluding Lrp and favoring H-NS binding.  
H-NS levels, as noted above, are also high in the UPEC cell and could regain prominence 
in tos operon repression without TosR (i.e., the unmarked tosR mutation does not 
overexpress the tos operon).  In addition, exogenous leucine inhibits TosR-mediated 
positive regulation of the tos operon, most likely through abrogating Lrp binding in the 
vicinity of Ptos. 
tos operon regulation in M9 minimal medium is different, compared to culturing 
in LB medium above.  In a minimal medium, the cellular Lrp levels are higher (104) and 
exogenous leucine is essentially absent, and as such the fraction of cells in the UPEC 
population expressing the tos operon is predicted to be slightly higher than in LB.  
However, as overproduction of Lrp in some situations (e.g., in the UPEC CFT073 ∆tosR 
background) can still induce the tos operon, nucleoid regulation is not abolished in M9 
medium.  Thus, tos operon expression could still be lower than necessary for detection in 
these assays.  As Lrp levels increase in wild-type UPEC CFT073, such as from pBAD-lrp, 
I predict that tos operon expression also increases resulting in rapid accumulation of 
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TosR and subsequent inhibition of Lrp-mediated positive regulation.  Without the ability 
to increase TosR levels (as would be the case in the ∆tosR background), the tos operon 
could be expressed in a manner similar to LB.  Nevertheless, all of these findings suggest 
that the H-NS and Lrp regulation switch is active in M9 minimal medium. 
When UPEC enters the urinary tract, some cells either previously exist in (i.e., 
there are small fractions of cells expressing the tos operon as in LB and M9 minimal 
medium) or change to an H-NS and Lrp regulatory switch configuration conducive to tos 
operon expression.  If the switch is previously on, these cells expressing the tos operon 
may be selected for in the urinary tract, and Lrp promotes tos operon expression.  TosR 
binding in the vicinity of Ptos, in addition, continues to promote expression of the tos 
operon in these cells.  If the switch is off in some UPEC cells, an environmental cue such 
as reduced leucine levels may switch the tos operon on.  In this case, either TosR 
overcomes H-NS repression to promote Lrp binding, which further induces tosR in a 
feedforward loop, or Lrp overcomes H-NS repression to induce tosR expression in the 
same feedforward loop.  At the same time, motility and other adhesin genes may be 
suppressed in these UEPC cells, ensuring variability in the UPEC population (i.e., cells 
not producing TosA may produce other adhesins or flagella, instead of all cells making 
all adhesins simultaneously with flagella).  As TosR levels accumulate, the tos operon 
may switch off in some other UPEC cells in the population.  This may be compounded by 
H-NS also regaining repressive prominence of the tos operon.  Motility, at this point, may 
switch on and an invasive infection could be promoted.  The tos operon may switch back 
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on at a later time, or, as the UPEC population synchronized, other cells could switch the 
tos operon on.   
I also hypothesize that NAPs (nucleoid-associated proteins), such as H-NS and 
Lrp, serve the key function in generating non-genetic variability among cells to exploit a 
variety of host niches or evade the host immune system (i.e., allow reciprocal regulation 
between adhesin- and motility-related genes to occur).  Indeed, the tos operon is 
optimally expressed when H-NS regulation does not predominate at Ptos.  This condition, 
in conjunction with low leucine levels, Lrp predominating at Ptos, and modest TosR levels 
(all thought to inhibit H-NS predominance at Ptos), likely occurs in the human urinary 
tract.   
In this work, I first set out to determine whether regulators encoded by the E. coli 
strain CFT073 tos operon were similarly encoded in other UPEC genomes.  In a survey 
of the genomic sequences of 317 UPEC bacteremia isolates from the Broad Institute 
(https://olive.broadinstitute.org/comparisons/ecoli_uti_bacteremia.3), it was discovered 
that nearly one-third of these strains harbor the tos operon.  The overwhelming majority 
(91%) of the tos operon containing UPEC strains simultaneously encode regulatory genes 
tosR, tosE, and tosF.  There are five variants of TosR (based on predicted amino acid 
sequence) followed by four variants of TosE and three variants of TosF.  TosR is a 
member of the PapB family, and TosE and TosF are both LuxR family members.  As 
discussed in this work, specific variants are associated with each other.  This 
overwhelmingly supports the conclusion that tosR, tosE, and tosF are genetically linked.  
It is also intriguing to note that tos operons encoding TosR variants four and five appear 
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to be localized to a self-transmissible plasmid, which confirms the hypothesis that the tos 
operon could be acquired by horizontal gene transfer.  However, even though the 
evidence in support of this hypothesis is overwhelming, to establish whether the plasmid 
transfer genes are functional, mating between different E. coli strains with and without 
these plasmids could be performed. 
 The tos operon also appears to be dynamic, meaning that some genes seem to 
have been acquired or lost from the operon at different times than other genes in the 
operon.  The GC contents of the tos regulatory genes (tosREF) are substantially lower 
(29.1%), than the tos structural genes (tosCBDA) (48.5%).  This is unusual for genes in 
an operon, which typically maintain similar GC content (such as for the case for 
tosCBDA) (424).  Nevertheless, as tosR and tosEF both have similar AT-richness, and all 
three genes are nearly always present or absent together, it seems most likely that the tos 
operon structural genes, at some point in their evolution, were inserted into a locus 
containing tosREF.  Both the former observation (some operons lack tos regulators) and 
latter hypothesis (tosCBDA were inserted into tosREF) predict that multiple pathways 
could regulate the tos operon, but TosR- and Lrp-mediated regulation would occur if Ptos 
from E. coli strain CFT073 was inserted into these operons lacking tosREF.  This 
regulation hypothesis could be tested as follows.  Ptos from E. coli CFT073 could be 
inserted into a tos operon not containing this promoter at a similar site to E. coli CFT073.  
Expression from this engineered tos operon could then be assessed with ectopic tosR and 
lrp expression. 
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 Both RNA-Seq and 5’ RACE were valuable techniques to map the tos operon 
promoter.  My work showed that tosRCBDAEF form a single transcript, and the region 
upstream of tosR can promote expression of a promoterless lacZ gene when engineered 
into a vector upstream of this lacZ gene.   RNA-Seq and 5’ RACE both identified the 
same transcriptional start site 23 bp upstream of tosR.  In turn, 7 bp upstream of the 
identified transcriptional start site is a canonical σ70 promoter.  As the leader sequence 
from this transcriptional start site is shorter than some leader sequences exhibiting post-
transcriptional regulation (466), it does not appear likely that such a mechanism accounts 
for tos operon regulation at the beginning of the tos transcript.  However, such a 
mechanism may still exist at other regions in the tos operon transcript, especially given 
the large gaps between tos operon genes (e.g., 199 bp between tosD and tosA).  Given 
that the tos operon is repressed when E. coli CFT073 is cultured under laboratory 
conditions (208, 227), and the tos promoter itself has the consensus sequence of a 
canonical σ70 promoter, these data also strongly suggest that repression and activation 
(overcoming repression) are likely mechanisms of tos operon regulation.   
 Using overexpression assays, I found that TosR both induces and represses 
expression of the tos operon.  This dual regulation is most likely dependent on cellular 
concentrations of TosR; when TosR levels are low, the tos operon is likely to be 
expressed, and when TosR levels are high, the tos operon is less likely to be expressed.  
This dual regulation of cognate operons is also seen among other PapB family members 
(179, 180, 202, 203, 404).  I have identified at least two TosR binding sites in the vicinity 
of Ptos, and I have predicted that TosR has different affinities for these binding sites, 
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which may couples TosR concentrations to TosR-mediated dual regulation.  The strong 
binding site is at least 160 bp upstream of Ptos and may function by obstructing the 
function of a repressor protein.  The weak binding site is near Ptos and may obstruct RNA 
polymerase or the function of another activator (e.g., Lrp).  An assay to verify whether 
TosR binds with different affinities to these sites in the vicinity of Ptos could include 
performing ITC (isothermal calorimetry) on purified TosR and DNA fragments 
containing TosR binding sites.  TosR binding affinities for these DNA fragments could 
subsequently be determined, as is already the case for other DNA binding proteins (467).  
To determine whether or not these binding affinities are consistent with TosR dual 
regulation in living cells, single cell sorting assays, for the purpose of comparing TosR 
and TosA levels, could be performed and compared with the ITC values above.   
As PapB family member binding sites do have some degree of AT-richness (182), 
which also appears to be the case for TosR, it seems logical to explore whether TosR, 
PapB, and FocB exert global regulation on E. coli gene expression.  This regulatory 
property has not previously been ascribed to the PapB family, but could be logically 
explored, given that other global regulators also bind AT-rich sequences (41-43, 94, 286, 
295-297, 309, 359).  To explore the consequences of expressing each PapB family 
member individually and in combination, on global gene expression, microarray, ChIP-
Seq, and RNA-Seq are all assays that could be utilized.   
Using single cell sorting, it could also be possible to numerically calculate the 
conditional entropy of tos operon expression at various cellular levels of TosR.  In so 
doing, a consistent physical language could be developed to describe tos operon (and 
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other operons) regulation.  For the sake of brevity, entropy describes the average amount 
of information associated with a probability distribution of a random variable; conditional 
entropy is the average amount of information associated with a probability distribution of 
a random variable with respect to another random variable (468).  I predict that the 
conditional entropy, itself, could be seen as describing widths of gene expression 
histograms of sorted cells (under an invariant scales assumption).  Narrow histograms 
(Figure 4-1A and 1B) have low gene expression variability and low entropy.  Wide 
histograms have high entropy (Figure 4-1C) and high variability in gene expression 
across the cell population.  In terms of the tos operon, low expression entropy may be 
observed with both high and low levels of TosR induction (i.e., most cells will not 
express tosA).  Expression entropy will be expected to increase with levels of TosR 
conducive to tosA expression. 
The global regulators H-NS and Lrp are also involved in regulation of the tos 
operon.  H-NS repression of the tos operon, in fact, may be where nearly all tos operon 
regulation is originally derived.  For instance, loss of H-NS results in a substantial 
increase in TosA synthesis, and neither TosR- nor Lrp-mediated regulation is required 
without H-NS.  This also makes sense in that H-NS represses genes acquired by 
horizontal transfer (41-43), the presumed method of tos operon acquisition by E. coli.  
Lrp is the presumptive positive regulator of the tos operon, through which any TosR-
mediated positive regulation is derived.  In agreement with this, loss of Lrp abolishes 
TosR-mediated regulation of the tos operon, but loss of TosR has no effect on Lrp-
mediated positive regulation of the tos operon.  Lrp is unable to overcome TosR-
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Figure 4-1.  Sample curves with predicted low and high gene expression entropy.  
The number of cells with a strongly repressed (A) or strongly induce (B) gene will be 
mostly binned into low and high expression levels, respectively (low entropy).  (C) Cells 
that are found in a situation where a gene could be either induced or repressed, with little 
certainty of either event, exhibit greater expression variability (high entropy).  For 
simplicity, the scales and number of cells sorted are assumed to be invariant in all figures.  
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mediated repression at high levels of lrp induction in both LB and M9 media.  To my 
knowledge, this may be the first description of a PapB family member being directly 
involved in Lrp-mediated regulation of its cognate operon, as opposed to regulating the 
expression of a gene that encodes a protein modifying Lrp regulation of the cognate PapB 
family operon (e.g., PapI) (179-181).  Thus, a new regulatory activity may have been 
ascribed to the PapB family.    
Predictions using known H-NS and Lrp binding sites (258, 358) reveal that high 
affinity H-NS binding sites may be found in the vicinity of the strong TosR binding site 
and overlapping the tos operon transcriptional initiation site.  Lrp binding sites may be 
located downstream of the strong TosR binding site and overlapping the weak TosR 
binding site.  However, future gel shift assays must be performed with purified H-NS, 
Lrp, and DNA fragments containing these sequences to verify whether these NAPs 
(nucleoid-associated proteins) bind these sequences.  In terms of the tos operon 
regulation model, it seems likely that in single cells, TosR, like other regulators (181, 307, 
315), promotes positive regulation by obstructing H-NS-mediated repression of the tos 
operon when bound to the strong TosR binding site.  Simultaneously, TosR binding to the 
strong TosR binding site may promote Lrp binding in the vicinity of Ptos, by possibly 
blocking H-NS obstruction at these sites.  At high cellular levels of TosR, TosR 
presumably obstructs Lrp positive regulation through binding the weak TosR-binding 
sites, which in turn may allow H-NS binding in the vicinity of Ptos.  H-NS, however, is an 
abundant NAP (95); therefore, any displacement of H-NS may only be transient.  To test 
whether TosR competes with H-NS and Lrp for binding sites in the vicinity of Ptos, gel 
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supershift assays could be performed with differentially tagged TosR, H-NS, and Lrp 
proteins, mixed in combination and at various concentrations with an antibody directed 
against the regulator of interest in each binding reaction (469). 
 Expression of the tos operon is sensitive to exogenous levels of leucine, 
suggesting that this is an environmental cue involved in tos operon regulation.  High 
leucine levels inhibit both TosR- and Lrp-mediated regulation of the tos operon.  
Previous work has already established that UPEC will likely encounter lower levels of 
leucine in the urinary tract compared with LB medium (401, 465).  To further determine 
whether Lrp binding to Ptos is perturbed by leucine, gel shift assays could be performed, 
as above, in the presence of leucine.  As TosR-mediated regulation of the tos operon 
occurs through Lrp, perturbed Lrp DNA binding would also be the presumptive 
mechanism of TosR sensitivity to leucine.  It is important to note, however, that RNA-
Seq assays on UPEC strains obtained from patients at a clinic (32) revealed that UPEC 
sensing leucine during an infection may be complex.  For instance, although the 
population of UPEC cells was generally more leucine-starved in the human urinary tract, 
compared with LB, some strains do not upregulate genes that would otherwise be 
inhibited by Lrp-leucine.  Thus, while lower leucine levels certainly promote tos operon 
expression, it may also be the case that at least some of the time a low exogenous leucine 
concentration may promote tos operon expression (i.e., TosR could repress the tos operon 
if levels of tosR expression were too high).  This may also agree with the finding that 
TosR and Lrp could induce the tos operon in LB, but the same regulators fail to induce 
the tos operon with a chromosomal copy of tosR in M9.  To further test this hypothesis, 
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lrp and tosR induction could be performed in the wild-type E. coli CFT073 background 
with a concentration gradient of leucine supplemented to M9 medium and assayed for 
TosA levels.  However, it may also be the case that gene regulation by nucleoid 
regulators, such as H-NS and Lrp, could be stochastic (371, 458-462) and RNA-Seq not 
able to consistently resolve differential expression of genes regulated by nucleoid 
proteins.  Therefore, to ascertain whether individual cells may be responding to low 
leucine in the urinary tract, high-resolution techniques, such as FISSEQ (fluorescent in 
situ sequencing) and SeqFISH (sequential in situ hybridization) (470, 471) in conjunction 
with conditional entropy studies could be utilized. 
An H-NS and Lrp switch (i.e., a switch between H-NS- and Lrp-mediated 
regulation at Ptos) also underpins regulation of the tos operon (see Figure 1-6).  For 
instance, when Ptos-lacZ is present on a multiple copy number plasmid, Lrp is able to 
promote expression of lacZ from this promoter.  I concluded this from the fact that this 
overexpression phenotype is not observed in the absence of Lrp.  At the same time, an 
hns mutation can suppress this lack of overexpression, from the Ptos-lacZ construct, when 
Lrp is also absent.  The overexpression phenotype is mirrored in a Western blot to detect 
TosA synthesis, which further shows that a switch in H-NS- and Lrp-mediated regulation 
is key to tos operon regulation.   A switch to Lrp prominence in regulation of the tos 
operon mediates positive regulation, and a switch to H-NS prominence in regulation of 
the tos operon mediates negative regulation.  In addition, I predict that an H-NS 
predominating switch is unlikely to be observed in vivo, as genes negatively regulated by 
H-NS were either not differentially regulated or upregulated during a human UTI (32).  
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However, genes negatively regulated by H-NS are not uniformly upregulated by all 
UPEC strains during human UTI, which suggests that RNA-Seq may have lower 
resolution than what is necessary to consistently resolve differential gene expression as 
described above.  To ascertain whether the H-NS occupancy part of the switch does not 
predominate during experimental UTI, FISSEQ and SeqFISH could again be utilized in 
conjunction with conditional entropy studies.    
At least some of this regulation may be due to changes in the concentrations of 
other NAP regulators.  Indeed, Lrp overexpression itself is sufficient to drive TosA 
synthesis, further supporting the idea that an H-NS and Lrp switch modulates tos operon 
regulation.  In this instance, Lrp binding to putative Lrp-binding sites in the vicinity of 
Ptos may be sufficient to override H-NS-mediated repression of the tos operon.  
Furthermore, as outlined above, TosR-mediated regulation is abrogated in hns and lrp E. 
coli CFT073 mutants, which shows that this switch itself underpins tos operon regulation.  
TosR, however, may also manipulate the switch to mediate positive and negative 
regulation of the tos operon as outlined above (i.e., bias the switch to favor one NAP).  It 
is important to note, however, that H-NS and Lrp are both global regulators (42, 105, 152, 
179, 183, 250, 296, 326, 346-355, 370, 372, 375, 377, 378, 385-389).  Thus, both the 
direct and indirect effects of this switch may be important for regulation of the tos operon.  
The importance of direct effects could be described with Lrp and H-NS competition gel 
supershifts as outlined above.  Indirect effects could be determined through transforming 
a transposon mutant library (generated in wild-type E. coli CFT073, hns, lrp and hns and 
lrp mutants) with the Ptos-lacZ vector to identify secondary mutations with perturbed tos 
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operon regulation.  To determine which additional environmental cues could inhibit 
H-NS-mediated repression, the Ptos-lacZ vector may also be used in the lrp mutant 
background for a Biolog® screen (472).  
An intriguing possibility for tos operon regulation is that it may also be 
stochastically regulated.  For instance, differential methylation may be stochastic and 
regulates the pap operon (458).  Furthermore, H-NS and Lrp may also manipulate 
methylation of PpapBA (371, 458-460), and some level of pap operon expression is 
observed even in the presence of H-NS (i.e., the negative regulator of the pap operon) 
(354).  These NAPs, in addition to IHF, also contribute to phase variation of the fimS 
element of the fim operon, another stochastic process (166, 169, 473).  H-NS and IHF 
may also propagate cell population noise in gene expression (i.e., promote higher entropy 
in the expression of genes regulated by each) (461, 462).  Thus, as H-NS and Lrp are 
regulators of the tos operon, it is logical to expect that some regulation of this operon will 
be stochastic.  To test this possibility, single cell sorting could be performed on UPEC 
strain CFT073 cells obtained from an LB culture, M9 minimal medium culture, and the 
murine urinary tract for TosA synthesis.  This will also be another instance where 
exploring the entropy of gene expression could be a useful metric for describing gene 
regulation both in an LB culture and the murine urinary tract.  An increase in entropy 
suggests a high degree of variability in the cellular population (i.e., cells are neither fully 
induced nor fully repressed), and a decrease in entropy suggests low population 
variability (i.e., most cells are inducing or repressing expression).  I predict that higher 
entropy suggests a more random and stochastic regulation profile.  In addition, I predict 
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that cells obtained from the urinary tract would likely have the highest tos expression 
entropy, followed by M9 minimal medium cells, and concluding with UPEC cells 
cultured in LB.  It is also expected that entropy will decrease for lrp mutations, as Lrp is 
the positive regulator of the tos operon (i.e., even fewer cells will be expected to express 
the tos operon).  Entropy for an hns mutation may, however, be less intuitive. For 
example it is unclear whether all cells will be binned into uniform high expression or 
binned into various levels of intermediate expression.  Nevertheless, these assays will 
delineate in which direction each NAP biases the switch (i.e., less variable for an lrp 
mutation and likely more variable for an hns mutation).   
To determine whether it may be possible to enrich for cells with the H-NS and 
Lrp switch locked into an Lrp predominated phase, providing additional support that 
there is some degree of stochasticity to tos operon expression, a transcriptional fusion of 
the tos operon with an antibiotic resistance cassette could be engineered, the E. coli 
culture treated with the respective antibiotic, and the cells resistant to antibiotic screened 
for TosA production.  With some additional knowledge about the E. coli input titer, an 
estimate of the number of cell generations, and the final output titer, it would be possible 
to estimate how many cells originally express the tos operon.  This may even allow for 
some estimation of the probability that a cell switches into an Lrp predominating phase of 
tos operon regulation.  The antibiotic may even be added at later time points to determine 
whether more or fewer cells (and the corresponding changes in the above probability) are 
switching into the Lrp predominating phase of tos operon regulation.  Similar assays 
could also be performed in vivo, where antibiotics could be supplemented into the 
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drinking water of mice treated with this construct.  Further entropy studies, examining 
motility and adhesin reciprocal regulation, as outlined below, could also be used to 
further demonstrate whether the state of this nucleoid switch could be enriched in vivo. 
Overexpression of tosEF leads to a decrease in flagella-mediated motility.  This 
finding is consistent with coordination between adhesin and flagellar operons previously 
discussed.  For example, when the tos operon, encoding the TosA adhesin, is expressed 
motility is suppressed.  It is intriguing to note that motility suppression is also attributed 
to the terminal gene of the pap operon, papX (187, 188), which is also regulated to some 
degree by PapB (188).  I found that this tos-related motility suppression is most likely 
mediated through inhibiting FliC synthesis (the main structural component of flagella).  
Thus, the tos operon is the first known E. coli RTX nonfimbrial adhesin operon to be 
integrated into the E. coli reciprocal regulation network (e.g., between adhesins and 
flagellar-mediated motility).  It is important to note, however, that I found that full 
motility suppression is an emergent phenomenon (i.e., it is superadditive).  This motility 
suppression is superadditive owing to the observation that both TosE and TosF together 
are required for full motility suppression, and motility suppression from each regulator 
individually summed together does not equal motility suppression when both regulators 
are present at the same time.  I note, however, that the precise level of TosEF control over 
motility is unknown (i.e., there are multiple levels of flagellar gene regulation) (116-119).  
Thus, gel shift assays must still be performed using purified TosE, TosF, and DNA 
fragments derived from flagellar gene promoters.  To determine whether secondary 
interactions are also important for TosEF-mediated motility suppression, tosEF 
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overexpression and motility assays could be performed in a library of transposon mutants.  
To corroborate these findings, it may also be of interest to perform RNA-Seq experiments 
on this overexpression construct to determine whether suppressor mutants are similarly 
differentially regulated by TosEF and whether motility genes are also differentially 
regulated in these mutants.  ChIP-seq or SELEX (systematic evolution of ligands by 
exponential enrichment) may also be performed to map additional TosEF binding sites.  
It remains unclear, however, why tosEF expressed from the chromosome show 
only a modest decrease in motility compared with tosEF expressed from a multiple copy 
number plasmid and why there is only a modest increase in motility when tosR, tosE, and 
tosF are simultaneously deleted in CFT073.  One intriguing possibility is that additional 
environmental stimuli are necessary to mediate motility suppression (i.e., this 
requirement could be overcome when TosE and TosF are present at high concentrations).  
To test whether environmental cues, especially those supporting tos operon expression, 
supplement TosEF repression of motility, soft agar motility assays may be performed on 
unmarked tosR single mutants, unmarked tosR, tosE, and tosF triple mutants, and wild-
type E. coli CFT073 in the presence of putative stimuli.  In addition, it is also a 
possibility that motility suppression may not be uniform across the CFT073 cellular 
population.  To determine whether this may also be an explanation for TosEF-mediated 
motility repression, a conditional entropy experiment may again be performed.  Cell 
sorting, with gates on TosA and FliC levels, could be performed on the tos operon 
mutants indicated above and wild-type CFT073.  The conditional entropy for FliC 
expression would be expected to decrease at high TosA levels (i.e., less variability in this 
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subpopulation with cells mostly suppressing motility).  These results may then be 
corroborated with cell sorting performed on wild-type cells obtained in vivo.  Consistent 
with the hypothesis that TosEF-mediated motility suppression is not uniform across the 
CFT073 population, cell sorting of unmarked tosR mutants will also be expected to reveal 
a conditional entropy higher at some TosA levels (i.e., motility suppression may be 
incomplete).  TosR overexpression assays, again explored with cell sorting and 
conditional entropy for FliC levels at specific TosR levels in both wild-type and tosEF 
mutant strains, could be performed to further connect tos operon regulation with E. coli 
reciprocal regulation. 
To my surprise, TosR also negatively regulates P fimbria synthesis and positively 
regulates E. coli biofilm components (curli and/or cellulose).  Such cross-regulation 
occurs between other homologous PapB family members (203, 204, 249, 250).  TosR, on 
the other hand, does not share significant homology with PapB; the two regulators only 
share 27% predicted amino acid sequence identity.  Nevertheless, this shows that even 
nonfimbrial adhesin operons could be involved in the reciprocal regulation between 
adhesin genes.  Intriguingly, ectopic expression of tosR results in an increased production 
of E. coli biofilm components (curli and/or cellulose).  To my knowledge, this is also the 
first instance of a cognate regulator of an RTX nonfimbrial adhesin operon participating 
in cross-regulation between adhesin genes and the first instance of a PapB family 
member regulating curli and/or cellulose synthesis.  Thus, adhesin operon reciprocal 
regulation is generalizable to other adhesin operons.   
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To further demonstrate whether TosR is a repressor of the pap operon, a qRT-
PCR assay may be performed on transcripts derived from cells overexpressing TosR.  To 
map the TosR binding sites in the vicinity of PpapBA and determine whether these binding 
sites overlap other regulatory sequences, gel shift assays could again be performed with 
shorter segments of this promoter region.  It will also be informative to explore whether 
TosR could regulate other adhesin operons (e.g., fim and foc operons).  To determine 
whether this additional regulation is possible, the same assays above could be used.  As E. 
coli does not simultaneously express all of its adhesin operons (251, 252), it is intuitive 
that adhesin regulators may also promote this phenotype and variability in the cell 
population (i.e., not all cells will express exactly the same adhesins at exactly the same 
time).  Although unintuitive, to test this hypothesis a cell sorting conditional entropy 
experiment could again be conducted to demonstrate whether low entropy in expression 
is observed among other adhesins (e.g., pap, fim, and foc operons) when TosA levels are 
high.  To demonstrate the importance of this phenotype during an infection, the same 
assay could also be conducted on UPEC bacteria collected during a murine experimental 
infection. 
To determine whether TosR directly binds in the vicinity of curli and/or cellulose 
synthesis operon promoters, gel shift assays could be performed using TosR-His6, PcsgD, 
PcsgBA, and PbcsA.  Additionally, to demonstrate whether TosR transcriptionally activates 
expression of the csg and bcs operons, qRT-PCR assays could be utilized in conjunction 
with ectopic expression of tosR.  In addition, to determine whether additional proteins 
contribute to TosR-mediated curli and/or cellulose production, Congo red binding assays 
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on YESTA (yeast extract and tryptone agar) plates could be performed with ectopic 
expression of tosR in a library of UPEC CFT073 transposon mutants.  Likewise, to 
analyze the conditional entropy of tosR expression (expressed from a plasmid) in addition 
to the tos, curli, cellulose, and flagellar operons, transcriptional fusions of genes encoding 
fluorescent proteins could be engineered in association with tosR expression or the 
expression of each operon above.  High-resolution microscopy could be utilized in a 
manner similar to another rugose biofilm study (234), and a frequentist approach to 
probability could be used to determine the conditional entropy of tos, curli, and cellulose 
operon expression.  This assay will also allow for a determination of the coincidence of 
expression of tosR and the other operons above, within a rugose biofilm (i.e., a situation 
with low conditional entropy).  To further our understanding of these structures in terms 
of gene expression and the behaviors of component cells, the conditional entropy of the 
expression of tosR with the other operons above could be mapped within the geography 
of the rugose biofilm.  FISSEQ and SeqFISH (470, 471), in conjunction with conditional 
entropy, could be utilized to estimate the state of the nucleoid (i.e., switched into an 
H-NS or Lrp predominating state) of cells associated with a rugose biofilm.  As ectopic 
expression of focB also promotes UPEC CFT073 weak Congo red binding, additional 
ectopic expression assays using other PapB family members and YESTA plates 
containing Congo red could be performed.  To determine whether FocB and other PapB 
family members promoting UPEC CFT073 binding to Congo red do function similarly to 
TosR, all of the above assays in this section could be repeated with the aforementioned 
PapB family members replacing TosR.        
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Finally, it was demonstrated in this work and elsewhere that NAPs H-NS and Lrp, 
making up the switch that regulates the tos operon, also make contributions to the switch 
between adherent and motile lifestyles (148, 179, 181, 202, 204, 279, 348, 351, 352, 354, 
355, 371-378).  In particular, H-NS mediates dual regulation of motility-related genes 
and negative regulation of adherence-related genes (148, 179, 181, 202, 326, 351, 354, 
371-379, 381).  Lrp mediates dual regulation of adherence-related genes and negative 
regulation of motility-related genes (148, 179, 202, 204, 279, 348, 352, 354, 355).  Thus, 
while both NAPs are global regulators (42, 105, 152, 179, 183, 250, 296, 326, 346-355, 
370, 372, 375, 377, 378, 385-389), symmetry may be maintained between E. coli cells in 
the population (i.e., H-NS mutants almost always have reduced motility, and Lrp mutants 
have lower expression of some adhesins).  In this same pursuit, from this work it appears 
that typical E. coli reciprocal regulation between adhesin genes and between adhesin and 
motility genes requires NAPs.  Indeed, the reduced motility of the UPEC strain CFT073 
hns mutant cannot be suppressed by an additional lrp mutation.  Surprisingly, PapA 
levels are dramatically decreased in the UPEC strain CFT073 hns and lrp double mutant, 
while TosA levels remain high.  Expression from PpapBA was previously observed in 
another hns and lrp double mutant E. coli strain not harboring the tos operon (354, 371).  
Therefore, some elements of adhesin reciprocal regulation are abrogated in nucleoid 
structuring mutants, as I predict that the TosA adhesin simply dominates over P fimbria 
in the cell population (i.e., little opportunity may exist to switch between adhesins).  To 
further determine whether the switch between nucleoid state, manifesting as a switch 
between E. coli lifestyles (e.g., adherent and motile), is similarly important in vivo, the 
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same tos operon antibiotic resistance cassette transcriptional fusion discussed above 
could be used to determine the conditional entropy of FliC, PapA, and other adhesins 
during experimental murine UTI.  This would not only provide an additional control for 
the same transcriptional fusion experiment described above, but to my knowledge be the 
first assay to directly demonstrate a nucleoid switch phenomenon underpinning E. coli 
reciprocal regulation during an experimental infection.  To my knowledge, this would 
also be the first experiment to provide evidence in strong support of reciprocal regulation 
at the single cell level in vivo.   
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APPENDIX A: 
TOSR VARIANTS 4 AND 5 ARE HARBORED ON A PUTATIVE  
SELF-TRANSMISSIBLE PLASMID 
 
 
 To verify that our developed project R search algorithm for GC content described 
in Chapter 2 identified correct tos operon sequences, a determination of the distance 
between the start and end of the tos operon was included (i.e., start nucleotide position of 
the operon subtracted from the last nucleotide position).  For some tos operons encoding 
TosR variants 4 and 5 this distance was negative (Table A-1), which suggests that the tos 
operon sequences ended before it began (i.e., the contig harboring the tos operon was a 
circular molecule).  Subsequent analysis revealed that tra genes and plasmid stability 
genes are also harbored on these contigs, which overwhelmingly supports the conclusion 
that these tos operons are on a self-transmissible plasmid.  
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Table A-1.  TosR variants predicted to be encoded on a self-transmissible plasmid.  
UPEC Strain TosR Variant Distance between tosC and tosAa 
HVH 21 TosR Variant 4 -124,599 bp 
HVH 138 TosR Variant 4 -109,149 bp 
KOEGE 131 TosR Variant 5 -93,424 bp 
a Start nucleotide position of tosC gene subtracted from the last nucleotide position of 
tosA  
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APPENDIX B: 
tosEF OVEREXPRESSION DOES NOT RESULT IN TOSA PRODUCTION 
 
 
 To determine whether tosEF overexpression could result in TosA production, 
suggesting that one or both of these regulators are involved in positive regulation of the 
tos operon, we performed pBAD-tosEF ectopic expression assays in wild-type UPEC 
strain CFT073 cultured in LB containing ampicillin (100 µg/mL) and a variety of L-
arabinose concentrations for 4 hours.  Western blotting using polyclonal anti-TosA 
antibodies blots on total proteins derived from the above constructs revealed that TosEF 
do not mediate TosA production, despite ectopic expression of these regulators (Figure 
B-1).  Thus, we conclude that TosEF are not involved in simple positive regulation of the 
tos operon. 
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Figure B-1. TosEF are not positive regulators of the tos operon.  A Western blot was 
performed using total proteins obtained from wild-type UPEC CFT073 harboring pBAD-
tosEF induced with the indicated concentrations of L-arabinose.  Bands corresponding to 
TosA were detected with polyclonal anti-TosA antibodies.  An X indicates a cross-
reacting band.  
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APPENDIX C: 
THE PHAGE TRANSDUCED, UNMARKED tosR MUTATION IN  
UPEC STRAIN CFT073 DOES NOT OVERPRODUCE TOSA 
 
 
 To determine whether phage transduction of the tosR mutation along with 
unmarking the construct could reveal contributions of secondary mutations to tos operon 
overexpression observed in Chapter 2, phage transduction and Western blotting with 
polyclonal anti-TosA antibodies were performed as outlined in Chapter 2.  It was 
revealed that this engineered construct did not overproduce TosA (Figure C-1), in 
contrast to the first unmarked tosR mutation (Figure 2-3C).  This suggests that a 
secondary mutation could contribute to the tos operon overexpression phenotype 
observed in the previously unmarked tosR mutation.  Indeed, subsequent 5’ RACE (rapid 
analysis of cDNA ends) performed on the first unmarked tosR mutation revealed that this 
unmarked mutation was also an inversion mutation with a previously unmarked lacZ 
mutation.  This may confound some conclusions from the original unmarked tosR 
mutation discussed in Chapter 2. 
   
 
 
169 
 
 
 
 
 
Figure C-1.  The transduced, unmarked tosR mutation does not lead to 
overproduction of TosA.  A Western blot was performed using total proteins obtained 
from a ΔtosRΔaph UPEC CFT073 strain (derived from a tosR mutation transductant).  
TosA was detected with a polyclonal anti-TosA antibody, and bands corresponding to 
TosA are indicated in the figure.  Equal amounts of proteins were loaded as determined 
using a Pierce BCA Protein Assay kit. 
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APPENDIX D: 
THE AREA IN THE VICINITY OF Ptos IS PREDICTED TO BE SIMILARLY 
BENT TO THE AREA IN THE VICINITY OF PpapBA 
 
Modified from: M. D. Engstrom and H. L. T. Mobley. 2016. Infection and Immunity 
84: 811-21.  
 
To determine whether regulation of the tos operon has elements similar to 
regulation of the pap operon, we utilized a web-based tool 
(http://www.lfd.uci.edu/~gohlke/dnacurve/) to predict DNA structure in the vicinity of 
Ptos and PpapBA (Figures D-1A and 1B).  Indeed, both Ptos (Figure D-1A) and PpapBA 
(Figure D-1B) regions are similarly bent.  Thus, it seems likely that a PapB family 
member, H-NS, and Lrp could potentiate tos operon regulation.  In addition, a region of 
DNA in the vicinity of PlacZ, unrelated to both Ptos and PpapBA, does not exhibit a curved 
architecture (Figure D-1C).    
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Figure D-1.  An AT-rich region near Ptos is predicted to be bent similar to a 
corresponding region near PpapBA.  (A) A predicted DNA curvature plot of a region near 
Ptos, obtained from http://www.lfd.uci.edu/~gohlke/dnacurve/ using an AA Wedge Model 
and oriented in the 5’ to 3’ direction, is indicated.  (B) The same web-based tool as above 
was used to generate a predicted DNA curvature plot of a region near PpapBA.  (C) The 
predicted DNA curvature plot, modeled using the same methods as above, of the region 
in the vicinity of PlacZ is shown.   
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APPENDIX E: 
NUMEROUS PUTATIVE REGULATORY SEQUENCES ARE FOUND IN THE 
VICINITY OF Ptos 
 
Modified from: M. D. Engstrom and H. L. T. Mobley. 2016. Infection and Immunity 
84: 811-21.  
 
 To determine whether predicted H-NS- (258, 456) and Lrp-sites (358) could be 
found in the vicinity of Ptos, this region was searched for these predicted high affinity 
sites.  A BLASTN search was also conducted to map putative additional binding sites.  
We found, in addition to predicted TosR binding sites, putative high affinity H-NS 
binding sites and clusters of Lrp binding sites (Figure E-1).  In addition, a putative CitB 
binding site (457) was also found near Ptos.  Thus, multiple regulatory systems may be 
involved in tos operon regulation. 
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Figure E-1.  H-NS and Lrp binding sites are predicted in the vicinity of Ptos.  
Predicted H-NS binding sites are marked with a red bar; predicted Lrp binding sites are 
marked with black bars; the predicted strong and weak TosR binding sites are denoted 
with blue bars; a predicted CitB binding site is denoted with a white bar; Ptos is indicated 
with a green bar, and the predicted transcriptional start site is denoted with a  “+1” and 
hooked arrow.  
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APPENDIX F: 
LEUCINE AND NUCLEOID STRUCTURE PERTURBATIONS POTENTIALLY 
CONTRIBUTE TO tos OPERON REGULATION DURING HUMAN UTI 
 
 
To determine whether TosR-mediated regulation of the tos operon could be 
modulated by the addition of exogenous leucine to LB medium, we performed pBAD-
tosR ectopic expression assays in wild-type UPEC CFT073 cultured in LB containing 
ampicillin (100 µg/mL) and 0.6 mM L-arabinose for 4 hours with and without additional 
exogenous leucine (Figure F-1).  From this work, TosR-mediated expression of the tos 
operon is inhibited by additional exogenous leucine.  In agreement with exogenous 
leucine being important for tos operon negative regulation, several genes expected to be 
downregulated by Lrp-leucine were generally upregulated in clinical UTI RNA-Seq 
experiments (Table F-1), and several genes expected to be upregulated by Lrp, but 
inhibited by leucine, were also generally upregulated in the human urinary tract (Table 
F-2) (32).  This suggests that leucine levels are low in vivo.  Likewise, in the same RNA-
Seq experiment, it was revealed that a number of genes downregulated by H-NS, like the 
tos operon, were similarly generally upregulated in vivo (Table F-3).  This suggests that 
H-NS-mediated negative regulation is less prominent in the human urinary tract, which is 
a condition that supports tos operon expression. 
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Figure F-1.  Exogenous L-leucine negatively regulates TosR-mediated tos operon 
positive regulation.  A Western blot was performed using total proteins obtained from 
wild-type UPEC CFT073 harboring pBAD-tosR-His6 induced with 0.6 mM L-arabinose 
in the presence of the indicated concentrations of additional L-leucine in LB medium.  
Bands corresponding to TosA were detected with polyclonal anti-TosA antibodies.  
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Table F-1.  Clinical UTI genes downregulated by Lrp in the presence of leucine. 
 
UPEC Strain Gene Log2(UR/LB)a* Log2(UTI/LB)b* Log2(UTI/UR)c* 
HM26 livK 7.56 10.02 2.47 
 livJ 4.54 7.59 3.06 
 brnQ 2.61 5.67 3.06 
HM27 livK 7.54 8.48 0.94 
 livJ 5.02 5.60 0.58 
 brnQ 1.94 3.95 2.01 
HM46 livK 8.84 7.63 -1.21 
 livJ 5.08 5.53 0.45 
 brnQ 1.93 2.94 1.01 
HM65 livK 6.24 2.15 -4.09 
 livJ 1.70 2.79 1.09 
 brnQ -0.06 2.30 2.36 
HM69 livK 6.79 3.66 -3.13 
 livJ 5.17 1.38 -3.79 
 brnQ 2.26 3.10 0.84 
a Log2 transformed fold increase of gene expression in urine compared to LB 
b Log2 transformed fold increase of gene expression in human UTI compared to LB 
c Log2 transformed fold increase of gene expression in human UTI compared to urine 
*A log2 transformed fold change <-2 or 2< is considered differentially expressed 
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Table F-2.  Clinical UTI genes upregulated by Lrp in the absence of leucine. 
 
UPEC Strain Gene Log2(UR/LB)a* Log2(UTI/LB)b* Log2(UTI/UR)c* 
HM26 htrE 1.27 6.38 5.11 
 stpA 2.17 4.88 2.71 
 serB -0.32 4.24 4.56 
 lolC 0.95 4.91 3.96 
HM27 htrE 0.13 3.20 3.07 
 stpA 1.49 4.19 2.70 
 serB -0.21 3.10 3.32 
 lolC -0.08 3.73 3.81 
HM46 htrE 0.46 5.21 4.75 
 stpA 2.01 3.85 1.84 
 serB 0.18 1.69 1.51 
 lolC -0.26 1.23 1.48 
HM65 htrE 1.75 1.11 -0.65 
 stpA 1.99 2.45 0.46 
 serB -2.43 -0.68 1.75 
 lolC -2.63 -2.42 0.21 
HM69 htrE -0.63 0.27 0.90 
 stpA 2.12 4.32 2.20 
 serB -0.35 1.29 1.64 
 lolC -0.91 1.64 2.55 
a Log2 transformed fold increase of gene expression in urine compared to LB 
b Log2 transformed fold increase of gene expression in human UTI compared to LB 
c Log2 transformed fold increase of gene expression in human UTI compared to urine 
*A log2 transformed fold change <-2 or 2< is considered differentially expressed 
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Table F-3.  Clinical UTI genes downregulated by H-NS. 
 
UPEC Strain Gene Log2(UR/LB)a* Log2(UTI/LB)b* Log2(UTI/UR)c* 
HM26 fis -0.38 2.19 2.58 
 hdfR -0.23 4.26 4.50 
 rcsD 0.48 2.50 2.02 
 papA —   —   —   
 fimA 0.73 4.21 3.48 
 csgA 1.79 7.31 5.52 
HM27 fis -1.43 2.26 3.68 
 hdfR 0.51 4.13 3.63 
 rcsD 0.49 2.54 2.05 
 papA 2.00 -0.48 -2.48 
 fimA 0.71 7.44 6.73 
 csgA 1.66 5.58 3.92 
HM46 fis -0.69 3.34 4.04 
 hdfR -0.58 2.08 2.66 
 rcsD -0.09 0.79 0.87 
 papA — — — 
 fimA 0.31 0.39 0.08 
 csgA 1.52 3.83 2.31 
HM65 fis -5.85 -4.83 1.03 
 hdfR 0.49 1.59 1.10 
 rcsD 1.81 2.14 0.32 
 papA — — — 
 fimA -3.56 -0.21 3.35 
 csgA -2.31 -0.13 2.18 
HM69 fis 0.06 3.15 3.09 
 hdfR -0.46 1.67 2.13 
 rcsD -0.23 1.01 1.24 
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 papA -0.20 7.70 7.90 
 fimA 0.30 -2.89 -3.19 
 csgA 1.05 -0.35 -1.40 
a Log2 transformed fold increase of gene expression in urine compared to LB 
b Log2 transformed fold increase of gene expression in human UTI compared to LB 
c Log2 transformed fold increase of gene expression in human UTI compared to urine 
*A log2 transformed fold change <-2 or 2< is considered differentially expressed 
— Gene is not encoded by this UPEC strain 
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APPENDIX G: 
TOSR POSITIVELY REGULATES CURLI AND/OR CELLULOSE 
PRODUCTION IN UPEC STRAIN CFT073 
 
 
 To determine whether ectopic expression of tosR mediates curli and/or cellulose 
production, showing that other adherence-mediating components may be under TosR 
regulation, UPEC strain CFT073 harboring pBAD-tosR-His6, pBAD-papB, pBAD-focB, 
or the empty pBAD plasmid were spotted onto YESTA (yeast extract and tryptone agar) 
Congo red plates (10 g/L tryptone, 1 g/L yeast extract, 15 g/L agar, 50 µg/mL Congo red, 
and 1 µg/mL Coomassie Brilliant Blue G-250) containing ampicillin (100 µg/mL) and 10 
mM L-arabinose.  After incubation for 48 hours at 37 °C, strain CFT073 harboring 
pBAD-tosR-His6 strongly exhibits the rdar (red, dry, and rough) phenotype (Figure G-
1A).  This suggests curli and/or cellulose were produced by a UPEC CFT073 strain that 
expressed tosR (230-233).  Thus, production of E. coli biofilm components may be 
coordinated with TosA synthesis and further underscores how tos operon regulation may 
be coordinated with other adherence-mediating components.  In addition, ectopic 
expression of focB also weakly promotes UPEC CFT073 binding of the Congo red dye 
(Figure G-1B), which suggests that FocB, and possibly other PapB family members, 
may coordinate synthesis of curli and/or cellulose with other adhesins.  
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Figure G-1.  Ectopic expression of TosR and FocB promote curli and/or cellulose 
synthesis.  (A) After 48 hours of incubation at 37 °C on a YESTA (yeast extract and 
tryptone agar) plate containing 40 µg/mL Congo red, 1 µg/mL Coomassie Brilliant Blue 
R-250, ampicillin (100 µg/mL), and 10 mM L-arabinose, UPEC CFT073 harboring 
pBAD-tosR-His6 exhibits the rdar (red, dry, and rough) phenotype indicative of curli 
and/or cellulose production.  The CFT073 strain harboring the empty pBAD plasmid 
does not bind the Congo red dye.  (B) After 48 hours of incubation under the same 
conditions as above, UPEC CFT073 harboring pBAD-tosR-His6 exhibits the rdar 
phenotype.  UPEC CFT073 harboring pBAD-focB weakly binds the Congo red dye, 
which suggests low production of curli and/or cellulose.  The CFT073 stains harboring 
pBAD-papB and the empty pBAD plasmid do not bind the Congo red dye. 
 
 
 
 
 
183 
 
APPENDIX H: 
RECIPROCAL REGULATION OF ADHESIN- AND MOTILITY-RELATED 
GENES IS ABROGATED IN UPEC STRAIN CFT073 hns AND lrp MUTANTS 
 
 
 To determine whether fliC expression, reduced in an H-NS mutant (375, 376), 
could be restored with the additional mutation of lrp [a mutation previously observed to 
enhance motility (355)], we performed Western blots on whole cell proteins obtained 
from wild-type CFT073, ∆hns, ∆lrp, and ∆hns∆lrp using anti-FliC antibodies (Figure H-
1A).  FliC levels cannot be restored in the ∆hns∆lrp background.  Likewise, to determine 
whether reciprocal regulation between adhesins is possible in the CFT073 ∆hns∆lrp (a 
background suggested to favor pap operon expression), we performed a pBAD-tosR-His6 
overexpression assay (Figure H-1B).  Unexpectedly, PapA levels were low regardless of 
ectopic expression of tosR, which suggests that adhesin reciprocal regulation is abolished 
(i.e., I hypothesize that the mechanism to ensure some expression of alternative adhesin 
operons is lost without H-NS and Lrp).   
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Figure H-1.  H-NS and Lrp serve a key function mediating reciprocal regulation 
between adhesin- and motility-related genes.  (A) A Western blot was performed using 
total proteins obtained from the indicated CFT073 strains cultured in tryptone medium.  
Bands corresponding to FliC were detected using polyclonal anti-FliC antibodies.  (B) A 
Western blot was performed using total proteins obtained from the CFT073 ΔhnsΔlrp 
mutant harboring pBAD-tosR-His6 induced with the indicated concentrations of L-
arabinose in LB medium.  Polyclonal anti-PapA antibodies were used to detect PapA.  
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